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Embryonic stem (ES) cells are featured by their ability of self-renewal and 
pluripotency. Although external signalling pathways as well as epigenetic 
signatures have been shown necessary for ES cells maintenance, considerable 
evidence indicates that naïve pluripotency of ES cells is dependent on their 
specific transcription network that regulate the gene expression programs in a 
spatially and temporally orchestrated and precise pattern. Delineating the 
transcription network within ES cell system should be a fascinating science 
challenge that would provide new insights into the fundamental nature of 
pluripotency as well as advance its application in regenerative medicine. My 
thesis project has applied computational and systems biology tools to dissect 
transcriptional network of mouse ES cells, and has extensively expanded our 
knowledge of the network by introducing novel self-renewal and pluripotency 
associated transcription factors into the known core regulatory circuit. 
Furthermore, I looked into coactivators that facilitate the functions of 
transcription factors and further linked coactivator regulation to higher-order 
chromatin structure. This is the first study of in vivo higher-order chromatin 
organization that is unique to pluripotent cells based on the binding sites of 
transcription factors and coactivators, adding a new content to the list of  
unusual findings regarding the chromatin structure in ES cells as well as a new 
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CHAPTER I: Literature review 
 
1.1 Derivation and culture of pluripotent stem cells 
Although the era of embryonic stem (ES) cells is considered to begin officially 
in 1981, when mouse ES cells were first isolated and successfully cultured in 
vitro as self-renewal and pluripotent cell lines by two groups (Evans and 
Kaufman, 1981; Martin, 1981), the adventure to search for exogenous cells 
that are capable of recapitulating early embryogenesis had started earlier. At 
the beginning, researchers had tried to manipulate early mouse embryogenesis 
by embryonal carcinoma cells (EC) cells. EC cells are the pluripotent stem 
cells from teratocarcinomas, which are highly malignant tumors that 
occasionally occur in a gonad of a fetus and are comprised of a mixture of a 
large population of undifferentiated cells and differentiated cells of multiple 
lineages. EC cells could be maintained indefinitely with mitotically inactivated 
embryonic fibroblast in vitro, and is able to give rise to cells of multiple 
lineages (Finch and Ephrussi, 1967). However, further studies have found out 
that EC cells were karyotypically abnormal or unable to differentiate normally 
(Berstine et al., 1973; Papaioannou et al., 1975), which led to the efforts to 
isolate a new type of stem cells, embryonic stem cells, from the mouse 
embryo.  
Embryonic stem cell lines are derived from the inner cell mass (ICM) of the 
mouse blastocyst at embryonic day 3.5 (E3.5). These cells were initially 
maintained in culture as self-renewal and pluripotent cell lines in either EC 
cell-conditioned medium (Martin, 1981), or in a co-culture system in which 
cells were grown on a layer of mitotically inactivated mouse embryonic 
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fibroblast (MEF) feeder population in the presence of blood serum (Evans and 
Kaufman, 1981). Since medium conditioned by feeder cells is sufficient to 
sustain the self-renewal and pluripotent state of mouse ES cells, the presence 
of a diffusible factor has been postulated. Further research has found out that 
under serum-free culture conditions, specific cytokines promoted the 
maintenance of ES cells. Leukaemia inhibitory factor (LIF) and bone 
morphogenetic protein 4 (BMP4), a member of the transforming growth factor 
(TGF) β family, were required to sustain ES cells indefinitely in culture 
(Chambers and Smith, 2004; Ying et al., 2003), as in the absence of them, ES 
cells identity cannot be preserved, which led to profound differentiation. 
Similar to mice, ES cells have also been established from other primates 
(Thomson and Marshall, 1998), and the extensive studies and characterization 
of these ES cells finally led to the derivation of human ES cells, which hold 
tremendous potential for the development of cell transplantation therapies for 
regenerative medicine and the treatment of various human diseases. The first 
successful human ES cell line was derived by Thomson group (Thomson et 
al., 1998). They isolated human ES cells from the blastocyst derived from day 
5 to day 8 blastocysts after in vitro fertilization (IVF) and plated them onto 
mitotically inactivated MEF cells. Under in vitro conditions, they exhibit the 
prolonged undifferentiated proliferation and differentiation potential, which 
are the two basic characteristics of ES cells. Two years later, Reubinoff et al. 
(Reubinoff et al., 2000) confirmed that human ES cells could be efficiently 
derived from surplus embryos. Since then, rapid progress has been achieved 
and numerous studies have described the derivation of new human ES cell 
lines and optimized the methods of growing undifferentiated human ES cells. 
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Similar to mouse ES cells, human ES cells can also be cultured under feeder 
free conditions, however, instead the requirement of LIF and BMP4, human 
ES cells rely on Activin and FGF2 for the maintenance, suggesting that mouse 
ES cells may not be equivalent to human ES cells in the developmental stage.  
In fact, besides culture conditions, human and mouse ES cells differ in a few 
other aspects, such as morphology, gene expression profile and epigenetic 
landscapes, as shown in Table 1.  
Table 1.1: Comparison of mouse and human ES cells. 
      
4 
 
Recently, Brons et al., (2007) demonstrated that pluripotent stem cells may be 
derived from the late epiblast layer (embryonic day 5.5–7.5) of post 
implantation mouse embryos, and these cells are called EpiSCs (post-
implantation epiblast derived stem cells) (Brons et al., 2007). These cells 
display profound differences from mouse ES cells in the combination of 
growth factors that maintain their pluripotent states. They can only be cultured 
using chemically defined media supplemented with FGF2 and Activin, and 
they display flat colony morphology, which resemble the culture conditions 
and morphology of human ES cells. More importantly, upon stimulation by 
Activin and Fgf2, mouse ES cells can develop to EpiSCs, indicating that 
EpiSCs are in a more advanced developmental stage than are ES cells and it 
may be at the same developmental stage as human ES cells. Although EpiSCs 
are able to form teratomas, they contribute very little to the germline in 
chimeric mice.   
FAB-SCs, another form of pluripotent stem cells, can be derived from mouse 
blastocysts in the presence of bFGF, activin, BIO (which is a GSK3 kinase 
inhibitor) and an anti-LIF antibody (Chou et al., 2008). These cells cannot 
differentiate as mouse ES cells unless stimulated by LIF and BMP4 or force 





Figure 1.1. Origin of stem cells during mammalian embryogenesis. In this 
figure, the pluripotent cells of the embryo are tracked in green. From left to 
right, the morula-stage mouse embryo (embryonic day 2.5; E2.5) holds a core 
of pre-ICM cells that turn into ICM cells at cavitation/blastulation (E3–E4). At 
this stage, ES cell and Trophoblast stem (TS) cell lines can be derived in vitro, 
and implantation occurs in vivo. FAB-SCs can be derived from mouse 
blastocysts in combination of bFGF, activin, BIO and an anti-LIF antibody.  
As the blastocyst fully expands (and undergoes implantation in vivo), the ICM 
delaminates giving rise to a primitive ectoderm and a primitive endoderm 
layer. At this stage, pluripotent cell lines that are known as embryonal 
carcinoma (EC) cells can be derived from the primitive ectoderm. EpiSCs are 
derived from E5.5–E5.75 post-implantation epiblasts in the presence of activin 
and bFGF. At E6 and subsequent stages, the experimental ability to derive ES 
Cells, TS cells and EC cells from the mouse embryo is progressively lost, and 
the in vivo embryo will start gastrulating. (Adapted from Bioani and Sholer et 
al. 2005) 
 
Another source of pluripotent stem cells is provided by induced pluripotent 
stem cells (iPSCs) from somatic cells by enforced expression of a few 
pluripotency-associated transcription factors. The discovery of induced 
pluripotency can be traced back to the work of somatic cell nuclear transfer 
(SCNT) that first established by Briggs and King (Briggs and King, 1952; 
King and Briggs, 1955). The cloning of Dolly sheep further showed that the 
genome of even terminally differentiated cells preserve the potential to 
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develop into an entire organism (McLaren, 2000; Wilmut et al., 1997). 
However, SCNT is technically challenging and the cloned animals always 
exhibit abnormalities in gene expression and phenotype. An alternative 
approach is developed by in vitro hybridization between somatic and 
pluripotent cells. The hybrid cells by fusion of EC cells with somatic cells, 
such as thymocytes, resemble EC cells in terms of biochemical properties and 
differentiation potential, while lose the features of somatic cells (Miller and 
Ruddle, 1976, 1977), indicating that some soluble regulatory factors in EC 
cells confer a pluripotent state to somatic cells. However, hybrid cells lack 
therapeutic potential because of their abnormal ploidy and the presence of 
nonautologous genes from the pluripotent parent. A great breakthrough was 
achieved by Yamanaka and Takahashi in 2006 (Takahashi and Yamanaka, 
2006). The original idea was to induce pluripotency from somatic cells by 
enforced expression of specific transcription factors, which was based on the 
observation that lineage-associated transcription factors were able to change 
the cell fate when ectopically expressed in certain heterologous cells (Davis et 
al., 1987; Laiosa et al., 2006; Xie et al., 2004; Zhou et al., 2008). To induce 
pluripotency, they performed an elegant screen for factors within a pool of 24 
pluripotency-associated candidate genes and came out a core set of four genes, 
Oct4, Sox2, Klf4 and c-Myc, called “Yamanaka genes”, which are minimally 
required to be enforced expressed for reprogram mouse fibroblasts to iPSCs. 
The resultant mouse iPSCs have passed the most stringent test of pluripotency, 
tetraploid complementation, a technique in which iPSCs are injected into a 
tetraploid blastocyst and are shown to contribute to the generation of an entire 
living mouse (Kang et al., 2009; Zhao et al., 2009). The iPSCs field has 
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progressed at a breathtaking pace in the last 5 years, including derivation of 
iPSCs from other species, such as human; optimization of the efficiency of 
iPSCs generation; development of virus-free factors delivery system and 
establishment of disease-specific iPSCs. In addition to being an exciting 
academic research model to study cellular development, iPSCs hold 
significant therapeutic potential for regenerative medicine, disease modeling 
and drug development. Notwithstanding these achievements, iPSCs 
technology remains in its infancy and a better understanding of the 
reprogramming process is required in order to develop more efficient 
strategies for pluripotency induction and a careful analysis of the genomic and 
epigenomic characteristics of iPSCs, as well as the development of a robust 
protocol for directed differentiation are required for future utilities of iPSCs in 
clinic medicine. 
Although different types of pluripotent stem cells have been generated and 
broadly expand our knowledge for pluripotency, the biggest challenge remains 
to produce mature, functional and pure derivatives of cell types that can be 
utilized for transplantation purposes. To facilitate these developments, a large 
amount of efforts is put to get a comprehensive understanding of the biology 
of ES cells including genes that are important for the maintenance of ES cells, 
especially human ES cells. However, due to the ethical challenge of the source 
of human ES cells and the inability to test pluripotency of human ES cells by 
chimera formation, extensive work has been carried out initially on mouse ES 
cells. Mouse ES cells are easier to manipulate and have been extensively 
characterized for 20 more years than human ES cells; therefore the discovery 
on mouse ES cells will eventually shed light on the understanding of human 
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ES cells. In my thesis work, I focus all my studies on mouse ES cells, and 
particularly on the transcriptional regulation of these cells, to understand the 
molecular mechanisms underlying pluripotency. 
 
1.2 Characteristics of mouse embryonic stem (ES) cells 
Mouse ES cells are well known for two distinguished properties: self-renewal 
and pluripotency. Self-renewal is the ability of ES cells to proliferate 
continuously in culture in undifferentiated state (Smith and Benchimol, 1988). 
More importantly, unlike EC cells and other primary cell lines that can only be 
passaged for several times before senesce, these cells can be passaged for 
years while maintaining normal karyotypes (Keller, 2005).   
The second property of ES cells is that they recapitulate full developmental 
potential when injected into mouse blastocysts, contributing cells to all three 
germ layers and to the germline of chimeric animals. It is known as 
pluripotency, which has attracted huge interest of numerous researchers 
because of its promising applications in regenerative medicine. The golden 
rule to judge pluripotency of ES cells is by their ability to integrate into the 
ICM of the blastocysts and contribution to germline formation. So far, 
pluripotency has only be proven conclusively in mouse ES cells, as they can 
completely integrate into the blastocyst, after transplantation, and exhibit high 
efficiency of chimera formation and germline transmission. ES cells can also 
be induced to differentiate in vitro by a number of strategies. By cultivation in 
vitro as 3D aggregates called embryoid bodies (EBs), ES cells can differentiate 
into derivatives of endoderm, mesoderm, and ectoderm. Removal from the 
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self-renewing environment by taking out cytokines, such as LIF or BMP4, 
from culture medium triggers intrinsic differentiation programs that resembles 
a developmental course that was interrupted when the ICM was extracted from 
the blastocyst. Moreover, adding in soluble molecules, such as retinoic acid, 
will stimulate ES cell differentiation as well.  
            
 Figure 1.2. Differentiation of mouse ES cells by EB formation. (A) Mouse 
ES cells cultured under feeder free condition; (B) Embryoid bodies (EB) are 
formed 8 days after suspension culture. (C-E) Examples of mesoderm lineage: 
Cardiomyocytes (C), Skeletal muscles (D) and Smooth muscles (E); (F-H) 
Examples of ectoderm lineage: Neurons (F), Glial (G) and Epithelial (H); (I-L) 
Examples of endoderm lineage: Pancreatic cells (I), Hepatocytes (K-L). 
 
However, the therapeutic use of ES cells will require more precise control 
over this process in order to make these cells differentiate efficiently and 
strictly to a specific lineage. Intensive work has been conducted to the field of 
directed differentiation to influence the lineage commitment of ES cells in 
vitro. Various strategies involving supplementation of growth factor cocktail, 
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cell co-cultures, conditioned medium and specific gene transfection are used 
to drive lineage specific emergence (Fair et al., 2003; Ogawa et al., 2005; 
Wells and Melton, 1999; Zhou et al., 2007c). Nevertheless, the improved 
knowledge of the molecular mechanisms governing ES cell maintenance and 
differentiation towards specific lineage are desired to better facilitate direct 
differentiation of ES cells for therapeutic applications. 
 
1.3 Application of ES cells 
As we have discussed above, the most extraordinary property of ES cells is 
their ability to re-enter embryogenesis. Indeed, a major interest of ES cells to 
the scientific community is their utility as cellular vehicles for engineering of 
the mouse genome. Mouse ES cells can be injected into the blastocysts and 
integrate into the ICM cells to produce viable chimeras. The derivation of 
transgenic mice from genetically modified ES cells was first reported in 1984 
(Bradley et al., 1984). Afterwards, ES cell technology has been most often 
used to produce null mutants (gene knockouts) through homologous 
recombination (Thomas and Capecchi, 1986) for the in vivo study of gene 
function during development and this can even be achieved in a conditional 
knockout manner. Moreover, they can also be used to introduce subtle genetic 
modifications down to the level of single nucleotide mutation in endogenous 
mouse genes. Transgenic mice derived from ES cells has not only 
revolutionized basic biological research through the creation of genetically 
altered animals, but also permits the evaluation of therapeutic strategies in 
models of human disease, as well as the investigation of disease progression in 
11 
 
a manner not possible in human subjects.  
The discovery of human ES cells has been considered as the key tool for 
understanding most of the fundamental questions in both basic and clinical 
human biology. Human ES cells may allow scientists to investigate how early 
human cells become committed to specific lineages and differentiated into the 
myriad functional cell types that build up tissues and organs of the entire body. 
The knowledge gained will greatly accelerate our understanding of the causes 
of birth defects and thus lead directly to their possible prevention. Human ES 
cells can also be applied as a valuable in vitro model system to study diseases 
that only occur in human or have significant difference between human and 
other species, such as HIV, HCV. In the clinic trail, they could be used to 
create an unlimited supply of cells, tissues, or even organs that could be used 
to restore function. Human ES cell-derived progeny have been successfully 
exploited in animal models of spinal cord injury (Keirstead et al., 2005; Sharp 
et al., 2010), retinopathies (Lamba et al., 2009), and Parkinson‟s disease 
(Yang et al., 2008). And this idea is greatly promoted by the generation of 
patient-specific iPSCs. Disease-specific iPSCs have already been created from 
patients suffering from amyotrophic lateral sclerosis (Dimos et al., 2008), 
juvenile onset type 1 diabetes mellitus (Park et al., 2008a), Parkinson‟s disease 
and spinal muscular atrophy (SMA) (Ebert et al., 2009). Critically, the 
pathophysiology of SMA could be recapitulated in motor neurones derived 
from patient-specific iPSCs. In the long run, these patient-specific iPSCs may 
be ideally suited for cellular therapy, given that they are derived from the 
patient to be treated, thus minimizing the risk of immune rejection. However, 
it is noteworthy that these iPSCs, however, are only the starting point for the 
12 
 
preparation of cells for clinic trials, as therapeutic cells should be 
differentiated cell lines with the characteristics proper of the various tissues 
(muscle, neural, epithelial, haematic, germinal, etc.).  Methods for obtaining 
therapeutic cells from human ES cells or iPSCs are still being studied and 
even if successful for some specific cell types, a testing assay to certain that 
the inoculation or therapeutic implant was free of stem cells is also crucial, as 
the remnant stem cells may result in tumors. 
 
1.4. Molecular characteristics of ES cells 
The maintenance of ES cells engages complex and precisely controlled 
molecular and cellular regulatory machinery. While self-renewal and 
pluripotency associated genes are up-regulated to maintain the undifferentiated 
state of ES cells, genes that induce differentiation are suppressed but poised 
for subsequent expression during cellular differentiation. Tremendous effort 
has been applied to uncover the molecular mechanisms governing self-renewal 
and pluripotency in ES cells, and based on our current knowledge, the 
balanced state of ES cells is achieved through the complex interplay of cell 
cycle regulation, signaling pathways, epigenetic modification, small regulatory 
RNAs as well as ES-specific transcriptional network. 
1.4.1. Cell cycle regulation 
Cell cycle program of mouse ES cells is characterized by extraordinarily rapid 
proliferation rate and a pluripotent cell specific cell cycle structure, which is 
controlled by an unusual mode of cell cycle regulation. The work from the last 
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few years has revealed the importance of cell cycle regulation to the 
maintenance of ES cells, as the process of self-renewal requires the 
coordination of cell cycle progression and cell-fate determination (self-
renewal versus commitment). A few transcription factors as well as cell cycle 
regulators appear to be critical to this regulation. 
Mouse ES cells have relatively short cell cycle period compared with 
differentiated cells, with ~8 to 10 hours total generation time, and an unusual 
cell cycle structure, with a reduction in the duration of G1 phase. Although 
human ES cells share a similar cell cycle structure, their generation time is 
significantly slower (~32-38 hours; (Dalton, 2009; Ohtsuka and Dalton, 2008) 
indicating that a short division may not be a pre-requisite for pluripotency. 
This is supported by the study showing that slowing cell cycle of mouse ES 
cells with chemical inhibitors has no measurable impact on the maintenance of 
ES cells (Stead et al., 2002). Instead, other observations suggest that 
mechanisms making up the specific cell cycle structure are more crucial to the 
ES cell maintenance. The short G1 phase allows ES cells to be less responsive 
to the differentiation signals sent by certain mitogenic signaling pathways that 
are active and act as potent differentiation inducer during G1 phase in somatic 
cells. It has been shown that mitogenic signaling pathways inhibit mouse ES 
cells self-renewal and promote their differentiation, while self-renewal of 
mouse ES cells is enhanced by the addition of inhibitors of mitogenic 
signaling pathways to the culture medium (Burdon et al., 2002; Burdon et al., 
1999). Furthermore, the extended S phase may also shield cells from extrinsic 
differentiation signals by maintain chromatin in an “open” euchromatic state 
to facilitate rapid activation or repression of genes (Filipczyk et al., 2007; 
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Herrera et al., 1996).  
                
 
Figure 1.3. The cell cycle of ES cells. The cell cycle of ES cells is shortened 
relative to that of most other cells, which is due to an abbreviated G1 phase. 
For most cells, the transition through early G1 phase requires the accumulation 
of cyclin D, resulting in the hyperphosphorylation of the retinoblastoma 
tumour suppressor protein (RB) by cyclin D–CDK4 or cyclin D–CDK6 
complexes (D/4,6). Inactivation of RB by hyperphosphorylation results in the 
mitogen-independent activity of cyclin E–CDK2 complexes, the defining 
characteristic of late G1 phase. In ES cells, cyclin E–CDK2 (E/2) is 
constitutively active throughout the cell cycle, which allows the transition of 
ES cells from M phase directly to late G1. The resulting absence of the cyclin 
D-dependent early G1 phase shortens the G1 phase and the entire cell cycle. + 
refers to cyclin–CDK activity: +/-, negligible; +, low; ++, intermediate; +++, 
high (Adapted from Orford and Scadden et al., (Orford and Scadden, 2008)). 
 
A direct relationship between cell cycle regulation and master regulators of ES 
cells has recently been described. Oct4 and Sox2 are shown to regulate miR-
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302, which targets cyclin D1, Rb, E2F1 and p130 (Card et al., 2008) and 
Nanog is suggested to be a regulator of G1 to S transition in ES cells through 
regulation of CDK6 and CDC25A, which are key players in the G1 cell cycle 
(Zhang et al., 2009).  
The role of cell cycle regulation in maintaining ES cell identity is further 
emphasized by the study of reprogramming and iPSCs derivation. Myc is one 
of the four “Yamanaka factors” for iPSCs generation. Although subsequent 
studies have demonstrated that Myc is dispensable for the iPSCs recipe, it is 
shown to be critical for the early stages and high efficiency of reprogramming 
as it maintains the cells in a proliferative state in which they respond better to 
the other exogenous factors (Knoepfler, 2008; Zhao and Daley, 2008). Unlike 
other transcription factors in the reprogramming recipe, Oct4, Sox2 and Klf4, 
which have significant functions for maintaining self-renewal and 
pluripotency in ES cells, there is no much evidence indicating the direct 
relationship between the expression level of Myc to the state of ES cells, as no 
developmental defects have been observed in c/N-Myc knockout mice. 
However, there is considerable evidence linking Myc to the cell cycle 
regulation in ES cells. Elevated c-Myc expression accelerates progression 
through G1 by positively regulating cyclin-Cdk activity, whereas ES cells lost 
its specific cell cycle structure during differentiation while the expression of 
Myc is downregulated (Cartwright et al., 2005; White and Dalton, 2005). All 
these data place Myc at the center of a regulatory network linking fundamental 
self-renewal and pluripotency mechanisms to the cell cycle machinery in ES 
cells. 
1.4.2. Small regulatory RNAs 
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Recent research have discovered a large populations of non-coding RNAs 
(ncRNAs), which comprise a large fraction of transcriptome in the cell, and 
many of them have been shown to have important biological functions in a 
wide range of cellular processes. Small ncRNAs are not functioning as 
translated proteins, but able to influence gene expression at post-
transcriptional level. They are mainly in charge of gene suppression or silence 
through partial complementary to one or more messenger RNA (mRNA) 
molecules, generally in 3' UTRs.  
There are three types of ncRNAs have been identified so far, including 
microRNAs, piRNAs and siRNAs, and among them, microRNA is most 
extensively studied in ES cells. MicroRNAs are ~22nt small RNAs found in 
all eukaryotic cells. They suppress gene expression by degradation of target 
mRNA transcripts or inhibition of mRNA translation (Kloosterman and 
Plasterk, 2006). Profiling microRNAs expression in ES cells have identified a 
unique repertoire of microRNAs (Houbaviy et al., 2003; Suh et al., 2004), 
which are not present or exist at very low levels in somatic cells. These ES cell 
specific microRNAs are down-regulated as ES cells differentiate 
(Viswanathan et al., 2008), suggesting their role in the maintenance of ES 
cells. The function of microRNAs in ES cells can be first learned in the 
knockout studies. Dicer (an RNase III-family nuclease critical for microRNA 
generation) knockout mice die at early stages of embryogenesis and Dicer-
deficient ES cells are defective in differentiation (Kanellopoulou et al., 2005; 
Murchison et al., 2005). ES cells deficient for DGCR8, which results in a 
complete absence of mature microRNAs, fail to differentiate properly in 
response to differentiation signals. All these reinforce the important roles of 
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microRNAs pathways in maintaining pluripotency of ES cells. Interestingly, 
members of this set of ES cell specific microRNAs possess the same or similar 
seed motif, indicating common target mRNAs (Gangaraju and Lin, 2009). 
Significantly, recent studies have shed light on the molecular and functional 
interaction between microRNA and core transcriptional circuity in maintaining 
the „stemness‟ of ES cells. Many of the microRNAs are shown to be directly 
regulated by important transcription factors, Oct4, Sox2, Nanog, c-Myc and 
Tcf3 in ES cells (Marson et al., 2008). In turn, these microRNAs were shown 
to inhibit the epigenetic silencing of pluripotency factors (Gangaraju and Lin, 
2009). 
Despite the importance of microRNAs in pluripotency and self-renewal, 
detailed mechanisms and the crosstalk with transcription network remain 
elusive. During differentiation, different set of microRNAs might be induced 
to facilitate the process by down-regulation of pluripotency associated gene. 
Further mechanism studies are required to elucidate the functions of 
microRNAs in both the maintenance and inhibition of pluripotency. 
1.4.3. Epigenetic regulations 
Epigenetic regulation is specifically defined as heritable changes in the 
chromatin structure by mechanisms independent of changes in the primary 
DNA sequence (Surani et al., 2007). As substrate of transcription, chromatin is 
subjected to various forms of epigenetic regulation, including histone 
modification, histone variants, chromatin remodeling, and DNA methylation. 
The crucial role of epigenetics in modulating the transcriptional outcome and 
thereby regulating cell fate decisions has emerged over the last decade. 
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Examination of the epigenetic status of ES cells has identified a number of 
pluripotent cell specific properties that maintain undifferentiated state while 
preserving the ability to respond rapidly to differentiated signals. 
A distinct feature of ES cell chromatin is called „poised‟ state. It is featured at 
specific regulatory sites, particularly those at lineage specific transcription 
factor loci, which appear to be in a silent status but poised for activation in 
response of subsequent signal for differentiation. These loci are 
characteristically associated with both repression marker, histone H3 lysine 27 
tri-methlation (H3K27me) and  activation marker, histone H3 lysine 4 tri-
methylation (H3K4me), consisting a „bivalent domains‟ (Bernstein et al., 
2006). Upon differentiation, the repression marker H3K27me was lost at 
lineage specific transcription factors loci and the expression of those genes 
was activated; whereas the activation marker H3K4me was erased from loci 
that remain silent to eventually repress the expression from those genes. Thus, 
„bivalent domains‟ provide a hyperdynamic and plastic chromatin structure to 
ES cells. It is believed that polycomb group (PcG) proteins are responsible for 
maintaining the repressive state in the „bivalent domains‟. In general, PRC2, 
which is composed of EZH2, SUZ12 and EED, is the complex that initiates 
transcription repression. Loss of Ezh2 or Suz12 causes deficiency in cell 
proliferation in the inner cell mass and early embryonic lethality (Lee et al., 
2006). Genome wide mapping studies of PcG proteins in both human and 
mouse ES cells has demonstrated that the genes regulated by the PcG proteins 
are co-occupied by H3K27me3 markers. These genes are transcriptionally 
repressed in ES cells and are preferentially activated when differentiation is 
induced. Interestingly, the pluripotency factors Oct4, Sox2 and Nanog co-
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occupy a significant fraction of the PcG protein regulated genes (Boyer et al., 
2006a; Lee et al., 2006). The histone variant, H2AZ, is also required for gene 
repression in ES cells. In ES cells, H2AZ is enriched at silenced promoters 
targeted by PcG proteins and H3K27me3 and plays an important role in 
silencing lineage promoting genes (Creyghton et al., 2008).  
 
Figure 1.4. Bivalent chromatin domains in ES cells. Bivalent domains mark 
the promoters of developmentally important genes in pluripotent ES cells. PcG 
proteins proteins catalyze the tri-methylation of histone H3 on lysine 27. As 
such, bivalent genes are said to be silent, yet poised for activation. H2AZ is 
highly enriched in a manner that is remarkably similar to PRC2 and may also 
be an important regulatory component at bivalent genes. Upon differentiation, 
the bivalent histone marks can be resolved to monovalent modifications in 
which the gene is “ON” or “OFF”. Bivalent domains can also be maintained or 
newly established in lineage-committed cells (Adapted from Sha, K. and 
Boyer, L. A. StemBook, 2009). 
 
Besides histone covalent modifiers and histone variant, ATP dependent 
chromatin remodeling enzyme also regulate ES cell chromatin structure in a 
self-renewal and pluripotent state. On the basis of domain structure, the ATP-
dependent remodeling factors can be grouped into four families (SWI/SNF, 
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ISWI, Mi-2/CHD, and INO80), with each family having broad functions in 
diverse biological processes and cell types (Boyer et al., 2000; Wang et al., 
2007). Recent studies implicate SWI/SNF components as important regulators 
of ES cells. Knockout Brg1, which is the ATPase for SWI/SNF complex, 
results in lethality at the blastocyst stage, thus no ES cells can be derived from 
Brg1 deficient embryo (Bultman et al., 2000). In addition, knocking down 
Brg1 in ES cells led to ES cell differentiation (Ho et al., 2009). Genome wide 
mapping studies has shown that Brg1 interacts with master regulators Oct4, 
Sox2 and Nanog to control the expression of pluripotency associated genes 
(Liang et al., 2008). Other studies have revealed that the composition of the 
BAF complex varies during development (Lessard et al., 2007; Yan et al., 
2008) and that an ES cell specific BAF (esBAF) complex is required for 
pluripotency and self-renewal (Ho et al., 2009).  Downregulation of CHD1, 
which is one of the ATPase subunits of the chromodomain helicase DNA-
binding (CHD) family, compromises ES cell self-renewal (Gaspar-Maia et al., 
2009). The NuRD component Mbd3 is required for maintainance of ES cell 
pluripotency, but not self renewal (Kaji et al., 2006). However, interestingly, a 
unique NuRD complex called NODE that lacks Mbd3 but contains Mta1/2 and 
Hdac1/2 has been shown to interact with Nanog and Oct4 in ES cells and is 
recruited to Nanog/Oct4 target genes, independently of Mbd3 (Liang et al., 
2008). In addition, ES cells depleted of Tip60-p400 subunits, which contains a  
bipartite SWI/SNF like ATPase as well as intrinsic acetyltransferase activities, 
exhibit altered morphology and are impaired in their ability to self renew 
(Fazzio et al., 2008). 
1.4.4. Signaling pathways 
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ES cells can be maintained in an undifferentiated state in culture, but are 
poised for rapid differentiation. Extracellular signals provided by several 
soluble factors have been identified that exert either positive or negative 
effects on ES cell maintenance. 
One approach to elucidate the requirement of ES cells for extrinsic stimulation 
has been to refine the culture medium conditions. When ES cells were first 
isolated from the blastocyst, they were cultured on a feeder layer of mitotically 
inactivated fibroblasts together with fetal bovine serum (FBS) (Smith and 
Benchimol, 1988; Williams et al., 1988). These feeder cells and FBS, create 
the very first extrinsic environment for ES cells. However, it is too complex to 
dissect the critical signaling pathways in feeder cultured ES cells as the 
complex communication between feeder cells and ES cells as well as 
undefined multifactorial components in serum. A key advance was the 
discovery of LIF (leukaemia inhibitory factor), which is able to sustain ES 
cells maintenance in the absence of feeder cells. LIF is known to function 
through binding to its receptor, LIFR (leukemia inhibitory factor receptor), to 
dimerize with gp130 on the cell membrane, resulting in the phophorylation of 
STAT3 (Signal transducer and activator of transcription 3) via JAK (Janus 
kinase) activation (Burdon et al., 2002; Niwa et al., 1998). Phosphorylated 
STAT3 dimerizes and translocates to the nucleus to activate a variety of 
downstream genes to maintain ES cell specific gene expression profiles.  
However, LIF is only able to sustain the undifferentiated state of mouse ES 
cells in the presence of medium, suggesting that additional factors in the 
medium are required for ES cell maintenance. BMP4 (bone morphogenetic 
protein 4) is considered to be a key factor derived from serum in culture to 
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influence the undifferentiated status of ES cells. In combination of LIF signal, 
BMP4 can support ES cell culture in the absence of serum by activating the 
expression of SMAD1 (MAD homolog 1), which, in turn, upregulates the 
expression of Id (inhibitor of differentiation) to suppress differentiation (Ying 
et al., 2003). By contrast, in the absence of LIF, BMP4 induce non-neural 
differentiation by interacting with different SMAD (SMAD1, 5, 8), which, in 
the contrary, repress the expression of Id (Rajan et al., 2003; Ying et al., 
2003). 
Although LIF is required for preserve the pluripotent state of ES cells for in 
vitro feeder free culture, in vivo ICM cells are able to develop into ES cells in 
the absence of LIF signaling, indicating that alternative pathways might be 
involved. Recent studies have challenged our knowledge of regulation by 
signaling pathways in ES cells that based on empirical configurations of the 
culture environment. They proposed that ES cells are intrinsically self-
maintaining if shielded effectively from inductive differentiation stimuli 
including FGF4 (fibroblast growth factor-4) and GSK (glycogen synthase 
kinase-3) signaling pathways. In the mice embryo, FGF4 is produced in the 
ICM cells and are firstly postulated to promote proliferation of the ICM. In ES 
cells, FGF4 are secreted in an autocrine manner, which stimulate a RAS-ERK 
signaling cascade, results in a massive accumulation of phosphorylated 
ERK1/2. FGF4 as well as ERK2 deficient ES cells are resistant to 
differentiation along the neural and mesodermal lineage (Kunath et al., 2007; 
Stavridis et al., 2007), indicating that FGF4/ERK pathway is responsible for 
the exit of undifferentiated state and differentiation into neural or mesodermal 
lineage. However, neither LIF nor BMP4 has been shown to block the 
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activation of FGF4/ERK signaling (Ying et al., 2003). In combination with 
LIF, inhibitors of either FGF receptor tyrosine kinase or ERK cascade can 
replace the requirement for serum/BMP4 and supports robust long-term ES-
cell propagation (Ying et al., 2008). Though inhibiting FGF/ERK signaling 
reduces differentiation, two inhibitors compromise the viability and 
proliferation of ES cells. ES-cell propagation has been reported to be enhanced 
by an inhibitor of glycogen synthase kinase-3 (GSK3) (Sato et al., 2004). 
Importantly, combination of these three inhibitors is able to support derivation 
and proliferation of ES cells bypassing both LIF and BMP pathways, 
suggesting that LIF and BMP pathways act downstream of FGF/ERK pathway 
to block cell commitment (Ying et al., 2008).  
              
 
Figure 1.5.  Blocking FGF4/ERK and GSK3 signaling pathways are able 
to maintain ES cell. phospho-ERK signaling is either inhibited upstream by 
chemical antagonists (A) or counteracted downstream by LIF and BMP (B). 
(Adapted from Ying et al., (Ying et al., 2008)) 
 
GSK3 was initially identified as the kinase responsible for phosphorylation 
and inhibition of glycogen synthase.  It acts as a downstream regulatory switch 
for numerous signaling pathways and involved in the regulation of a variety of 
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biological processes. GSK3 is negatively regulated by PI3K 
(Phosphatidylinositol 3-Kinase)-mediated activation of Akt/PKB (Protein 
Kinase-B) and it has a further role in the canonical WNT signaling pathway 
(Clodfelder-Miller et al., 2005). Inhibition of GSK3 using small molecules 
stimulates the activation of canonical WNT signaling (Doble and Woodgett, 
2003). 
In the canonical WNT pathway, Wnt proteins bind to cell-surface receptors of 
the Frizzled family, which inhibit a „β-catenin destruction protein complex‟, 
composed of axin/GSK3/APC (adenomatosis polyposis coli). This stabilizes 
the pool of β-catenin and enables it to translocate into the nucleus and interact 
with TCF (transcription factor 3)/LEF (Lymphoid enhancer-binding factor) 
family transcription factors to promote specific gene expression (Wu and Pan, 
2010). It seems that WNT pathways have dual functions in ES cells.  
Numerous studies have reported that WNT signaling contribute to the 
maintenance of pluripotency (Wang and Wynshaw-Boris, 2004). For example, 
Wnt signalling has been found to specifically inhibit neural differentiation  
(Aubert et al., 2002; Haegele et al., 2003). However, several other studies have 
implicated a role of WNT signaling in differentiation process. Repression of 
Apc in ES cells casues differentiation defects both in vitro and in teratomas 
(Kielman et al., 2002) and similar phenotype was observed when a dominant 
negative β-catenin without phosphorylation sites was stablized (Kielman et al., 
2002). The contradictory conclusion may due to the interplay of WNT 
signaling with other signaling pathways or the function of its downstream 
transcription factors. 
1.4.5. Transcription network 
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Extrinsic signaling pathways eventually lead to the nucleus and result in the 
transcriptional responses to sustain the „stemness‟ of ES cells by either 
activation or repression of specific sets of genes. A major advance in 
understanding the gene expression profiling in ES cells has come with the 
identification of a transcription network that centered by three master 
transcription factors, Oct4, Sox2 and Nanog (Boyer et al., 2005; Chen et al., 
2008; Loh et al., 2006). 
Oct4 is encoded by Pou5f1 gene and belongs to the POU family transcription 
factor. During embryogenesis, it is expressed in the pluripotent cells of the 
ICM and epiblast, but repressed in trophectodermal cells (Nichols et al., 1998; 
Palmieri et al., 1994; Rosner et al., 1990; Scholer et al., 1990). Oct4-deficient 
mouse embryo die following implantation due to a lack of ICM cells (Nichols 
et al., 1998). In ES cells, Oct4 acts as a gatekeeper to prevent ES cell from 
differentiation. However, the dosage of Oct4 is critical for pluripotency, as 
loss of Oct4 lead to differentiation into trophectoderm by interaction with 
Cdx2, which is a trophectodermal marker; while a twofold increase of Oct4 
cause cell differentiated into a mixed population of mesodermal and 
endodermal cells (Niwa et al., 2005).  
Oct4 has been reported to regulate diverse downstream targets by forming 
heterodimers with Sox2 (SRY-related HMG box 2). Sox2 is an HMG domain-
containing transcription factor that has a similar expression pattern to that of 
Oct4 during mouse preimplantation development (Chew et al., 2005; Kuroda 
et al., 2005; Rodda et al., 2005). Sox2-null mice embryo fails to develop 
beyond implantation and have primary defects in the pluripotent epiblast. 
Similar to Oct4-null blastocysts, Sox2-null blastocysts are incapable of giving 
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rise to pluripotent ES cells (Avilion et al., 2003; Nichols et al., 1998). In ES 
cells, Sox2 difficient ES cells differentiated mainly to trophectodermal lineage 
(Maruyama et al., 2005), whereas a two-fold overexpression of Sox2 resulted 
in the differentiation of ES cells into a mixture of lineages except endoderm 
(Kopp et al., 2008). Interestingly, forced expression of Oct4 is able to rescue 
the pluripotency of Sox2-null ES cells (Masui et al., 2007).  
Another master regulator residing in the same complex with Oct4 (Wang et 
al., 2006) is Nanog, an NK-2 class homeobox transcription factor, whose 
expression  is activated at 8-cell stage and later highly restricted to ICM and 
epiblast (Chambers et al., 2003; Mitsui et al., 2003). Nanog knockout embryos 
fail to form epiblasts, and are mostly composed of disorganized 
extraembryonic tissue (Chambers et al., 2003; Mitsui et al., 2003). More 
recently, it has been shown that although downregulation of Nanog 
predisposes ES cells towards differentiation, ES cells can however self-renew 
in the complete absence of Nanog (Chambers et al., 2007). This finding 
suggests that Nanog plays a major role in stabilizing the “stemness” state of 
ES cells.  
Oct4, Sox2 and Nanog are not working alone, and instead, they are found to 
form an interconnected autoregulatory network. They bind to their own cis-
regulatory elements (eg., promoter, enhancer) and the cis-regulatory elements 
of the other two genes to collaboratively regulate their own expressions. 
Furthermore, genome wide mapping studies have found out that Oct4, Sox2 
and Nanog share a substantial fraction of target genes across the mouse and 
human genome (Boyer et al., 2005; Chen et al., 2008; Loh et al., 2006), 
including both transcriptionally active genes and repressed genes. In addition, 
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their binding sites are in close proximity, which indicates that these proteins 
work in concert. 
Recent studies have begun to provide new insights to add in more components 
into the current regulatory map, expanding our knowledge to the 
understanding of ES cells. Noval transcriptional regulators have been 
uncovered,  such as Esrrb (Ivanova et al., 2006; Loh et al., 2006), Tbx3 
(Ivanova et al., 2006), Sall4 (Elling et al., 2006; Sakaki-Yumoto et al., 2006; 
Wu et al., 2006; Zhang et al., 2006), Zfx (Galan-Caridad et al., 2007), Zic3 
(Lim et al., 2007), Klf family (Jiang et al., 2008), and Ronin (Dejosez et al., 
2008). These transcription factors are preferentially up-regulated in the 
undifferentiated ES cells. Depletion of these factors impairs the ability of ES 
cells to proliferate or maintain pluripotency. 
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Figure 1.6. Model of core ES cell regulatory circuit. Oct4, Sox2, and Nanog 
occupy actively transcribed genes, including transcription factors and 
signaling components necessary to maintain the ES cell state. The three 
regulators also occupy silent genes encoding transcription factors that, if 
expressed, would promote other more differentiated cell states. PcG proteins 
co-occupy at this latter set of genes to inhibit RNA polymerase II (POL2) to 
produce complete transcripts. The interconnected autoregulatory loop, where 
Oct4, Nanog, and Sox2 bind together at each of their own promoters, is shown 
(bottom left). (Jaenisch and Young, 2008) 
 
Another critical finding to appreciate the importance of transcription factors in 
ES cell regulation is provided by the generation of iPSCs. Introducing specific 
transcription factors into somatic cells, initially as Oct4, Sox2, Klf4 and Myc, 
is able to reprogram the differentiated state to pluripotent state, completely 
converting the cell cycle and epigenetic landscape to pluripotent cell specific 
manner. Subsequent studies have shown that the combination of transcription 
factors for reprogramming can be varied; for example, Oct4, Nanog, Sox2 
together with Lin 28 is also able to generate successful iPSCs (Park et al., 
2008b), which is emphasizing the potential significance of novel transcription 
factors and encouraging the study of identification of novel key transcription 
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2.1 SUMMARY OF CHAPTER II 
Identification of transcriptional regulators governing the transcriptional 
network to maintain the identity of embryonic stem (ES) cells is crucial to the 
understanding of ES cell biology. In this work, we identified a zinc finger 
protein, Zfp143 as a novel regulator for self-renewal of ES cells. Depletion of 
Zfp143 by RNAi causes loss of self-renewal of ES cells. We characterized 
Nanog as one of the downstream targets of Zfp143, as Zfp143 directly binds to 
Nanog proximal promoter and regulate its expression. Chromatin 
immunoprecipitation and EMSA show the direct binding of Zfp143 to Nanog 
proximal promoter. Knockdown of Zfp143 or mutation of Zfp143 binding 
motif significantly down-regulates Nanog proximal promoter activity. 
Importantly, enforced expression of Nanog is able to rescue the Zfp143 
knockdown phenotype, indicating that Nanog is one of the key downstream 
effectors of Zfp143. More interestingly, we further show that Zfp143 regulates 
Nanog expression through modulation of Oct4 binding. Co-
immunoprecipitation experiments revealed that Zfp143 and Oct4 physically 
interact with each other. This interaction is important because Oct4 binding to 
Nanog promoter is promoted by Zfp143. Furthermore, besides Nanog, Zfp143 
co-occupy other targets with Oct4 as well, including genes that are known to 
be essential for ES cells, such as Trp53 and Jarid2, indicating that Zfp143 
may act as an activator to recruit and modulate Oct4 binding at specific loci in 
the ES cell genome, thus promote the expression of ES-specific gene 
expression and control ES cell self renewal.  Our study reveals a novel 
regulator functionally important for the self-renewal of ES cells and provides 
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Embryonic stem (ES) cells are isolated from the inner cell mass (ICM) of 
blastocysts at day 3.5 of mouse development(Loebel et al., 2003). These cells 
are considered self renewal, as they can regenerate themselves as stem cells 
continuously and pluripotent as they exhibit the ability to differentiate into 
most specialized cell types found in the adult mouse(Geijsen et al., 2004; 
Schmitt et al., 2004). The derivation and manipulation of these cells, 
particularly human ES cells, hold great promise for both basic biological 
research and regenerative therapeutic medicine. The maintenance of ES cells 
is cooperatively controlled by external signaling pathways such as LIF/STAT3 
pathway (Matsuda et al., 1999; Niwa et al., 1998; Raz et al., 1999) and BMP 
pathway (Ying et al., 2003), the intrinsic transcriptional network,  centered 
around the core transcription factors, Oct4, Sox2 and Nanog(Loh et al., 2006), 
epigenetic modifications by chromatin-modifying enzymes as well as small 
regulatory RNA molecules.  
Genetic studies and genomic mapping studies have shown that Oct4, Sox2 and 
Nanog are essential regulators of embryogenesis and ES cell identity 
(Chambers et al., 2003; Chambers and Smith, 2004; Mitsui et al., 2003; 
Nichols et al., 1998) and considered as the base to establish the transcriptional 
network. Oct4 is encoded by Pou5f1 gene and belongs to the POU family 
transcription factor. It is preferably expressed in the pluripotent cells of the 
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ICM and epiblast, acts as a gatekeeper to prevent ES cell differentiation. It has 
been reported to regulate diverse downstream targets by forming heterodimers 
with Sox2 (SRY-related HMG box 2). Sox2 is an HMG domain-containing 
transcription factor that has a similar expression pattern to that of Oct4 during 
mouse preimplantation development (Chew et al., 2005; Kuroda et al., 2005; 
Rodda et al., 2005). Both Oct4- and Sox2-null mice have primary defects in 
the pluripotent epiblast and both Oct4- and Sox2-null blastocysts are incapable 
of giving rise to pluripotent ES cells (Avilion et al., 2003; Nichols et al., 
1998). Interestingly, the forced expression of Oct4 is able to rescue the 
pluripotency of Sox2-null ES cells (Masui et al., 2007). Another key regulator 
residing in the same complex with Oct4 (Wang et al., 2006) is Nanog, an NK-
2 class homeobox transcription factor, whose expression is also highly 
restricted to ICM and epiblast (Chambers et al., 2003; Mitsui et al., 2003). 
Nanog knockout embryos fail to form epiblasts, and are mostly composed of 
disorganized extraembryonic tissue (Chambers et al., 2003; Mitsui et al., 
2003). More recently, it has been shown that although downregulation of 
Nanog predisposes ES cells towards differentiation, ES cells can however self-
renew in the complete absence of Nanog (Chambers et al., 2007). This finding 
suggests that Nanog plays a major role in stabilizing the “stemness” state of 
ES cells. Strikingly, recent work has found that introducing specific 
transcription factors to somatic cells, initially as Oct4, Sox2, Klf4 and Myc, is 
able to reprogram the differentiated state to pluripotent state, which has draw a 
significant attention to the importance of transcription network in ES cells. 
Subsequent studies have shown that the combination of transcription factors 
for reprogramming can be varied, emphasizing the potential significance of 
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novel transcription factors and encouraging the study of identification of novel 
key transcription factors in ES cells. 
In this study, we report Zfp143 (a selenocysteine tRNA gene transcription-
activating factor) as a novel regulator that maintains the undifferentiated state 
of ES cells by regulating the transcription of Nanog. Depletion of Zfp143 by 
RNA interference (RNAi) resulted in cellular differentiation and a significant 
reduction in Nanog expression. ChIP and luciferase assays revealed Zfp143 
binding at the proximal promoter region of Nanog. Furthermore, we found that 
it interacts with Oct4 on this cis-regulatory element of Nanog. Our data extend 
knowledge of the transcription network in ES cells by integrating Zfp143 as an 
upstream activator of Nanog, through modulation of Oct4 binding. 
 
2.3 MATERIALS AND METHODS 
Cell culture – E14 or D3 mouse ES cells, cultured under feeder-free 
conditions were maintained in Dulbecco‟s Modified Eagle-Medium (DMEM, 
GIBCO), with 15 % heat-inactivated ES qualified fetal bovine serum (FBS, 
GIBCO), 0.055 mM β-mercaptoethanol (GIBCO), 2mM L-glutamine, 0.1 mM 
MEM non-essential amino acid, 5,000 units/ml penicillin/streptomycin and 
1,000 units/ml of LIF (Chemicon). 293T cells were cultured in DMEM with 
10 % FBS and maintained at 37 
o
C with 5 % CO2. The human ES cell-line 
(H1, WiCell) was cultured as described previously (Brandenberger et al., 
2004).
 
HEK293T (293) cells were cultured in DMEM supplemented with 10% 
FBS.  In differentiation experiments,
 
cells were treated with 1 µM of retinoic 
acid (RA) for mouse ES cells and 10 µM RA for human ES cells for 5 days. 
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Transfection and short hairpin RNA mediated knockdown – The 19 
nucleotides targeted by the siRNAs are GGCAGATGGTGACAATTTA (for 
Zfp143-1) and GCAGTACGCAGCAAAGGTA (for Zfp143-2); we obtained 
similar results for the 2 RNAi constructs for Zfp143 knockdown. Transfection 
of shRNA and overexpression plasmids was performed using Lipofectamine 
2000 (Invitrogen) according to manufacturer‟s instructions. Briefly, 1.5 μg 
plasmid DNA was transfected into ES cells on 60 mm plates for RNA and 
protein extraction. Detection of alkaline phosphatase, which is indicative of 
the non-differentiated state of ES cells, was carried out using a commercial ES 
cell characterization kit (Chemicon). 
Secondary replating assay - After 3 days of puromycin selection, shRNA-
transfected cells were trypsinized and resuspended in medium. Ten-thousand 
cells were plated onto newly gelatin-coated 60-mm plates to form secondary 
ES cell colonies. After 4 days, emerging colonies were stained for alkaline 
phosphatase activity. For all the data shown (unless indicated otherwise), the 
cells were harvested and analyzed after 4 days of puromycin selection. 
Detection of alkaline phosphatase, which is indicative of the undifferentiated 
state of ES cells, was carried out using a commercial ES Cell Characterization 
Kit from Chemicon (catalog no. SCR001). 
ChIP and RNA expression analysis – ChIP was performed as described 
previously(Loh et al., 2006) with Zfp143 antibody (H00007702-M01, 
Abnova); Oct4 antibody (sc-8628, Santa Cruz); HA antibody (sc-7392, Santa 
Cruz); Sox2 antibody (sc-17320, Santa Cruz) or RNA polymerase II antibody 
(05-623, Upstate). RNA extraction, reverse transcription and quantitative 
realtime PCR were carried out as described previously (Loh et al., 2006).  
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Co-immunoprecipitation – Transfected cells were lysed in cell lysis buffer 
(50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP40, 10% 
glycerol with protease inhibitor cocktail) for 1 h. Whole cell extracts were 
collected and precleared. Beads coated with Oct4 (sc-8628, Santa Cruz) or HA 
(sc-7392, Santa Cruz) antibody were incubated with the precleared whole cell 
extracts at 4 
o
C for overnight. The beads were washed with cell lysis buffer 4 
times. Finally, the beads were boiled in 2x sample buffer for 10 min. The 
eluents were analyzed by either protein staining or Western blot.  
Sequential ChIP- Oct4 antibody was crosslinked to protein G sepharose 
beads using DMP to prevent the leaching of antibody during SDS elution. The 
beads were then incubated with chromatin extracts overnight. Subsequently, 
the beads were washed and eluted with 1% SDS elution buffer at 37°C for 45 
minutes. The eluate was diluted to a final SDS concentration of 0.1% and 
incubated with fresh antibody-bound beads for the second IP. For the final 
round of IP, washed beads were eluted with 1% SDS elution buffer at 68°C for 
30 minutes. Eluate was decrosslinked in the presence of pronase and heated at 
68°C for 6 hours and DNA was purified by phenol:chloroform extraction.  
GST pulldown assay – Full-length Zfp143 and various deletion fragments 
were cloned into pET42b (Novagen). The plasmids were transformed into 
BL21 E coli. The Zfp143 proteins were expressed and purified with GSH-
sepharose beads (Amersham) followed by Ni-NTA beads (Qiagen). The 
purified proteins were bound to GSH beads and incubated with Oct4 
overexpressed cell lysates for 2 h in 4 
o
C. The beads were washed 6 times with 
cell lysis buffer. The eluents were analyzed by Western blot. 
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Electrophoretic mobility shift assays (EMSAs) – DNA binding domain of 
Zfp143 was cloned into pET42b (Novagen). The plasmid was transformed 
into BL21 E coli. The DNA binding domain of Zfp143 protein was expressed 
and purified with GSH-sepharose beads (Amersham) followed by Ni-NTA 
beads (Qiagen). The purified protein was dialyzed against dialysis buffer 
(20mM HEPES, pH 7.9, 20% glycerol, 100mMKCl, 0.83mM EDTA, 1.66mM 
DTT, Protease Inhibitor Cocktail (Roche)) at 4
o
C for 4h. The concentration of 
the protein was measured with a Bradford assay kit (Bio-Rad). Double-
stranded DNA oligonucleotides (Proligo) labeled
 
with biotin at the 5' termini 
of the sense strands were annealed
 
with reverse strands in annealing buffer (10 
mM Tris-HCl, pH
 
8.0, 50 mM NaCl, 1 mM EDTA) and purified with an 
agarose gel DNA extraction kit (Qiagen). The sense strand sequence is shown 
in Figure 2.3A. EMSA was performed in a 10-µl reaction mixture containing 
10mM HEPES, pH 7.5, 10mM KCl, 10mM MgCl2, 1mM DTT, 1 mM EDTA, 
10% glycerol, 3 ng of biotin-labeled oligonucleotide, 1 µg of poly(dI-dC) 
(Amersham) and 100ng recombinant Zfp143 DNA binding domain protein. 
Binding reaction mixtures
 
were incubated for 10 min at room temperature and 
then subjected to electrophoresis on pre-run 5% native
 
PAGE gels in 0.5x TBE 
buffer. Gels were transferred
 
to Biodyne B nylon membranes (Pierce 






Luciferase assay – E14 embryonic stem cells were transfected with reporter 
constructs by Lipofectamine 2000 (Invitrogen) following the manufacture‟s 
protocol. A Renilla luciferase plasmid (pRL-SV40 from Promega) was co-
transfected as an internal control. Cells were harvested after 36 h and the 
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luciferase activity of the cell lysates was measured with the Dual-luciferase 
Reporter Assay System (Promega).  
Plasmids – The promoter region of murine Nanog was amplified from 
genomic DNA. Primers for amplification, with restriction sites for cloning 
purposes indicated in lowercase, were:  
GTCTGTagatctAATGGAAGAGGAAACTCAGATCC (Nanog promoter 
forward); 
CCACACacatgtCAGTGTGATGGCGAGGGAAGGG (Nanog promoter 
reverse); 
Products were cloned into pGL3 vector and sequence-verified. For the Nanog 
proximal promoter luciferase construct containing deletion of Zfp143 binding 
site, the sequence CCTCTTTTTGGG was deleted. 
DNA microarray – Illumina kits was applied for cDNA expression profiling. 
mRNAs derived from Zfp143 knockdown shRNA and Luc shRNA treated ES 
cells were reverse transcribed, labeled and analyzed using Illumina microarray 
platform (Sentrix Mouse-6 Expresion BeadChip v1.1). Arrays were processed 
as per manufacturer‟s instructions. Three biological repeats of profiles (each 
for control and knockdown) were used to generate statistically significant gene 
lists. The microarray data were analyzed by SAM. The thresholds for the 
differentially expressed genes were (I) more than 2 fold change and (II) q-
value of less than 0.05. 
Primer sequence 
For quantitative PCR 
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Zfp143 maintains the undifferentiated state of ES cells 
As Oct4, Nanog and several other key regulators of ES cells are 
predominantly expressed in the ICM, the identification of genes that 
preferentially expressed in ICM would be promising to provide a potential list 
of regulators for the maintenance of ES cells.  A list of 48 genes 
predominantly expressed in ICM has been uncovered by Yoshikawa et al. 
using whole mount in situ hybridization (Yoshikawa et al., 2006). Their 
specific expression patterns suggest their potential roles in regulating early 
embryogenesis and the identity of ES cells as well. Zfp143 is one of the genes 
in the list. To check its expression pattern in both mouse and human ES cells 
and during differentiation, mouse E14 cells and human H1 cells were treated 
with retinoic acid (RA) to induce differentiation. The expression of Zfp143 
was downregulated, resembling the expression pattern of Pou5f1 and Nanog, 
indicating the positive correlation between lost of its expression and lost of ES 
cell identity (Figure 2.1).   
                        
41 
 
Figure 2.1. Zfp143 expression is downregulated in both human and mouse 
ES cells upon RA induced differentiation. Real-time PCR analysis of 
Zfp143 expression in human and mouse ES cells upon RA induced 
differentiation. 10uM Retinoid Acid (RA) was used to induce mouse (A) or 
human (B) ES cells differentiation. Zfp143 expression was downregulated as 
both mouse and human ES cells differentiate. Data are presented as the mean 
± SEM. *, P<0.05; **, P<0.005. 
 
To assess the functional role of Zfp143 in ES cells, we depleted endogenous 
Zfp143 by RNAi. Two short-hairpin RNAi constructs targeting different 
regions of Zfp143 coding sequence were used to ensure that the effects were 
specific. Both RNAi constructs were effective in reducing the transcript level 
of Zfp143 compared with empty vector and control luciferase RNAi (Figure. 
2.2B). Strikingly, Zfp143 knockdown cells lost the typical mouse ES colony 
morphology. Alkaline phosphatase (AP) staining of pluripotent ES cells (red 
color) was reduced dramatically in the Zfp143 knockdown cells, indicative of 
differentiation (Figure. 2.2A). RNAi depletion of three other ICM-specific 
transcripts (Etv5, Mll3, 4930548G07Rik) (Yoshikawa et al., 2006) did not 
result in a differentiation phenotype (data not shown). This indicates that not 
all genes which are preferentially expressed in ICM will be important in the 
maintenance of ES cells. 
To gain insights into the molecular alteration induced by Zfp143 knockdown, 
the expression of pluripotency and lineage marker genes was analyzed. The 
expression of Nanog and Esrrb was reduced to 50% and 65 % respectively 
relative to the control, while the expression of Pou5f1and Sox2 did not show 
appreciable changes (Figure. 2.2C). Fgf5 and Cdx2, which are markers for 
primitive ectoderm and trophectoderm lineage respectively, were up-regulated 
(Figure. 2.2D).  
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Figure 2.2. Zfp143 is required for the maintenance of undifferentiated 
state of ES cells. (A) Zfp143 knockdown induced ES cells differentiation. 
Flattened fibroblast-like cells lacking alkaline phosphatase activity were 
formed when Zfp143 was depeleted by RNAi. In empty vector and luciferase 
shRNA-transfected cells, normal undifferentiated ES colonies with positive 
alkaline phosphatase staining (red color staining) were maintained. (B) 
Quantitative real-time PCR analysis of Zfp143 expression after knockdown 
using two shRNA constructs targeting different regions of the Zfp143 coding 
sequence. The levels of the transcripts were normalized against control empty 
vector transfection. (C) Realtime PCR analysis of ES cell-associated gene 
expression in Zfp143 knockdown ES cells. The levels of the transcripts were 
normalized against control empty vector transfection. (D) Real-time PCR 
analysis of lineage-specific marker gene expression in Zfp143 knockdown 




Knockdown experiments were repeated in D3 ES cells using the same 
conditions as described for E14 ES cells and similar results were gotten 
(Figure 2.3), suggesting the general roles of Zfp143 in mouse ES cells.  
                   
Figure 2.3. Zfp143 is required for the maintenance of undifferentiated 
state of D3 ES cells. (A) Zfp143 knockdown induced D3 ES cells 
differentiation. Flattened fibroblast-like cells lacking alkaline phosphatase 
activity were formed when Zfp143 was depeleted by RNAi. In empty vector 
and luciferase shRNA-transfected cells, normal undifferentiated ES colonies 
with positive alkaline phosphatase staining (red color staining) were 
maintained. Co-expression of RNAi-resistant Zfp143 could rescue the 
differentiation phenotype. Typical colony morphology of ES cells with 
positive alkaline phosphatase staining (red) was restored. (B) Quantitative 
real-time PCR analysis of Zfp143 expression after knockdown using two 
shRNA constructs targeting different regions of the respective transcripts. The 
levels of the transcripts were normalized against control empty vector 
transfection. (C) Real-time PCR analysis of ES cell-associated gene 
expression in Zfp143 knockdown D3 ES cells. The levels of the transcripts 
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were normalized against control empty vector transfection. (D) Real-time PCR 
analysis of lineage-specific marker gene expression in Zfp143 knockdown D3 
ES cells. The levels of the transcripts were normalized against control empty 
vector transfection. Data are presented as the mean ± SEM and derived from 
three independent experiments. *, P<0.05; **, P<0.005. 
 
To further characterize the Zfp143-depleted ES cells, we analyzed their ability 
to form colonies in a replating
 
assay. Transfected cells were dissociated with 
trypsin and replated
 
to allow the ES cells to expand into colonies. Zfp143 
knockdown reduced the number of ES cell colony-forming units
 
(CFUs) by 
fourfold to 19-fold compared with control knockdown, rescue experiments 
could significantly restored the colony forming ability
 
(Figure 2.4). These 
results suggest that Zfp143 plays a role in maintaining the self-renewal of ES 
cells. 
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Figure 2.4. Zfp143 knockdown reduced ES cell capacity to form colonies 
in replating assay. (A) Replating showed that Zfp143 knockdown ES cells 
had significantly reduced capacity to form alkaline phosphatase-positive 
colonies whereas co-expression of RNAi-resistant Zfp143 could rescue the 
capacity. (B) Counting of alkaline phosphatase-positive and differentiated 
colonies (per microscopy field) of the replated cells. Numbers of colonies 
counted are average of 5 different fields from three independent experiments. 
*, P<0.05; **, P<0.005.  
 
To exclude off-target effects of shRNA, we performed rescue experiments. 
Zfp143 RNAi-immune construct was made by introducing four silent 
mutations in the shRNA targeted region of Zfp143 open reading frame. The 
rescue expression construct was co-transfected with Zfp143 shRNA. 
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Figure 2.5.  Rescue of differentiation phenotype induced by Zfp143 RNAi. 
(A) Co-expression of RNAi-resistant Zfp143 could rescue the differentiation 
phenotype induced by Zfp143 knockdown. RNAi-resistant Zfp143expression 
constructs were co-transfected with corresponding Zfp143 RNAi construct into 
mouse ES cells. Typical colony morphology of ES cells with positive alkaline 
phosphatase staining (red) was restored. (B) Co-expression of RNAi-resistant 
Zfp143 rescued the down-regulation of Zfp143 upon knockdown by two RNAi 
constructs. (C) RNAi-resistant Zfp143 rescued the down-regulation of Nanog 
and Esrrb upon Zfp143 knockdown by two RNAi constructs. (D) RNAi-
resistant Zfp143 restored the differentiation markers Fgf5 and Cdx2 to normal 
ES cell level. Data are presented as the mean ± SEM and derived from three 
independent experiments. *, p<0.05; **, p<0.005. 
 
The result showed that RNAi-resistant Zfp143 was able to rescue the 
differentiation phenotype induced by Zfp143 depletion (Figure 2.5A). The 
expression of pluripotency and lineage marker genes was comparable to 
normal ES cell levels (Figure 2.5B, C and D). The second RNAi-immnue 
Zfp143 expression construct was also able to rescue the second shRNA 
targeting different region of Zfp143 transcript. All these data demonstrate that 
the Zfp143 knockdown phenotype is indeed caused by the Zfp143 RNAi. 
As depletion of Zfp143 by RNAi led to differentiation, DNA microarray 
experiments were performed to capture the transcriptome change in the whole 
genome level after transfection of shRNA expression constructs. 167 genes 
were upregulated and 259 genes were downregulated to more than two folds. 
The expression of a few essential self-renewal-related genes including Nanog, 
Sox2, Tcfcp2l1 and Jmjd1b were reduced (Figure 2.6), consistent with real 
time PCR results, indicating that Zfp143 can positively regulate the expression 
of many self-renewal genes. 
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Figure 2.6. Global gene expression changes after knockdown of Zfp143. 
DNA microarray analyses were performed to measure gene expression 
changes after Zfp143 knockdown. The morphology and alkaline phosphatase 
staining are shown for both the control and Zfp143-depleted cells. Microarray 
heatmaps depicting expression changes of selected self renewal-associated 
marker genes are shown. Red indicates increased expression compared to 
control samples, whereas green means decreased expression. The genes 
expression levels were mean centred to show their relative change. 
 
Zfp143 binds to and regulates Nanog 
Next, we investigated how Zfp143 maintains the undifferentiated state of ES 
cells. As Nanog was down-regulated when Zfp143 was reduced by RNAi, we 
therefore asked if Nanog is a direct target of Zfp143. ChIP assay was 
performed using a monoclonal antibody raised against Zfp143.  
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Figure 2.7. Zfp143 and Oct4 co-occupy Nanog proximal promoter. (A) 
Specificity of Zfp143 monoclonal antibody. Western blotting analysis of 
Zfp143 knockdown and control ES lysates were carried out using anti-Zfp143 
monoclonal antibody. β-actin served as loading control. (B) The locations of 
the amplified products (black boxes) along Nanog proximal promoter. (C) 
Zfp143 binds to Nanog proximal promoter. ChIP assay was performed using 
anti-Zfp143 monoclonal antibody to detect enriched fragments. Fold 
enrichment is the relative abundance of DNA fragments at the amplified 
region over a control amplified region. (D) GST antibody was used as mock 
ChIP control. (E) 3HA tagged Zfp143 construct was transiently transfected 
into ES cells, chromatin was extracted and subject to ChIP analysis using anti-
HA antibody. 3HA tagged GFP served as mock control. (F) Oct4 binds to 
Nanog proximal promoter. ChIP assay was performed using an anti-Oct4 
antibody to detect enriched fragments. (G) Zfp143 and Oct4 co-occupy Nanog 
proximal promoter. Sequential ChIP was performed using the anti-Oct4 
antibody first (O). The eluants were then subjected to a second ChIP using 
anti-Zfp143 antibody (OZ) or a control antibody (OC). Data are presented as 




The specificity of the antibody was characterized by western blotting using 
whole cell lysates transfected with control vector or Zfp143 RNAi constructs 
(Figure 2.7A). Real-time PCR was used to quantify the ChIP-enriched DNA 
along Nanog proximal promoter. The result showed that Zfp143 occupied the 
Nanog proximal promoter (Figure 2.7B, C) while mock GST ChIP did not 
show any significant enrichment in this region (Figure 2.7D). In addition, 
ChIP assay using HA antibody against ectopically expressed HA-Zfp143 
showed the same binding profile at the Nanog proximal promoter in ES cells 
(Figure 2.7E). These data independently confirm that Zfp143 binds to the 
Nanog proximal promoter in vivo. Interestingly, the profile of Zfp143 binding 
mirrored that of Oct4 binding at the Nanog proximal promoter (Figure 2.7F). 
Whether Zfp143 and Oct4 co-occupy this region of Nanog or in a mutually 
exclusive manner is of interest. To address this issue, we performed sequential 
ChIP assay. Chromatin extracts were first immunoprecipitated using the anti-
Oct4 antibody. The eluents were then subjected to a second ChIP using the 
anti-Zfp143 antibody or a control antibody. Further enrichment after the 
second ChIP indicated that Zfp143 and Oct4 co-occupied the same molecule 
of DNA (Figure. 2.7G, OZ). An anti-GFP antibody used as a control in the 
second round of ChIP did not show any further enrichment of the Nanog 
sequence (Figure. 2.7G, OC). Thus, we conclude that Oct4 and Zfp143 co-
occupy the Nanog proximal promoter.  
A Zfp143 consensus binding site can be found at the peak region revealed by 
Zfp143 ChIP (Figure 2.7C, E). Using the electrophoretic mobility shift assay 
(EMSA), we further showed that the DNA binding domain of Zfp143 could 
interact with this sequence (Figure 2.8A). Furthermore, mutagenesis of the 
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DNA probe revealed that the CCCA sequence which was reported to be 
critical for Zfp143 binding (Schaub et al., 1997) was required for this 
interaction (Figure 2.8A). These results showed that Zfp143 directly binds to 
Nanog proximal promoter through a conserved binding motif. 
Having established the interaction between Zfp143 and the Nanog proximal 
promoter, we sought to understand the functional roles of Zfp143 on this 
promoter. A mutation in the Zfp143 binding motif was introduced into a 
luciferase reporter construct driven by Nanog promoter. Reporter assays 
showed that the mutation reduced Nanog promoter activity (Figure 2.8B). To 
further dissect the functional roles of Zfp143, Zfp143 RNAi construct was co-
transfected with the Nanog proximal promoter driving luciferase reporter into 
normal ES cells. Nanog depletion by RNAi was used as a positive control. The 
depletion of Zfp143 reduced the Nanog proximal promoter activity to the same 
extent as mutating the Zfp143 motif (Figure 2.8C). Taken together, these data 
demonstrate that Zfp143 directly binds to Nanog proximal promoter and 
regulates Nanog expression.  
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Figure 2.8. Zfp143 regulates Nanog proximal promoter. (A) Zfp143 
directly binds to Nanog proximal promoter region. Electrophoretic mobility 
shift assays (EMSA) were used to analyze the binding of Zfp143 on Nanog 
proximal promoter. Purified recombinant DNA binding domain of Zfp143 was 
used for EMSAs. EMSA with the wild-type probe detected specific 
Zfp143/DNA complex. The effect of mutation on the Zfp143 DBD/DNA 
complex was also shown. The right panel shows the sequence of the Zfp143 
element (shown in red) and corresponding mutation (shown in green) used in 
this study. (B) Zfp143 binding site is crucial for Nanog promoter activity. 
Zfp143 binding site was mutated in the Nanog proximal promoter reporter 
(Mut) and tested for promoter activity in ES cells. (C) Depletion of Zfp143 
attenuates Nanog promoter activity. Nanog promoter-Luc reporter or control 
vector was co-transfected with Zfp143 RNAi construct into mouse ES cells 
and the luciferase activities were assayed. All luciferase activities were 
measured relative to the Renilla luciferase internal control. Data are presented 
as the mean ± SEM and derived from three independent experiments. **, 
p<0.005. 
 
Nanog is one of the key downstream effectors of Zfp143 for the 
maintenance of ES cells 
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As Nanog is a direct target regulated by Zfp143, we next investigate whether 
enforced expression of Nanog will rescue the effects induced by Zfp143 
knockdown. To test this hypothesis, Nanog was co-expressed in Zfp143 
knockdown ES cells.   
     
Figure 2.9. Nanog is a key downstream effector of Zfp143 for maintaining 
ES cells. (A) Enforced expression of Nanog could rescue the differentiation 
phenotype induced by Zfp143 knockdown. Typical colony morphology of ES 
cells with positive alkaline phosphatase staining (red) was restored in Zfp143 
knockdown cells with enforced expression of Nanog. ES cells were co-
transfected with a Nanog-expression vector and Zfp143 RNAi construct. The 
cells were stained for alkaline phosphatase activity and the morphologies were 
examined by microscopy. (B) Enforced expression of Nanog rescued the 
down-regulation of Nanog induced by Zfp143 knockdown. (C) Enforced 
expression of Nanog did not affect Zfp143 knockdown efficiency. (D) 
Enforced expression of Nanog rescued the up-regulation of Fgf5 and Cdx2 
induced by Zfp143 knockdown to normal ES cell level. Quantitative real-time 
PCR was used to determine the expression. Data are presented as the mean ± 
SEM and derived from three independent experiments. **, p<0.005. 
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ES cells co-transfected with control vector and Zfp143 RNAi construct 
differentiated, as observed by the loss of ES colony and alkaline phosphatase 
staining (Figure 2.9A). However, ES cells co-transfected with Nanog 
expression vector and Zfp143 RNAi construct were able to retain the 
undifferentiated phenotype of ES cells evidenced by morphology and alkaline 
phosphatase staining (Figure 2.9A, B). The depletion of Zfp143 was not 
affected by the enforced expression of Nanog, excluding the possibility that 
the rescued phenotype was due to inefficient depletion of Zfp143 (Figure 
2.9C). We further analyzed the transcripts of pluripotency and lineage markers 
affected by Zfp143 depletion. With the enforced expression of Nanog in 
Zfp143 knockdown cells, Fgf5 and Cdx2 were not induced (Figure 2.9D). 
These data suggest that Nanog is one of the key effectors of Zfp143 and can 
compensate for the depletion of Zfp143 in ES cells. 
 
Zfp143 is a novel Oct4 interacting transcription factor 
Since Oct4 and Zfp143 co-occupy Nanog proximal promoter and share the 
same binding pattern, we tested for potential interaction between the two 
proteins. Co- immunoprecipitation experiments were performed using ES cell 
nuclear extracts. Zfp143 was found to co-precipitate with Oct4 (Figure 
2.10A). The reciprocal co-immunoprecipitation could not be performed as we 
found that our Zfp143 antibody could not efficiently immunoprecipitate 
Zfp143 from nuclear extract. Hence, we transfected a construct expressing 
HA-tagged Zfp143 into ES cells to do the reverse co-immunoprecipitation 
experiment. Using an anti-HA monoclonal antibody to immunoprecipitate 
HA-Zfp143, we showed that Oct4 co-immunoprecipitated with HA-Zfp143 
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(Figure 2.10B). Co-IP results obtained in a heterogeneous cell type 293T cells 
overexpressing Oct4 and HA-Zfp143 independently confirmed this interaction 
(Figure 2.10C, D). 
                    
 
Figure 2.10. Zfp143 is an Oct4 interacting protein. (A) Co-IP using ES cell 
nuclear extracts was performed using anti-Oct4 antibody. Western blotting 
was carried out with anti-Zfp143 antibody. Control IP was performed using 
anti-GFP antibody. The affinity of anti-Oct4 antibody to pull down Oct4 was 
detected in lower panel. (B) Reverse co-IP using the ES cell lysates transiently 
expressing 3HA tagged Zfp143 was performed using anti-HA antibody. 
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Western blotting was carried out with anti-Oct4 antibody. Control HA IP was 
performed using ES cell lysates transiently expressing 3HA tagged GFP. (C) 
Co-IP using 293T cell lysates overexpressing Oct4 and 3HA tagged Zfp143 
was performed using anti-HA antibody. Western blot was carried out with 
anti-Oct4 antibody. 293 cell lysates expressing 3HA tagged GFP and Oct4 
served as control. (D) Reverse co-IP using 293T cell lysates overexpressing 
Oct4 and 3HA tagged Zfp143 was performed using anti-Oct4 antibody to 
confirm the interaction between Zfp143 and Oct4. Western blotting was 
carried out with anti-HA antibody. 293 cell lysates expressing 3HA tagged 
GFP and Oct4 served as control. (E) Schematic diagram of full length and 
truncated forms of Zfp143 protein. (F) GST pull down assay was carried out 
using GST-tagged Zfp143 proteins and 293T cell lysates overexpressing Oct4. 
Western blot was performed with anti-Oct4 antibody. (G) GST-tagged full 
length and different truncated forms of Zfp143 proteins.  
 
To determine the region of Zfp143 that interacts with Oct4, full length and 
truncated fragments of Zfp143 were expressed and purified as recombinant 
GST-fusion proteins (Figure 2.10E, G). These proteins were immobilized onto 
GSH-sepharose beads and incubated with extracts harvested from 293T cells 
overexpressing Oct4. Zfp143 containing only the N-terminal repeats failed to 
pull down Oct4 (Figure 2.10F). However, the fragment containing only the 
DNA binding domain of Zfp143 was able to pull down Oct4. This 
demonstrates that the DNA binding domain of Zfp143 interacts with Oct4. 
 
Zfp143 modulates the binding of Oct4 at Nanog promoter 
We have demonstrated that Zfp143 and Oct4 interact with each other and co-
occupy Nanog proximal promoter to regulate Nanog. However, whether they 
work independently is not clear. To gain insights into the molecular 
mechanism of this regulation, we depleted Zfp143 and examined the 
occupancy of Oct4 at different genomic sites. ES cells transfected with Zfp143 
shRNA constructs were crosslinked and the extracts were used for ChIP assay. 
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The protein level of Oct4 was not altered by Zfp143 depletion (Figure 2.11A).  
As expected, the binding of Zfp143 on Nanog proximal promoter was reduced 
upon depletion of Zfp143 (Figure 2.11B). Interestingly, we observed the 
reduction in Oct4 binding on the same region as well (Figure 2.11C) when 
Sox2 binding was not affected (Figure 2.11D). Oct4 occupancy at Oct4 
enhancer which is not occupied by Zfp143 (data not shown) was however not 
affected (Figure 2.11E). To further investigate the relationship between 
Zfp143 and the basal transcription machinery, we performed ChIP against 
RNA polymerase II. Consistent with the reduction in Nanog transcript after 
Zfp143 depletion, the binding of RNA polymerase II to Nanog proximal 
promoter was also significantly reduced (Figure 2.11F). These data indicate 
that Zfp143 controls the binding of Oct4 at Nanog promoter. 
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Figure 2.11. The binding of Oct4 to chromatin is dependent on Zfp143. 
(A) Zfp143 knockdown did not affect Oct4 protein level. Western blotting 
analysis of control ES lysates and Zfp143 knockdown lysates were carried out 
using anti-Zfp143 monoclonal antibody and anti-Oct4 antibody. β-actin served 
as loading control. (B) Zfp143 binding was reduced upon Zfp143 knockdown. 
Chromatin extracts from control ES cells or Zfp143 knockdown cells were 
subjected to ChIP using anti-Zfp143 antibody. (C) Oct4 binding was reduced 
upon Zfp143 knockdown. Chromatin extracts from control ES cells or Zfp143 
knockdown cells were subjected to ChIP using anti-Oct4 antibody. (D) Sox2 
binding was not affected upon Zfp143 knockdown. Chromatin extracts from 
control ES cells or Zfp143 knockdown cells were subjected to ChIP using 
anti-Sox2 antibody. The primers used to detect ChIP-enriched DNA in (B-D) 
were the peak pair of primers numbered 3 in Figure 2B. (E) Oct4 binding at 
Pou5f1 enhancer was not altered upon Zfp143 knockdown. ChIP using 
chromatin from control ES cells or Zfp143 knockdown cells was performed 
using anti-Oct4 antibody to detect Oct4 binding at enhancer region of mouse 
Pou5f1. (F) RNA polymerase II binding was reduced upon Zfp143 
knockdown. Chromatin extracts from control ES cells or Zfp143 knockdown 
cells were subjected to ChIP using anti-RNA polymerase II antibody. The 
primers used were schematically shown in the lower panel. Data are presented 
as the mean ± SEM and derived from three independent experiments. *, 
p<0.05. 
 
Zfp143 co-occupy other targets with Oct4 in the genome of ES cell  
Our data has revealed that Zfp143 co-occupy Nanog promoter with Oct4 and 
regulate Nanog expression. However, besides Nanog, it would be interesting 
to know whether Zfp143 targets other downstream genes that are essential for  
ES cells, and more importantly, whether Zfp143 and Oct4 interaction and 
modulation is also applied for other gene regulation is of our interest. A group 
has performed a large scale analysis to evaluate the binding of ZNF143 to 
mammalian promoters containing the consensus binding element and variants 
therein by bioinformatics in the human genome (Myslinski et al., 2006). Their 
data provided a list of putative genes whose promoters contain ZNF143 
binding motif. Based on this list, we have identified two genes that have been 
shown critical for ES cell maintenance, Jarid2 and Trp53. We validated the 
binding of Zfp143 on the promoter of Jarid2 and Trp53 by ChIP in ES cells 
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(Figure 2.12B, E). Furthermore, we found Oct4 bind to their promoter as well 
(Figure 2.12C, F), resembling the binding profile of Zfp143 and Oct4 on 
Nanog promoter. Therefore, we propose the protein partner Zfp143-Oct4 is 
not just a specific regulatory unit for Nanog promoter, but specifically regulate 
a few important genes in ES cells and thus maintain the entire transcriptional 
circuit controlling self renewal of ES cells. 
      
 
Figure 2.12. Zfp143 and Oct4 co-occupy other targets that are important 
for ES cells. (A, D)The locations of the amplified products (black boxes) 
along Jarid2 (A) and Trp53 (D) promoter. (B, E) Zfp143 ChIP on Jarid2 (B) 





Zfp143, also known as STAF, is a zinc finger protein that was originally 
identified in Xenopus laevis as the transcriptional activator of the tRNASec 
gene and was then be found to be the transcription activator of snRNA and 
snRNA-type genes transcribed by RNA Pol II and III(Schaub et al., 1997; 
Schuster et al., 1998; Schuster et al., 1995). Zfp143 also plays a critical role in 
basal and tissue-specific expression of transaldolase and regulating the 
metabolic network controlling cell survival and differentiation(Grossman et 
al., 2004). In addition, Zfp143 is inducible by DNA damaging agents such as 
gamma-irradiation, etoposide and adriamycin and activates gene expression in 
response to DNA damage and binds to cisplatin-modified DNA(Ishiguchi et 
al., 2004). During mouse early embryogenesis, Zfp143 is one of the 48 genes 
expressed predominantly in the inner cell mass (ICM)(Yoshikawa et al., 
2006), which suggests it might be a good candidate for further analysis of its 
role in preimplantation development and cellular pluripotency. 
Differentiation induced by Zfp143 knockdown indicates that it plays a role in 
the maintenance of ES cells. The entire transcriptional program has been 
disturbed due to the knockdown, a number of self renewal and pluripotency 
associated genes were downregulated, while multiple lineage marker genes 
were significantly upregulated. More importantly, the depletion of Zfp143 
leads to a reduction of Nanog level, while the level of Pou5f1 and Sox2 is 
modestly affected. This suggests that Zfp143 is directly regulating Nanog. 
Using ChIP and EMSA assays, we showed that Zfp143 binds to Nanog 
proximal promoter and maintains its activity. Enforced expression of Nanog 
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rescued the differentiation induced by Zfp143 depletion, suggesting that 
Nanog is one of the key effectors of Zfp143. Besides Nanog, we also found 
two other self-renewal and pluripotency associated genes, Jarid2 and Trp53, 
are bound and regulated by Zfp143. Although we cannot exclude the 
possibility that there could be other important self-renewal or pluripotency 
associated genes directly controlled by Zfp143, our findings that Nanog is able 
to compensate for the depletion of Zfp143 in ES cells highlight the importance 
of Nanog in the whole transcription network. It is also conceivable that 
overexpression of Nanog renders the ES cells more resistant to differentiation 
(Chambers et al., 2007). 
Zfp143 (Staf) has seven contiguous zinc-finger repeats for DNA binding 
located in the middle of the protein and two transactivation domains at the 
amino-terminal portion(Schuster et al., 1998). Binding site selection 
experiments identified the 18-bp DNA sequence 
TACCCATAATGCATYGCG as its consensus binding sites (Schaub et al., 
1999a; Schaub et al., 1997). However, known Staf-binding sites revealed a 
high degree of divergence (Schaub et al., 1999b). At Nanog proximal 
promoter, we have identified a 15bp binding motif for Zfp143 at the peak 
region of its binding, CCCAAAAAGAGGCT, which is consistent with the 
previous consensus motif and the first CCCA is shown to be the key sequence 
for the binding affinity. 
The co-occurrence of an octamer and Zfp143 motif is often found in the distal 
sequence element of a large number of RNA polymerase II and III transcribed 
snRNA-type genes (Schaub et al., 1997). It has been shown that the trans-
activation function of the distal sequence element is mediated essentially by 
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Oct-1 and Zfp143 binding at the octamer and staf motif (Schaub et al., 1997). 
Our results here indicate that this octamer/Zfp143 motif regulation model is 
not restricted to sn-RNA type genes only, but also used to control the gene 
expression of an ES cell-specific gene. Disruption of either motif, Oct4 or 
Zfp143, as shown by EMSA and luciferase assays, downregulates the 
transcription of Nanog. It has been shown that addition of an octamer element 
in the vicinity of a Zfp143 binding site in the Xenopus Pol II UIb2 and Pol III 
U6 genes produced a synergistic effect on transcriptional activation, thus 
suggesting a functional cooperativity between the two DNA-bound factors. 
However, the molecular mechanism of how octamer binding protein and 
Zfp143 collaborate to control the transcription was not explained. Here, we 
demonstrate for the first time that Zfp143 interacts with Oct4 through its DNA 
binding domain. 
Knocking down of Zfp143 significantly reduced Oct4 binding on the Nanog 
proximal promoter while Oct4 transcription and protein level as well as its 
binding on other cis-regulatory elements remained unaltered. Our data show 
that Oct4 binding at the Nanog promoter is dependent on Zfp143. It should be 
noted that Zfp143 depletion did not lead to a complete loss of Oct4 binding. It 
is possible that there exists other Zfp143 independent binding of Oct4 at other 
nearby sites. Although Oct4 and Sox2 heterodimer extensively co-occupies 
genome-wide targets (Boyer et al., 2005; Loh et al., 2006), this study shows 
that Oct4 can interact with factors other than Sox2 to assist in its binding to 
chromatin and regulate transcription. 
Nanog expression is restricted to pluripotent ES cells and precisely controlled 
during mouse embryogenesis. To date, two cis-regulatory regions have been 
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uncovered (Figure 2.13). The first region is an enhancer 5 kb upstream of the 
transcription start site. This site is reported to be bound and positively 
regulated by STAT3, T (brachyury), Nanog-Sall4 complex and Klf 
transcription factors (Klf2, Klf4 and Klf5) (Jiang et al., 2008; Loh et al., 2006; 
Suzuki et al., 2006). The second important regulatory region is the proximal 
promoter which is bound and regulated by the Oct4-Sox2 heterodimer and 
FoxD3 (Kuroda et al., 2005; Pan et al., 2006; Rodda et al., 2005). Oct4-Sox2 
complex and FoxD3 directly bind to Nanog proximal promoter and promote 
Nanog expression. However, the precise balance between the maintenance of 
Nanog level and the ability of lineage differentiation requires negative 
regulators in the transcription network. Several repressors have also been 
characterized to down-regulate Nanog expression. Tcf3, a transcription factor 
downstream of Wnt signaling pathway, directly binds to Nanog promoter and 
represses its expression. The depletion of Tcf3 delayed ES cells differentiation 
and up-regulated Nanog protein level (Pereira et al., 2006). p53, another 
negative regulator of Nanog, represses Nanog expression after 
phosphorylation of the Ser315 which is induced upon differentiation (Lin et 
al., 2005). GCNF (Gu et al., 2005), an orphan nuclear receptor, mediates 
Nanog repression upon RA-induced ES cells differentiation by binding to 
Nanog promoter and 3‟UTR region. Most of the transcription activator and 
repressors binding sites at Nanog regulatory regions have been discovered and 
validated for direct binding (Table 2.1). Recent study mapping 13 transcription 
factor and 2 regulators binding sties in ES cells further reveals extensive co-
localization of Nanog, Smad1, STAT3, Klf4, Esrrb and Tcfcp2l1 on Nanog 
enhancer and n-Myc, c-Myc Zfx and E2f1 on the proximal promoter (Chen et 
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al., 2008). Other than sequence-specific DNA binding transcription factors, 
recent studies have begun to uncover novel pathways involved in the 
regulation of Nanog. Jmjd2c, a histone demethylase that converts H3K9 
trimethylation to dimethylation, has recently been identified to regulate the 
H3K9Me3 status of Nanog(Loh et al., 2007). Specific demethylation of 
H3K9Me3 by Jmjd2c at the Nanog promoter could inhibit the binding of 
transcription co-repressors such as HP1 and KAP1 and sustain Nanog 
expression (Loh et al., 2007). At the post-transcriptional regulation level, 
microRNA has been reported to exert functional roles in regulating Nanog 
expression. For instance, miR-134 is found to specifically attenuate the 
translation of Nanog(Tay et al., 2008). Altogether, these studies highlight the 
intricacy in modulating the expression of Nanog through positive and negative 
regulation at both the transcriptional and post-transcriptional levels. 
              
Figure 2.13. A model depicting the different transcriptional regulators 
that interact with Nanog cis-regulatory regions. Nanog is regulated by both 
activators and repressors. The enhancer and promoter regions of Nanog are 
shown as the blue bar and orange bar, respectively. STAT3, T, Klf 
transcription factors (Klf2, Klf4, and Klf5), and Nanog-Sall4 complex occupy 
the Nanog enhancer and activate Nanog transcription. The Oct4-Sox2 
complex, FoxD3, and Zfp143-Oct4 complex positively regulate the proximal 
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promoter. Tcf3 and p53 occupy the promoter and exert repressive roles. 
GCNF binds to two regulatory elements located at 2.5 kb upstream of the 
transcription start site and 3‟-untranslated region to repress Nanog expression 
upon retinoic acid-induced differentiation. Abbreviations: GCNF, germ cell 
nerve factor; kb, kilobase. 
 
Table 2.1. Known transcription activator and repressor binding sites at 
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3.1 SUMMARY FOR CHAPTER III 
Cellular differentiation is the process by which a less specified cell becomes a 
more specialized cell type, characterized by the constant change of gene 
expression pattern during the differentiation process. Identifying the subset of 
genes that initiate the differentiation process is critical to dissect the molecular 
mechanisms underlying differentiation and further control and manipulate the 
progress for application to clinical medicine. The current methods of 
identifying differentially expressed genes by comparing different cell types 
inevitably include a large portion of genes that respond to, rather than regulate, 
the differentiation process. We demonstrate through the use of biological 
replicates and a novel statistical approach that the gene expression data 
obtained without prior separation of cell types are informative for detecting 
differentially expressed genes at the early stages of differentiation. Applying 
the proposed method to analyze the differentiation of mouse embryonic stem 
(ES) cells to embryoid bodies (EB), we successfully generated a gene list of 
transcription regulators during differentiation, and further identified and 
experimentally verified Smarcad1 as novel regulators of pluripotency and self-
renewal. Furthermore, using the genes identified by our method, we 
constructed a gene regulatory network that strongly indicates the importance 
of Notch signaling pathway in triggering the early differentiation of ES cells. 
Our statistical approach can be formalized as a statistical test that can be 






Differentiation process is initiated by gradual loss of differentiation inhibiting 
genes and induction of differentiation genes, thus lead to the change of highly-
controlled modifications in gene expression. The search for marker genes is 
widely pursued in almost every differentiation process, although a principled 
approach is still missing. The current practice is to separate distinguishable 
cell types, measure gene expression from each cell type, and then identify 
differentially expressed genes. Such methods require the expression data for 
both cell types to be available. A limitation of these methods is that by the 
time the cell types are distinguishable, for example by morphology; many 
genes have already shown differential expression. This set of differentially 
expressed genes may include the class of “early marker genes” that are 
enriched for markers of early differentiating cell lineages as well as genes 
whose down-regulation triggers differentiation. However, the set of 
differentially expressed genes will also include a second, larger class of genes 
in which gene expression is not important to the regulation of the 
differentiation process but in which genes are simply characteristic of the fully 
differentiated cell types. Traditional sample comparison procedures are not 
designed to separate the two classes differentially expressed genes and as a 
result, the large lists of differentially expressed genes usually do not provide 
direct guidance for dissecting underlining mechanisms of differentiation. As a 
benchmark experiment, Zhou et al. used fluorescence activated cell sorting 
(FACS) to obtain the subset of differentiating mouse ES cells that express a 
GFP under the control of an Oct4 promoter (Oct4+) and the subset of cells that 
do not express Oct4-promoter controlled GFP (Oct4-) (Zhou et al., 2007a). 
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Oct4 is one of the master regulators of self-renewal of mouse ES cells, and its 
expression level is extensively used as the indicator of the differentiation state 
(Ivanova et al., 2006). Differentially expressed genes between Oct4+ and 
Oct4- cells reported by Zhou et al. were used as a benchmark gene list (Zhou 
et al., 2007a). 
Recognizing early marker genes enables separation of cell types at an early 
stage of differentiation; in turn, separating cell types at an early stage of 
differentiation enables identification of early marker genes. However, neither 
piece of the puzzle is currently available to a study of a new differentiation 
process. We demonstrate that, contrary to common belief, early marker genes 
can be detected by measuring the average expression of a mixture of cell 
types, provided that enough biological replicates have been measured and 
statistical test based on variance ratio has been used. In this study, we provide 
a novel statistical method to identify early marker genes during differentiation 
based on the theoretical reasoning, and applying this method to analyze the 
process of mouse ES cell differentiation, we further performed two validation 
experiments. 
 
3.3 MATERIALS AND METHODS 
The statistical model for the Differentiation-Test  
Model for cell-level transcript copy numbers. Let gtrcy  denote the gene 
expression level (copy number) of gene transcript g in cell c  of biological 
replicate (sample) r  at time t . Without loss of generalizability, assume that 
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during the first differentiation event, a parental cell population becomes a 
mixture of two cell types. For a cell, let ( ) {0 1}d d c    denote its cell type: 0 
for the parental and 1 for a descendent cell type. Suppose there are 
rn  cells in 
biological replicate (sample) r . Let trX  denote the proportion of the cells that 
belong to a differentiated cell type ( 1d  ). The copy number of transcript g 
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 where 
1trn  are the number of cells of type 1, gt is the mean copy number of 
transcript g  in the parental cell type ( 1d  ), and gt  is the difference of the 
mean copy numbers between the descendent cell type ( 1d  ) and the parental 
cell type ( 0d  ).The mean of the copy number of transcript g  is 
 1r gt r gt r gt tr gtn n n X      . 
Model for raw microarray data. The raw microarray readouts are the 
fluorescence intensities of fluorophores attached to the hybridized RNA 
molecules. These readouts are monotone transformations of the transcript copy 
numbers with measurement noise. A commonly accepted model between 
transcript copy number and fluorescence intensity is given by Rocke and 
Durbin (Rocke and Durbin, 2001): 
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gtr is a multiplicative error term with  2,~ 0,gtr gN   ; gtr  is an 
additive background noise error term with  2,~ 0,gtr gN   ; and gc is a „„unit-
conversion‟‟ constant. Except for low-abundance transcripts, the 
multiplicative error dominates the additive error and thus the latter can be 
ignored (Rocke and Durbin, 2001). This practice is consistent with the 
observation that the microarray readouts are approximately linear to the 
targeted transcripts (Cope et al., 2004; Irizarry et al., 2003). After 
normalization and log transformation of the raw data, a normal error model 
can be derived from (2), which has general support from independent literature 
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 (3) 
where gtrZ is the normalized and log transformed microarray readout. The 
normalization removes the differences of cell numbers and overall 
fluorescence intensities across samples, and therefore the subscript r  in rn  
was dropped. The independence of mean  log log logg gt tr gtn c X    and 
the technical noise gtr in model (3) was often assumed in published analyses, 
because the log transformation of the raw data usually removes the 
dependences between the mean and the variance of the raw array data (see 
(2)). Nevertheless, to ensure such an independence, the authors recommend 
first applying the variance stabilization normalization (VSN) (Huber et al., 
2003) before performing the following tests. 
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The test statistic. Within the model for raw microarray data, the search for 
differentially expressed genes is turned into a gene-by-gene test of its 
differentiation effect: 
0 1: 0 : 0gt gtH vs H    (4) 
at time t  for gene g . To identify an appropriate test statistic, we examine the 
behavior of the variance of measured data. Given transcript g  and time t , the 
variance of its microarray measurement (6) across the replicates is: 
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 (5) 
where   
2
1 gt tr gtE X    is the factor derived by the Delta method of 
variance calculation (Casella G, 2002). log n represents the average intensity 
of the log transformed microarray readouts of the thr  sample, which was 
adjusted to be the same by almost all normalization procedures, and therefore 
its variance is 0. Equation (5) shows that the variation of the log transformed 
microarray readout stems from at least two sources, one being the difference 
of the proportions of cell types across biological replicates (  Var trX ), the 
other being the measurement error (
2
,g ). The differentiation effect gt  
contributes to the first term   2Var tr gtX   in (9). Under the null hypothesis 
0gt  , this term is 0. Under the alternative hypothesis, this term is positive 
and contributes to a larger variation of the measurements gtrZ . However, a 
large variation of the measurements gtrZ  does not necessarily favor the 
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alternative hypothesis, because it might be confounded by a large 
measurement error 
2
,g . To adjust for the measurement error, the 









































where  0Var gZ  is the sample variance of the initial time point. If we assume 
the differentiation effect is the least manifested at the first time point, the test 
statistic DT  can be used to rank genes for their differentiation effect at time t . 
Under the null hypothesis, the test statistic follows an F-distribution: 
0~ ( 1, 1)gt tDT F R R  , where tR  and 0R  are the number of biological 
replicates at time t  and time 0, respectively. With the null distribution, the 
Differentiation-Test reports both the p-value and the q-value (related to false 
discovery rate) (Storey and Tibshirani, 2003) for every gene. With a q-value 
cutoff of 0.1, Differentiation-Test reported 137 and 116 genes in 4-day and 8-
day EBs, respectively. The overlap of the two gene lists contained 31 genes (
30p-value 1.28 10  ). The p-value was generated from the Fisher‟s Exact 
Test for enrichment analysis. 
Construction of the gene regulatory network. The gene regulatory network 
in 4-day EBs is constructed as follows: 
1) Node selection. The Differentiation-Test was applied to 4-day EB and 0-
day ES data, and the genes with a q-value threshold of 0.1 were selected. 
73 
 
These genes should express different amounts of transcripts between the ES 
and the differentiated cells. Among these genes, the ones with Gene Ontology 
annotation of Transcriptional Regulation (GO: 0003700) and Signal 
Transduction (GO: 0007165) were selected as nodes of the gene regulatory 
network. 
2) Regulatory relationship. From whole genome transcription factor (TF) or 
histone modification factor binding data (ChIPseq (Chen et al., 2008)and 
ChIP-chip (Boyer et al., 2006b)), if one node from step 1 binds to the genomic 
neighborhood region of another node, then a tentative regulatory relationship 
is drawn as an undirected edge between the two nodes (Figure 9). 
Furthermore, gene knockdown followed by microarray analysis data (Ivanova 
et al., 2006)were merged to the tentative regulatory relationships. When a 
tentative regulatory relationship is supported by the change of target gene 
expression after the knockdown of the putative regulatory node, the undirected 
edge is subsequently changed into a directed edge, with an activation or a 
repression sign to reflect the concordant or reverse directions of expression 
changes between the regulator and the target gene. 
Determining the binding site distribution of the transcription factor RBP-
J. 10kb upstream sequences (5k upstream and 5k downstream of the 
transcription start site) were collected for every gene in Figure 10. The 
position specific weight matrix (PSWM) of RBP-J was obtained from 
Transfac database. A sliding window with the same length of the PSWM was 
used to scan the upstream sequences, on both strands, and a likelihood ratio 
score was recorded for each sliding window(Jensen and Liu, 2004). Two sets 
of scores were computed for every upstream sequence.  
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1. Upstream binding affinity. An upstream binding affinity is a sum of the all 






T LR I LR 
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where LRi is the likelihood ratio of the i
th
 sliding window. N is the total 
number of sliding windows on a sequence. I(.) is a 0-1 indicator function. 
When δ is very small, the upstream binding affinity is the same as what‟s used 
in Conlon et al. (Conlon et al., 2003). Increasing δ will filter out false positive 
binding sites from the computation of upstream binding affinity. 
2. Number of putative binding sites. The number of putative binding sites of 
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It is basically the counts of sliding windows that reached the threshold δ.  
The average T    and N   were computed from genes in the differentiation 
module and those in the pluripotency module (Figure 9). 
Transcription profiling. Total RNA for transcriptional profiling was obtained 
from B6 mouse ES cells at 0 day (undifferentiated), 4 days and 8 days of 
spontaneous differentiation. B6 mouse ESC were cultured on mouse 
embryonic feeders (MEFs) using standard methods as previously described 
(Ramalho-Santos et al., 2002) in 15% FCS supplemented with LIF. 
Undifferentiated ES cell samples were obtained by trypsinising near confluent 
plates of ES cells and depleting the MEFs by plating the cells onto gelatin 
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coated plates for 2×20 min. The ES on gelatin samples were MEF depleted ES 
cells seeded on gelatin coated dishes and cultured until they reached, 70% 
confluency. To ensure the undifferentiated ES cell samples were free from 
MEF contamination, MEF depleted ES cells that passaged once on gelatin 
were used as 0-day ES cell samples. To make EBs, the ES cells on gelatin 
were seeded into non-adherent petri dishes, and LIF was withdrawn to induce 
differentiation. Half of the EB media was changed every 3–4 days. The 
formation of EBs was consistent with previous studies (Doetschman et al., 
1985; Robbins et al., 1990). After 8 days, numerous cystic structures were 
observed and became progressively larger over time. After about 10 days, 
beating foci of cardiac myocytes could be observed in some EBs, indicating 
the terminal differentiation of some cell types. Total RNA was extracted from 
the different samples using the RNeasy kit (Quiagen) and amplified using a 
two-round linear amplification strategy as previously described (Ramalho-
Santos et al., 2002). The labeled RNA was then hybridized to Affymetrix 
MgU74A microarrays according to the manufacturer‟s instructions. 
Normalization and probe-level modeling were done with dChip software (Li 
and Wong, 2003). 
Short hairpin RNA mediated knockdown. Feeder-free E14 mouse ES cells 
were cultured at 37°C with 5%CO2. All cells were maintained on gelatin-
coated dishes in DMEM (Gibco), supplemented with 15% heat-inactivated 
FBS (Gibco), 0.055 mM b-mercaptoethanol (Gibco), 2 mM l-glutamine, 0.1 
mM MEM nonessential amino acid, 5,000 units per ml penicillin–
streptomycin, and 1,000 units per ml LIF (Chemicon), as described previously. 
Transfection of shRNA constructs was performed using Lipofectamine 2000 
76 
 
(Invitrogen) according to manufacturer‟s instructions. Briefly, 1.5 mg plasmid 
DNA was transfected into ES cells on 60 mm plates for RNA extraction. 
Puromycin (Sigma) selection was introduced 1 day after transfection at 1.0 
mg/ml, and maintained for 2 and 4 days before harvesting. Detection of 
alkaline phosphatase, which is indicative of the nondifferentiated state of ES 
cells, was carried out using a commercial ES cell characterization kit 
(Chemicon). shRNA targeting specific genes was designed as previously 
described (Reynolds et al., 2004; Ui-Tei et al., 2004). The 19-nucleotide 
hairpin-type shRNAs with a 9-nucleotide loop were cloned into pSUPER.puro 
(Bgl II and Hind III sites, Oligoengine). Three shRNA, targeting different 
regions of respective transcripts, were designed for each gene to ensure 
specificity. pSuperpuro constructs expressing shRNA against luciferase 
(Firefly) were used as controls. The 19 nucleotide sequence for each gene is 
listed below: 
Smarcad1:                                                       Pias2: 
GAAGCTCTGTTTACAAAGA           GCCCTGCGGTTCAGATTAA 
GAAGAGCGTAAGCAAATTA           GCCTTCGACTTCAATTACA 
GTATGAGGATTACAATGTA           GTTCAAGTGTCTTTAGTAA 
 
RNA extraction, reverse transcription, and quantitative real-time PCR. 
Total RNA was extracted using TRIzol Reagent (Invitrogen) and purified with 
the RNAeasy Mini Kit (Qiagen). Reverse transcription was performed using 
SuperScript II Kit (Invitrogen). DNA contamination was removed by DNase 
(Ambion) treatment, and the RNA was further purified by an RNeasy column 
(Qiagen). Quantitative PCR analyses were performed in real time using an 
ABI PRISM 7900 sequence detection system and SYBR green master mix, as 
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previously described (Ng et al., 2003). For all the primers used, each gave a 
single product of the correct size. In all controls lacking reverse transcriptase, 
no signal was detected. Each RNAi experiment was repeated at least three 
times with different batches of ES cells. 
 
3.4 RESULTS 
The rationale behind the Differentiation-Test. During the early stages of 
differentiation, a parental population of cells gives rise to at least one 
descendent cell type, generating a mixed population of both parent and 
descendent cells (Figure 3.1).  
             
Figure 3.1. A toy example of gene expression levels during a cellular 
differentiation process. (A) Two differentiation events happened at T1 and 
T2, respectively. From T1, Gene 1 has two expression levels in two subsets of 
cells in the cell mixture. Gene expression data are available at t0 to t4. (B) The 
solid black and green lines are not observed after T1 and T2, respectively; 
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instead, the dotted lines are observed as mean expression levels of the cell 
mixture from microarray data. 
 
In a general experimental design, the average expression of a gene in the cell 
mixture is measured, for example by microarrays, at a few time points (≥2) 
during the differentiation process. Biological replicates (≥3) are available for 
every time point. Our task is to identify the earliest group of genes that have 
differential expression patterns. For a toy example (Figure 3.1), this group of 
genes includes Gene 1 only, although all three genes have changed expression 
values over time. After time T1, the average expression level in a mixed cell 
population is measured for Gene 1 (dotted line, Figure 3.1B). After T1, the 
variance of measured expression of Gene 1 across biological replicates should 
inflate as compared to its variance before T1. The reason for this variance 
inflation is that the percentage of descendent cells is not identical across 
biological replicates (Figure 3.2).  




Figure 3.2. An illustration of the inter-replicate variations of the average 
expressions of a gene. An average expression of a gene is measured by 
microarray profiling in a parent population (A) and a mixture of parental and 
descendent populations (B). The histograms are for the (unobserved) cell level 
expressions of a gene. The three biological replicates after differentiation have 
different mixture proportions of cell types. 
 
For example, at t2, biological replicate 1 may have 50% parental cells and 
50% descendent cells, whereas biological replicate 2 may have an 80%–20% 
split of parental and descendent cells in the mixture (see Fig 5B of Dietrich 
and Hirragi et al. (Dietrich and Hiiragi, 2007)as an example). In contrast to a 
nearly 100% parental cell population at t0 for all biological replicates, the 
difference in percentage of sub-populations after differentiation is a signal that 
can be utilized in a statistical method, hereafter referred to as Differentiation-
Test (Methods). 
At the starting point of a differentiation process, nearly 100% of the cells in all 
biological replicates come from the parental cell population. In other words, 
almost every cell in any biological replicate at time 0 (Figure 3.1) takes a 
parental cell type. The gene expression level in each cell has the same 
(parental) mean, while the actual cell level expression values fluctuate around 
the mean due to the cell-to-cell variation.  Thus a histogram of the cell level 
expression values of a certain gene in a parental population will show a uni-
modal distribution (Figure 3.2A).  Suppose at certain stage of the 
differentiation process, the cell population has been divided into multiple 
groups. For simplicity of illustration, we assume there are two cell groups after 
differentiation. A gene differentially expressed in the two groups will have 
two different mean expression levels (Figure 3.2B). A histogram of cell level 
expression values of this gene may take a bi-modal shape. These assumptions 
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are supported with experimental data on biological replicate embryos (Dietrich 
and Hiiragi, 2007). We do not observe the histograms of cell level expressions 
with microarrays due to the difficulty of conducting the single cell 
experiments. With microarrays, we can only observe the average expression of 
all the cells in the population. With a single measurement of the average gene 
expression it is impossible to distinguish whether the underlying histogram of 
the cell level expressions is a mixture or uni-modal. Now, suppose we have 
replicates of cell populations with different mixture proportions (Figure 
3.2B1~B3).  Since the underlying distribution is a mixture and the mixture 
proportion is different across the replicates, the observed average expression 
value (denoted by the red bars in the histogram) varies across the replicates. 
For the biological replicates before differentiation, the variation due to 
different mixture proportion of cell types is much less,  because all replicates 
have nearly 100% the parental cell population (Figure 3.2A1~A3).  
Now consider two genes. Gene 1 is differentially expressed after 
differentiation and Gene 2 is not (Figure 3.1). Gene 1 would have an extra 
source of variation of its mean values across biological replicates compared to 
Gene 2. In real applications there can be more than two cell types in the cell 
mixture after differentiation, however the principle holds: a differentially 
expressed gene would have one more source of variation than a non-
differentially expressed gene.  Although the description of rationales above 
has various simplified assumptions, inflation of variance is intrinsic to  
unsynchronized differentiation events across biological replicates. Neither the 




Analysis of differentiation of mouse embryonic stem cells. 
We used this approach to study the differentiation of mouse ES cells into 
embryoid bodies (EB). Very early in this differentiation process, different 
subsets of mouse ES cells start to show different expression changes that then 
bias the development towards different lineages. These early marker genes are 
probably small in number, and the timing of their changes in early 
differentiating cells may be stochastic and exhibit large variation in replicate 
experiments. As differentiation continues, there will be further changes in the 
expression of these genes as well as in a larger number of other genes 
characteristic of the fully differentiated states of the various lineages (e.g., 
ectoderm, mesoderm, visceral and definitive endoderm). Strictly speaking, a  
time dependent mixture of two or more cell populations, as formulated in the 
Methods section and the above titration experiment, is too simplistic to model 
the setting of mouse ES to EB differentiation. However, the Differentiation-
Test derived from such a model should still be applicable in this setting.  
At an early time point, such as 4 days after differentiation, the stochastic 
timing of the changes in an early marker gene will lead to increased variability 
of its measured expression level in biological replicates. The Differentiation-
Test was designed to detect exactly this increased variability. To test this idea, 
we differentiated mouse ES cells spontaneously into EBs (Figure 3.3). Gene 
expression of six biological replicates of undifferentiated mouse ES cells (0-
day), as well as 4-day, 8-day and 14-day EBs was measured by Affymetrix 
microarrays (Methods).  
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Figure 3.3. Phase contrast micrographs of differentiating mouse ES cells 
on gelatin. (A) 0-day ES cells. (B)8-day EB. 
 
These time points represented early stages of mouse ES differentiation 
because after 8 days, numerous cystic structures were observed to become 
progressively larger over time. As an exploratory analysis of data quality, we 
plotted the scatter plot of standard deviation ( gs  ) vs. mean for every gene at 
each time point and fitted LOWESS (Locally Weighted Scatterplot 
Smoothing) regression curves (Ivanova et al., 2006) (Figure 3.4). These plots 
show that gs  is not influenced by the mean expression value. We therefore did 
not perform variance stabilization normalization to this dataset. 
Figure 3.4. Scatter plots of standard deviation vs. mean.  The mean 
expression value (x-axis) of a gene across replicate samples is plotted against 




The variances of 4-day and 8-day EBs were respectively compared to the 
variance of 0-day ES cells (Figure 3.5). More genes with larger variances were 
found in 4-day and 8-day samples than in 0-day samples, indicating 
differential expression might be detectable at 4-day and 8-day stages. As a 
control, the variance of 0-day samples were compared to that of Oct4+ cells 
from data of Zhou et al (Zhou et al., 2007a) (Figure 3.5C). An increased 
number of genes with larger variances were not observed in either 0-day 
samples or Oct4+ cells.  
 
 
Figure 3.5. Variance comparison. Each dot represents a transcript, with its x 
and y axes representing the variances of the microarray measurements of this 
transcript at different time points. An increased number of genes with larger 
variances was observed in 4-day (A) and 8-day EBs (B) as compared to in 0-
day ES cells. In contrast, a balanced distribution of variances was observed 
between 0-day ES cells and Oct4-GFP positive sorted cells (C).  
 
Then, we applied the Differentiation-Test to this dataset and identified the top 
200 differentially expressed genes of 4-day and 8-day EBs. The statistical 
significance of the overlap between the Differentiation-Test reported gene lists 
and the benchmark genes from Zhou et al was assessed by Fisher‟s Exact Test, 




 for 4-day and 8-day EBs, 
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respectively. These small p-values were not due to a particular cutoff of the 
number of top-ranking genes reported (Table 3.1).  
Table 3.1 Fisher’s Exact Tests between top-ranked genes of the 
Differentiation-Test and benchmark gene list. 
              
In contrast, in testing 10,000 random lists of 200 genes each against the 





 (Figure 3.6).  
 
Figure 3.6 Significance calibration from 10,000 random gene lists.  10,000 
randomly picked gene lists of 200 genes each were compared to the 
benchmark gene list. A histogram of calculated R values is shown. R = K/E 
(K), where K is the number of overlapped genes between a random list and the 
benchmark list, and E(K) is its expectation. Out of the 10,000 R values, only 
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one was greater than the Differentiation-Test‟s 4-day R value (=2.2); none of 
them was greater than the Differentiation-Test‟s 8-day R value (=2.3). 
 
In fact, the Differentiation-Test‟s top-ranked transcription regulators in 4-day 
EBs (Table 3.2) included a number of markers of early differentiation, 
including Sox4, Egr1, Id2, and Pax6 (ranked as 6, 9, 12, and 36, respectively), 
as well as known self-renewal regulators of mouse ES cells, including Klf4 
(Jiang et al., 2008), and Pou5f1 (Nichols et al., 1998; Niwa et al., 
2000)(ranked 1 and 13, respectively). In contrast, a traditional T-test between 
4-day EBs and undifferentiated mouse ES cells failed to reveal any of these 
differentially expressed genes because 4-day EBs still had a similar mean 
expression of the marker genes as 0-day mouse ES cells (Column H, Table 2). 
For example, T-test p-values for Klf4 and Pou5f1 are 0.90 and 0.95, 
respectively. These test results suggest that the Differentiation-Test detected 
differentially expressed genes in a very early stage of the differentiation 
process, generating consistent results to those obtained from a laborious 
experimental procedure of cell sorting. Cell sorting requires prior knowledge 
of a marker gene that is differentially expressed which may not be available 
for every differentiation process in future studies. 
Table 3.2. 200 top-ranked differentially expressed transcription 












Experimental validation of candidate genes for pluripotency and self-
renewal from gene list generated by Differentiation-Test. 
We hypothesized that the Differentiation-Test reported list would include 
uncharacterized critical regulators of pluripotency and self-renewal. Self-
renewal regulators should have a lower expression in differentiated cells and 
therefore should be detectable in the cell mixture of 4-day EBs. We used short 
hairpin RNA (shRNA) to further study two transcription regulators detected 
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by the Differentiation-Test, namely, Smarcad1and Pias2. They ranked 10 and 
55 respectively among all transcription regulators (Table 3.2). The other top-
ranking regulators were not picked for experimental validation because they 
had known regulatory roles in ES cell differentiation. Upon 2 days of 
Smarcad1 shRNA induction, ES cells started to take on a flattened 
morphology; large percentages of cells lost Alkaline Phosphatase (AP) 
staining (Figure 3.7A). 
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Figure 3.7 Depletion of candidate genes by RNAi for two days. Three 
shRNA constructs are used to target different regions of respective transcripts. 
(A) Two days after puromycin selection, typical colony morphology of ES 
cells with positive alkaline phosphatase (AP) staining (red) was maintained 
after Pias2 knockdown. Flattened fibroblast-like cells were formed after 
Smarcad1 depletion. In control empty vector or Luc shRNA transfected cells, 
normal undifferentiated phenotype with distinct ES cell colonies was 
maintained. (B) Quantitative real-time PCR analysis of gene expression in two 
days knockdown ES cells. The levels of the transcripts were normalized 
against control empty vector transfection. Data are presented as the mean ± 
SEM and derived from independent experiments. 
 
Quantitative real time polymerase chain reaction (qPCR) analysis showed that 
the knockdown of Smarcad1 induced the expression of Fgf5, a growth factor 
involved in multiple differentiation processes including differentiation to the 
neuronal lineage (Reuss et al., 2003)(Figure 3.7B). On the other hand, neither 
mock shRNA nor shRNA knockdown of Pias2 induced ES cell differentiation 
(Figure 3.7). 
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Figure 3.8 Depletion of candidate genes by RNAi for four days.  (A) Four 
days after pruomycin selection, Smarcad1 knockdown cells became more 
flattened fibroblast-like and completely lost the AP positive colony compared 
with the cells of two days knockdown. (B) Quantitative real-time PCR 
analysis of gene expression in four days knockdown ES cells. The levels of the 
transcripts were normalized against control empty vector transfection. Data are 
presented as the mean ± SEM and derived from independent experiments. 
 
At 4 days of shRNA induction, we observed further loss of AP staining 
(Figure 3.8A), reduction in pluripotency markers such as Pou5f1, Sox2, and 
Nanog, as well as induction of multiple differentiation marker genes including 
Fgf5, Cdx2, and Hand1, confirming that the cells depleted of Smarcad1 lost 
the ability to maintain their stemness state (Figure 3.8B). Multiple shRNA 
constructs targeting different regions of the target genes gave the same results. 
These results demonstrate the ability of the Differentiation-Test to identify 
novel self-renewal regulators.  
 
A gene regulatory network during differentiation. 
A regulatory network of early differentiation genes might reveal the critical 
events that underlie the earliest differentiation of ES cells. Using the genes 
identified by the Differentiation-Test, we constructed a gene regulatory 




            
 
Figure 3.9 A regulatory network in differentiating ES cells. Modules and 
regulatory relationships. Yellow and blue nodes represent genes that are up- 
and down-regulated in differentiated cells. All blue and yellow nodes are 
collectively termed as pluripotency and differentiation modules, respectively. 
Edges (plain edges, activators ↑ and repressors  )  represent evidence of 
regulatory relationships. Plain edges: the regulatory relationship is supported 
by the binding of the regulator to the target gene (ChIP-seq or ChIP-chip data). 
Activators: the regulatory relationship is supported by both the binding of the 
regulator to the target gene (ChIP-seq or ChIP-chip data) and down-regulation 
of the target gene expression when the regulator is knocked down (RNAi 
microarray data). Repressors: the regulatory relationship is supported by both 
the binding of the regulator to the target gene (ChIP-seq or ChIP-chip data) 
and up-regulation of the target gene expression when the regulator is knocked 
down (RNAi microarray data). 
 
 
Nodes of this GRN were top-ranked transcription factors and signal 
transduction genes detected by the Differentiation-Test in 4-day EBs (Figure 
3.9). Regulatory relationships among these nodes were taken from published 
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results of ChIP-chip experiments (Boyer et al., 2006b; Jiang et al., 2008; Loh 
et al., 2006), ChIP-seq experiments (Chen et al., 2008), and RNAi followed by 
microarray experiments (Ivanova et al., 2006). Comparing the mean 
expression value of a gene in Oct4 expressing cells (Oct4+) and Oct4 non-
expressing cells (Oct4-) (Zhou et al., 2007a), we separated the differentiation 
regulators into two modules: the upregulated module during differentiation 
(termed the differentiation module, yellow nodes, Figure 3.9) and the 
downregulated module (termed the pluripotency module, blue and red nodes, 
Figure 3.9).  
 
Systematic over-representation of RBP-J binding sites in the upstream 
regions of the differentiation module. 
The differentiation module of the transcription network for early 
differentiation is enriched with a number of canonical downstream targets of 
the Notch signaling pathway (yellow nodes, Figure 3.9). This makes it 
attempting to hypothesize that Notch signaling is a pathway that triggers the 
activation of the differentiation module at the early differentiation stage of 
mosue ES cells. To investigate this hypothesis, we analyzed the binding site 
distribution of the transcription factor RBP-J, a key mediator of Notch 
signaling (Tanigaki et al., 2002), in the upstream regions of all regulatory 
protein genes in Figure 3.9.  
Tuning the threshold δ enabled a comprehensive view of the likelihood of 
RBP-J binding to the genes of the two modules, and minimized the bias of 
using a predetermined threshold to call putative binding sites. With a wide 
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spectrum of δ, average upstream binding affinity and average motif count in 
the upstreams of the differentiation module are all consistently larger than 
their counterparts of the pluripotency module (Figure 3.10A, Figure 3.11). In 
particular, with a threshold of 500, there are on average 14.2 putative binding 
sites on an upstream sequence in the differentiation module, as compared to 
8.7 putative sites on an upstream sequence in the pluripotency module. Both 
the scale and the consistency of the overrepresentation of the RBP-J motif in 
the upstreams of the differentiation module provide supporting data for 
Notch‟s potential role of triggering differentiation of mouse ES cells. These 
data are consistent with recent reports that Notch signaling promotes neural 
lineage entry of mouse ES cells (Lowell et al., 2006) and it is required for 
undifferentiated human ES cells to form the progeny of all three embryonic 
germ layers (Yu et al., 2008). 
To test if the RBP-J is among one of the most potent regulators for the 
differentiation module, we used the PRIMA software (Elkon et al., 2003) to 
test all 332 non-redundant mammalian DNA binding motifs available in 
TRANSFAC v10.2 (Figure 3.10B). Four motifs were found to be enriched in 
the upstream sequences of the differentiation module genes as compared to 
those of the pluripotency module genes (p-value ≤ 0.05). In particular, the 
RBP-J motif exhibited the second smallest p-value (0.022) and the largest 
enrichment factor (2.0) among the 332 motifs. 
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Figure 3.10 Enrichment of the RBP-J motif in the upstreams of the 
differentiation module. (A) Average upstream binding affinity of RBP-J both 
shows enhanced signals in the upstream sequences of the differentiation 
module genes as compared to that of the pluripotency module genes. (B) 
Testing of all 332 non-redundant mammalian DNA binding motifs available in 
TRANSFAC v10.2, four motifs were found to be enriched in the upstream 
sequences of the differentiation module genes as compared to that of the 
pluripotency module genes (p-value ≤0.05). In particular, the RBP-J motif 
exhibited the second smallest p-value (0.028) and the largest enrichment factor 
(2.0) among the 332 motifs. 
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Figure 3.11 Average motif counts. Average motif counts of RBP-J in the 
upstreams of the differentiation module are consistently larger than the counts 




If high-throughput measurements of gene expression at the single-cell level 
were available, currently available statistical tools (Table 3) would be 
applicable to the search for differentially expressed genes during 
differentiation. However, microarrays typically do not measure gene 
expression from a single cell but can only measure the average signal from a 
population of cells. Such data demand new gene expression models from the 
single-cell level to the cell-mixture level.  
Table 3.3 Two sample comparison methods. All these methods require gene 




The Differentiation-Test method makes a number of abstractions to the 
differentiation process. Most remarkably, the method assumes that the 
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differentiation process starts from a relatively homogeneous initial cell 
mixture and progresses into a more heterogeneous cell mixture with 
identifiable events of divergence of expression levels of certain genes during 
the process. There are at least two sources contributing to the heterogeneity of 
gene expression in a cell mixture, including the unsynchronized cell cycle 
stages and the cell type difference. The first source of heterogeneity is 
assumed to persist over time, and therefore it is adjusted for by the ratio of 
variances across time points. Statistically, when the initial cell mixture is not 
purely homogeneous, Equation (5) would have a non-zero first term in the 
summation. In such a scenario, the DT statistic still reflects the contrast of 
variation across time and the null distribution can be approximated by an F 
distribution with the same degrees of freedom. Therefore, the Differentiation-
Test does not require the initial cell mixture to be absolutely homogenous but 
does require the heterogeneity of the cell mixture to increase over time.  
The same set of core regulatory proteins and protein complexes interact and 
regulate the genes in both the pluripotency module and the differentiation 
module (Figure 3.9). The complex interactions of these regulatory proteins 
suggest that their pivotal roles in ES cells may not be sufficiently reflected in a 
binary description as “activators‟‟ or „„repressors‟‟, whereas they may serve to 
strike a balance between the multiple extrinsic signals that the cells receive, 
filter intrinsic noise of the system, and collectively predispose the ES cells to 
pro- or anti-differentiation states. The implications of such complex 
interactions to data modeling and interpretation are twofold. First, a predictive 
model for cell fate decision might require modeling the regulators as 
continuous rather than Boolean variables. A case in point is the observation 
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that the feedback loop of Oct4-Sox2-Nanog is capable of translating 
continuous differentiation signals into an irreversible bistable switch 
(Chickarmane et al., 2006). Second, gene knockout data should be interpreted 
with caution given that a regulator may not merely activate or repress gene 
expression but may also buffer variability in transcription by minimizing 
stochastic extrinsic and intrinsic signals that create noise in gene expression 
(Chi and Bernstein, 2009). A case in point is the deletion experiment of the 
Polycomb complex protein Suz12 (Pasini et al., 2007). Suz12(-/-) ES cells are 
viable and exhibit defective differentiation, which seems to contradict the role 
of the Polycomb group as a repressor complex that suppresses the expression 
of lineage-specific differentiation genes in ES cells (Boyer et al., 2006b). 
However Suz12 (-/-) ES cells exhibit a global loss of H3K27 trimethylation 
(H3K27me3) (Pasini et al., 2007), which may have lost a buffering mechanism 
that renders the intrinsic signal for pluripotency unrestrictedly amplified. More 
experiments, such as a series of knockdowns of Suz12 into different 
concentrations, may produce data to further investigate such questions. 
The new gene expression and RNA knockdown data suggest that Smarcad1 is 
a chromatin modeling factor that contributes to maintaining the pluripotency 
of ES cells. Smarcad1 is structurally classified into the SWI2/SNF2 
superfamily of DNA-dependent ATPases that are catalytic subunits of 
chromatin-remodeling complexes. Although the importance of other members 
of the SWR1-like subfamily in chromatin remodeling (EP400, INOC1, and 
SRCAP) has already been elucidated, little was known about the biological 
function of Smarcad1 in transcriptional regulation. Homozygous mutation of 
Smarcad1 gives rise to a number of phenotypes including prenatal-perinatal 
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lethality (Schoor et al., 1999), confirming the importance of Smarcad1 in 
regulating early development. Smarcad1 preferentially binds to transcription 
start sites in embryonic carcinoma cells (Okazaki et al., 2008), which suggests 
that Smarcad1 is a gene specific transcription regulator rather than a 
ubiquitous chromatin modeling factor. These data and our observations 
collectively suggest that Smarcad1 might be an overlooked sequence-specific 
















CHAPTER IV: Coactivators p300/CBP regulate self-renewal 
of mouse embryonic stem cells by mediating long-range 
chromatin structure 
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4.1 SUMMARY FOR CHPATER IV 
p300 and CBP are two highly homologous transcription coactivators that are 
essential for transcriptional activation and coordinate a variety of cellular 
processes, including embryogenesis and development. p300-deficient mouse 
embryonic stem (ES) cells are viable but are severely compromised in the 
ability to differentiate. However, the underlying molecular mechanism has not 
been clearly addressed. In this study, we found that p300 and CBP play 
redundant roles in maintaining the undifferentiated state of mouse ES cells. 
They are recruited by master regulators (Oct4, Sox2, Nanog, etc) through 
protein interaction to activate cell-specific gene expression. Furthermore, 
using the chromatin conformation capture (3C) technique, we found that 
p300/CBP are involved in the formation of long-range chromatin looping 
structure specific to the pluripotent state of ES cells. Characterization of the 
interacting DNA elements revealed that some contain enhancer activities 
which were dependent on p300 and CBP. In conclusion, our work, for the first 
time, characterizes coactivators p300/CBP in ES cells as self-renewal 
regulators through mediating nuclear architecture, which promote extensive 









Embryonic stem (ES) cells are isolated from the inner cell mass of mammalian 
preimplantation embryo at the blastocyst stage (Evans and Kaufman, 1981; 
Keller, 2005). These cells are pluripotent in that they can self-renew 
continuously while retaining the capacity to differentiate into multiple 
lineages. Expression of protein-coding genes in ES cells is spatially and 
temporally regulated in a highly orchestrated and precise pattern by an ES 
cell-specific transcriptional network. A few essential sequence-specific 
transcription factors have been characterized, such as Oct4, Sox2 and Nanog 
(Chambers and Smith, 2004; Loh et al., 2006). They are indispensable for the 
maintenance of ES cell identity and more strikingly, introducing them into 
somatic cells is able to reprogram these differentiated cells to pluripotent state 
(Takahashi and Yamanaka, 2006). Over the last few years, intensive efforts 
have been directed at identifying transcription factors and their binding targets 
in order to decipher the secrets of transcriptional network in ES cells, 
however, besides transcription factors, another critical insight for 
understanding transcriptional control mechanisms was provided by 
coactivators, which are multiple intermediary proteins that are recruited by 
transcription factors and enhance specific gene transcription by countering the 
repressive effects of local chromatin.  
The transcriptional coactivators p300 (Ep300) and CREB-binding protein 
(CBP) are two highly homologous genes, which are capable of interacting 
with a large variety of transcription factors playing central roles in a wide 
range of cellular processes including proliferation, differentiation and 
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apoptosis (Chan and La Thangue, 2001; Goodman and Smolik, 2000). Studies 
in mice have shed light on the critical roles that p300 and CBP play in 
embryogenesis. Homozygous p300 and CBP knockouts, as well as CBP/p300 
double heterozygotes are embryonically lethal (Yao et al., 1998). Studies with 
heterozygous and chimeric mice demonstrated requirements for p300 and CBP 
for tissue and organ development as well as normal adult stem cell self-
renewal and differentiation (Kawasaki et al., 1998; Kung et al., 2000; Oike et 
al., 1999). In the study of ES cells, p300 null ES cells exhibit normal self-
renewal capacity, however, embryoid body (EB) induced by p300 null ES 
cells has shown significantly abnormal expression pattern of germ layer 
markers (Zhong and Jin, 2009). Genome-wide mapping of p300 binding sites 
in mouse ES cells has uncovered that p300, as an enhancer binding protein, 
co-occured with Nanog, Oct4 and Sox2 cluster quite often, suggesting that 
p300 may be recruited by ES specific transcription factors to facilitate the 
communication of distant regulatory elements with proximal elements (Chen 
et al., 2008). Despite clear evidence for the participation of p300 and CBP in 
the transcriptional regulation of ES cells, the mechanisms of how these 
coactivators assist transcription factors and basal transcripitional machinery in 
up-regulation of gene expression in the context of ES specific chromatin 
structure is poorly understood. In addition, whether an extra copy of CBP is 
able to replace p300 when the function of endogenous p300 is lost in vivo (or 
vice versa) is unknown, leaving the issue of functional redundancy between 
these two homologous proteins unresolved. 
In this study, we have characterized the function of p300 and CBP in mouse 
ES cells and found that they are playing redundant roles in maintaining the 
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undifferentiated state of ES cells. Based on the analysis of genome mapping 
data and biochemistry assays, we further demonstrated that these coactivators 
were recruited to specific genomic loci by master regulators Nanog, Oct 
through protein-protein interactions. Domain mapping studies have identified 
that KIX and HAT domains are the functional domains for p300 and CBP in 
ES cells to connect transcription factors and activate gene expression. More 
importantly, using chromatin conformation capture (3C) technique, we found 
that loci co-occupied by p300, Nanog and Oct4 form long-range intragenic 
and intergenic looping interactions that are evolutionary conserved in both 
mouse and human. The observed in vivo chromatin conformation is specific to 
the pluripotent state as it was abolished in differentiated cells. Through ChIP-
3C and RNA interference (RNAi) studies, the presence of p300 and CBP was 
found to be crucial for the formation of such higher-order chromatin 
structures. Characterization of the interacting DNA elements revealed that 
some contain enhancer activities in vitro and in vivo that is dependent on p300 
and CBP. Our work, for the first time, characterizes coactivators p300 and 
CBP in ES cells as self-renewal regulator as well as bridging proteins for 
nuclear architecture which promote extensive crosstalk among multiple 
enhancers and promoters.  
 
4.3 MATERIALS AND METHODS 
Cell culture and transfection. E14 mouse
 
ES cells, cultured under feeder-free 
conditions on surfaces coated with 0.1% gelatin, were maintained in 
Dulbecco's
 





fetal bovine serum (FBS; GIBCO), 0.055 mM ß-
mercaptoethanol (GIBCO),
 
2mM L-glutamine (GIBCO), 0.1 mM minimal 
essential medium with
 
nonessential amino acids (GIBCO), and 1,000 U/ml of 
leukemia inhibitory factor (LIF)
 
(Chemicon). Transfection of shRNA and 
overexpression plasmids was performed using Lipofectamine 2000 
(Invitrogen) according to manufacturer‟s instructions. Briefly, 2.0μg plasmid 
DNA was transfected into ES cells on 60 mm plates for RNA and protein 
extraction. Detection of alkaline phosphatase, which is indicative of the 
nondifferentiated state of ES cells, was carried out using a commercial ES cell 
characterization kit (Chemicon). For RNAi–ChIP assays, 12μg plasmid DNA 
was transfected into ES cells on 150 mm plates. Puromycin (Sigma) selection 
was introduced 1 day after transfection at 1.0 μg ml−1, and maintained for 2–4 
days before harvesting. In differentiation experiments,
 
cells were treated with 
1 µM of retinoic acid (RA) for 4 days.
 
The human ES cell-line (H1, WiCell) 
was cultured feeder-free on Matrigel (BD). Condition medium used for 
culturing human ES cells contained 20% KO serum replacement, 1mM L-
glutamine, 1% non-essential amino acids and 0.1mM 2-mercaptoethanol and 
an additional 8ng.ml
−1
 of basic fibroblast growth factor (Invitrogen) 
supplemented to the hESC unconditioned medium. Medium was changed 
daily. The human ES cells were subcultured with 1mg.ml
−1
 collagenase IV 
(Gibco) every 5–7days. HEK293T (293) cells were cultured in DMEM 
supplemented with 10% FBS.  
RNA extraction, reverse transcription and quantitative real-time PCR. 
Total RNA was extracted using TRIzol Reagent (Invitrogen) and purified with 
the RNAeasy Mini Kit (Qiagen). Reverse transcription was performed using 
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SuperScript II Kit (Invitrogen). DNA contamination was removed by Dnase 
(Ambion) treatment, and the RNA was further purified by an RNAeasy 
column (Qiagen). Quantitative PCR analyses were performed in real time 
using an ABI PRISM 7900 sequence detection system and SYBR green 
master mix, as previously described. For all the primers used, each gave a 
single product of the correct size. In all controls lacking reverse transcriptase, 
no signal was detected. Each RNAi experiment was repeated at least three 
times with different batches of ES cells. The sequences targeted by shRNA 
and the primers for gene expression are in Table 1. 
Chromatin Immunoprecipitation (ChIP) and Real-Time PCR. ChIP 
assays were carried out
 
as described previously (Loh et al., 2006). Briefly, 
cells were cross-linked
 
with 1% formaldehyde for 10 min at room temperature, 
followed by the addition of 0.2 M glycine to inactivate the formaldehyde. 
Cells were then lysed to obtain chromatin extracts, which were sonicated to 
obtain DNA fragments with an average size of 300-500
 
bp. The resulting 
chromatin extracts were immunoprecipitated using anti-Nanog (Cosmo Bio 
#RCAB00022PF), anti-p300 (sc-585, Santa Cruz), anti-CBP (sc-583, Santa 
Cruz) or anti-GST (sc-459, Santa Cruz) polyclonal
 
antibodies immobilized on 
Protein-G beads. For all ChIP experiments,
 
real-time PCR analyses were 
performed in technical duplicates using
 
the ABI PRISM 7900 Sequence 
Detection System and SYBR Green
 
Master Mix as described previously (Loh 
et al., 2006). Relative occupancy
 
values (fold enrichment) were calculated by 
determining the apparent immunoprecipitation
 
efficiency (ratios of the amount 
of immunoprecipitated DNA to
 
that of the input sample) and normalized to the 
level observed
 
at a control region, which was defined as 1.0. All ChIP 
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experiments were repeated at least three times. For all the primers used, each 
gave a single product of the right size, as confirmed by agarose gel 
electrophoresis and dissociation curve analysis. Primer sequences are Table 1.  
Co-immunoprecipitation – Transfected cells were lysed in cell lysis buffer 
(50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP40, 10% 
glycerol with protease inhibitor cocktail) for 1 h. Whole cell extracts were 
collected and precleared. Beads coated with Oct4 (sc-8628, Santa Cruz) or 
Nanog (sc-7392, Santa Cruz) or p300 (sc-585, Santa Cruz) or CBP (sc-583, 
Santa Cruz) antibody were incubated with the precleared whole cell extracts at 
4 
o
C for overnight. The beads were washed with cell lysis buffer 4 times. 
Finally, the beads were boiled in 2x sample buffer for 10 min. The eluents 
were analyzed by either protein staining or Western blot.  
GST pulldown assay – Full-length nanog and CBP and various deletion 
fragments were cloned into pET42b (Novagen). The plasmids were 
transformed into BL21 E coli. The proteins were expressed and purified with 
GSH-sepharose beads (Amersham) followed by Ni-NTA beads (Qiagen). The 
purified proteins were bound to GSH beads and incubated with recombinant 
CBP or nanog proteins for 2 h in 4 
o
C. The beads were washed 6 times with 
cell lysis buffer. The eluents were analyzed by Western blot. 
Chromosome Conformation Capture (3C) assay and ChIP-3C assay. The 
3C assay was performed as described previously(Miele et al., 2006) with some 
modifications. Briefly, cells were crosslinked with 1% formaldehyde for 5 min 
at room temperature. The cells were then subjected to cell lysis. Nuclei were 





C with shaking. The enzyme was inactivated with SDS (1.3% 
final concentration) and shaking for 15 minutes at 65
o
C. 1x ligation buffer and 
TritonX-100 (1% final concentration) were then added to the nuclei and 
incubated for 1 hour at 37
oC. An 800 μl ligation reaction was prepared with 
400 Weiss Units T4 DNA ligase (NEB), 8 μl 10 mg/ml BSA, and 8 μl 100 
mM ATP. The sample was incubated for 4 hours at 16
o
C and 30 minutes at 
room temperature. The percentage of digestion and ligation of BglII fragment 
was analyzed. DNA was then purified and subjected to PCR amplification of 
chimeric products using Hot-Star polymerase (Qiagen). BAC clones of 
Children's Hospital Oakland Research Institute (CHORI) were used to prepare 
positive control template for the loci of interest. For mouse Dppa3-Nanog-
Slc2a3 cluster, we used the BAC clone RP24-73P7; for mouse Tcf3 locus, we 
used the BAC clones RP23-295I11 and RP24-313P9; for human DPPA3-
NANOG-SLC2A14 loci, we used the BAC clone RP11-277J24; and for human 
TCF7L1 locus, we used the BAC clones RP11-312D1. To assure that DNA 
templates prepared from 3C analyses are working and to standardize the cross-
linking frequency in all cell samples, we chose a primer pair that targets two 
nearby restriction fragments for the GAPDH (RP11-72G18) and Ndufa4 
(RP23-230A2) loci to be used as a control for the 3C analyses as they are 
constitutively expressed genes in human cells and mouse cells respectively, 
and they are also located on the same chromosome with the loci of interest. 
ChIP-3C assays were performed as essentially described previously with slight 
modifications (Horike et al., 2005; Murrell et al., 2004). Briefly, antibody-
specific immunoprecipitated chromatin was obtained as described above for 
ChIP assays. Chromatin still bound to the antibody-Protein-A-Sepharose 
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beads was digested with restriction enzyme, ligated with T4 DNA ligase, 
eluted, and de-crosslinked. After purification, the ChIP-3C material was 
detected for long range interaction with primers from the p300, Nanog and 
Oct4 co-binding regions. Primer sequences used for ChIP, 3C, and ChIP-3C 
assays are available in Table1. 
Luciferase reporter assays.  The p300, Nanog and Oct4 co-binding 
fragments of about 500 bp were cloned downstream of a luciferase gene 
driven by the Oct4 minimal promoter as described previously (Chew et al., 
2005). The constructs were co-transfected with either p300/CBP or empty 
vector construct into murine ES cells and the selection was performed with 
puromycin treatment.  Luciferase activity was determined 72 hours after 
transfection using the dual-luciferase reporter assay system (Promega).  
BAC clones and BAC recombineering using galK positive/negative 
selection. The bacterial artificial chromosome (BAC) clone RP11-277J24 was 
obtained from the Children's Hospital of Oakland Research Institute repository 
(http://www.chori.org/). BAC-containing bacterial stocks were propagated in 
LB medium supplemented with chloramphenicol. Modification of BACs was 
performed according to the procedure
 
described previously (Warming et al., 
2005). To introduce galK at the desired position, the galK cassette with 50 bp 
arms homologous to RP11-277J24 was PCR-amplified using 2 ng pGalK and 
25 pmol primers and the following PCR conditions: 94 °C for 45 s, 58 °C for 
45 s, 72 °C for 90 s, for 30 cycles. PCR primers for Del2, Del3 and Del4 are 
available in Table 1. Templates were removed from the PCR products by DpnI 
digestion and gel purification. For positive selection, 50 ml Luria–Bertani 
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(LB) medium supplemented with 12.5 μg chloramphenicol ml−1 was 
inoculated with SW102 bacteria containing pHB5 (SW102-pHB5); the 
bacteria were grown at 32 °C until an A600 of 0.6 was reached. The culture 
was heat-shocked at 42 °C for 15 min, then cooled briefly in an ice/water bath 
slurry and pelleted at 4500 g at 0 °C for 5 min. Bacteria were washed twice 
with 20 ml double-distilled H2O (ddH2O) and were finally resuspended in 
ddH2O. Subsequently, 25 μl of the electrocompetent SW102-pHB5 bacteria 
were transformed with 150 ng PCR product in a 0.2 cm cuvette using a Bio-
Rad Gene Pulser Pulse Controller (Bio-Rad) at 25 μF, 1.75 kV and 200 Ω. 
Bacteria were recovered in 1 ml LB medium for 1 h at 32 °C and then washed 
three times in 1 ml 1× M9 salts. Bacteria were resuspended in 500 μl 1× M9 
salts before plating serial dilutions onto M63 plates supplemented with 0.2 % 
galactose, 1 mg D-biotin l−1, 45 mg L-leucine l−1 and 12.5 μg 
chloramphenicol ml−1. Plates were incubated for 3 days at 32 °C. Gal+ 
colonies were streaked sequentially twice onto Gal indicator plates 
(MacConkey agar; BD Biosciences) supplemented with 0.2% galactose and 
12.5 μg chloramphenicol ml−1, and incubated overnight at 32 °C. Using the 
same recombination procedure, galK was replaced by two complementary 
oligos to the. Again, PCR fragments with arms complementary to 50bp 
homologous arms used for deletion were amplified in order to replace galK. 
The conditions for PCR amplification are the same outlined as above. The 
sequences of complementary are available in supplementary table S3. Again, 
the plasmid template was removed by DpnI digestion and gel purification. As 
described above, bacteria were heat-induced and transformed with 300 ng 
PCR product. The bacteria were recovered in 10 ml LB medium for 4.5 h at 32 
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°C, and were washed as described above. Serial dilutions were plated on M63 
medium supplemented with 0.2% glycerol, 1 mg D-biotin ml−1, 45 mg L-
leucine ml−1, 12.5 μg chloramphenicol ml−1 and 0.2% 2-deoxygalactose 
(DOG; Sigma-Aldrich) to select for bacteria in which the galK gene had been 
removed from the BAC. Plates were incubated for 3 days at 32 °C. 
Phosphorylation of DOG by GalK into 2-deoxygalactose-1-phosphate is toxic, 
resulting in the suppression of bacteria that failed to replace galK. This led to 
the exclusive growth of clones that contained the desired recombinant BAC. 
BAC clones with deletion were analysed by PCR, sequencing and BAC DNA 
restriction analysis. For this, ClaI, PmeI, XhoI triple-digested BAC DNA was 
separated electrophoretically at 50–100 V for approximately 24 h using a 0.6% 
agarose gel.  
BAC transfection and generation of stable cell lines. Stable cell lines were 
generated by transfection of mouse ES cells with engineered BAC plasmid 
using lipofectamine (Invitrogen) and selection in 1 mg/mL neomycin (Gibco) 
selection. Surviving ES cell clones were submitted to a second round of 
selection with a higher (2 mg/ml) neomycin concentration. ES cell clones 
survived for the second round were cultured for at least 5 passages and 
analyzed by RT-PCR to check the integration of complete engineered BAC 
clones. The correct clones were then extracted for RNA and analyzed for gene 
expression by RT-PCR. 























   
4.4 RESULTS 
p300 and CBP play redundant roles in maintaining the undifferentiated 
state of ES cells. 
To assess the functional roles of p300 and its closely related gene, CBP in ES 
cells, we depleted endogenous p300 and CBP to about 40%, respectively, by 
RNAi (Figure 4.1). Two short-hairpin RNA (shRNA) constructs targeting 
different regions of the transcript were used to ensure that the effects were 
specific. Alkaline phosphatase (AP) staining and the expression of 
pluripotency marker genes ware analyzed to evaluate whether the ES cells 
underwent differentiation. Consistent with the previous report (Zhong and Jin, 
2009), no morphology change of ES cells was observed due to the knockdown 
of p300. Typical colony morphology of ES cells with positive alkaline 
phosphatase staining (red) was maintained in p300 knockdown cells as in 
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control cells transfected by luciferase shRNA (Figure 4.1A). Similarly, 
depletion of CBP has no obvious effect on ES cells morphology neither 
(Figure 4.1A). In addition, pluripotency markers Pou5f1, Nanog were 
expressed at comparable levels in p300 or CBP depleted ES cells and control 
ES cells (Figure 4.1B, C). This data indicates that either p300 or CBP is not 
required for the self-renewal of ES cells.  
                     
Figure 4.1. p300 and CBP are dispensable for the maintenance of ES cells.  
(A) Alkaline phosphatase (AP) staining (red) was performed on control cells 
(Luc RNAi), p300 (p300 RNAi-1 and p300 RNAi-2) and CBP (CBP RNAi-1 
and CBP RNAi-2) knockdown cells two days after puromycin selection. (B) 
Quantitative real-time PCR analysis of expression of p300, Pou5f1 and Nanog 
on control and p300 knockdown cells. (C) Quantitative real-time PCR analysis 





Since p300 share very similar amino acid sequences with CBP, we 
hypothesized that CBP play a redundant role with p300 in ES cells. To test 
this hypothesis, simultaneous depletion of p300 and CBP by constructs 
expressing shRNAs targeting both two different transcripts was performed.  
Strikingly, double knockdown p300 and CBP at the same time led to cell 
differentiation and consequently disrupted ES cells self-renewal. Alkaline 
phosphatase (AP) staining of pluripotent ES cells (red color) was reduced 
dramatically in the double knockdown cells, indicative of differentiation 
(Figure 4.2A).  
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Figure 4.2. p300 and CBP are required and playing redundant roles for 
the maintenance of ES cells. (A) Concurrent knockdown of p300 and CBP 
led to ES cells differentiation. Differentiated cells with negative alkaline 
phosphatase staining were formed after knockdown using two sets of shRNA 
constructs targeting p300 and CBP. Typical colony morphology of ES cells 
with positive alkaline phosphatase staining (red) was maintained in empty 
vector and luciferase shRNA-transfected cells. (B-D) Quantitative real-time 
PCR analysis of  expression of (B) p300 and CBP, (C) ES cell-associated 
genes and (D) lineage-specific marker genes after knockdown using two 
shRNA constructs targeting different regions of the respective transcripts. The 
levels of the transcripts were normalized against control empty vector 
transfection. Data are presented as the mean ± SEM and derived from 3 
independent experiments.  
 
We further examined the expression of marker genes in double knockdown 
cells. To our expectation, the expression of self-renewal associated genes, 
Pou5f1, Sox2, Nanog and Esrrb was reduced in response to p300/CBP double 
knockdown (Figure 4.2C), while a strong induction of differentiation related 
genes were observed (Figure 4.2D), including mesoderm marker Bmp2, 
ectoderm markers Fgf5 and Nestin as well as trophectoderm markers Cdx2 and 
Hand1, suggesting that the resulting cells from double knockdown were likely 
to be composed of multiple differentiated cells.  
To further confirm the specificity of the knockdown experiments, RNAi-
resistant cDNA encoding p300 or CBP was co-transfected with p300/CBP 
shRNA. Interestingly, expression of either RNAi-resistant p300 or CBP to 
certain dosage was able to rescue the differentiation phenotype induced by 
double knockdown (Figure 4.3A). The expression of self-renewal and lineage 




       
Figure 4.3. Over-expression of p300 or CBP is able to rescue the double 
knockdown effect. (A) Rescue of concurrent knockdown phenotype by co-
expression of RNAi-resistant p300 or CBP. RNAi-resistant p300 or CBP 
expression constructs were co-transfected with corresponding p300/CBP 
RNAi targeting different regions into ES cells respectively. Typical colony 
morphology of ES cells with positive alkaline phosphatase staining (red) was 
restored. (B-D) Quantitative real-time PCR analysis of expression of (B) p300 
and CBP, (C) ES cell-associated genes and (D) lineage-specific marker genes 
after p300 or CBP rescue. The levels of the transcripts were normalized 
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against control empty vector transfection. Data are presented as the mean ± 
SEM and derived from 3 independent experiments.  
 
All these data strongly suggest that p300 and CBP are functionally redundant 
in the maintenance of self-renewal of ES cells. A reduction in the dose of one 
of them can be compensated by the other to cover the function deficit. 
 
p300 and CBP are recruited by Nanog, Oct4 and Sox2 through direct 
protein-protein interaction. 
Identifying the binding targets of transcription factors and cofactors is helpful 
for us to understand their regulatory mechanism through their downstream 
targets. Genome wide mapping study of p300 in mouse ES cells by ChIP-Seq 
has found that its binding sites are associated with Nanog, Oct4 and Sox2 
binding sites. Furthermore, enriched motif for p300 that generated from its 
ChIP-Seq data highly resembles sox-oct composite element (Chen et al., 
2008).  To validate the co-occupancy of p300 with Nanog, Oct4 and Sox2 in 
the ES cell genome, we performed p300 and CBP ChIP-qPCR on 44 sites 
randomly chosen from genomic sites that are bound by Nanog-Oct4-Sox2 
cluster as well as 12 sites bound by Myc cluster. The qPCR results are 
consistent with the ChIP-Seq data showing the binding preference of p300 to 
Nanog-Oct4-Sox2 cluster rather than Myc cluster and CBP has shown similar 
binding bias (Figure 4.4A). These data suggest that Nanog, Oct4 and Sox2 are 
recruiting both p300 and CBP as a coactivator complex to specific genomic 
sites. To test this hypothesis, we depleted Nanog, Oct4 or Sox2 by RNAi and 
checked for p300 and CBP binding. Our ChIP result showed that the binding 
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intensity of p300 as well as was reduced upon Nanog, Oct4 or Sox2 depletion 
(Figure 4.4B). 
         
 
Figure 4.4. p300 and CBP are recruited to Nanog-Oct4 -Sox2 cluster loci 
in mouse genome. (A) p300 and CBP binds to Nang-Oct4-Sox2 cluster loci, 
but not Myc cluster loci. ChIP assays were performed using anti-p300 or anti-
CBP antibody with extracts from ES cells. Fold enrichment is the relative 
abundance of DNA fragments detected by real-time PCR at the amplified 
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region over a control amplified region. Data are presented as the mean ± SEM. 
(B) Recruitment of p300 and CBP is dependent on Oct4, Sox2 and Nanog. 
ChIP assays were performed using anti-p300 or anti-CBP antibody with 
extracts from ES cells transfected with control RNAi construct, Oct4 RNAi 
construct, Sox2 RNAi construct or Nanog RNAi construct. The level of p300 
was not altered after RNAi  depletion of these TFs (data not shown). (C) p300 
and CBP interact with Nanog. Co-IP using nuclear extracts of ES cells was 
performed using anti-Nanog antibody. Western blotting was performed with 
anti-p300 or anti-CBP antibody. Control IP was performed using an anti-
greenfluorescent protein (GFP) antibody. (D) Reverse co-IP using the ES cell 
lysates was performed using anti-p300 or anti-CBP antibody. Western blotting 
was carried out with anti-Nanog antibody. Control IP was performed using an 
anti-GFP antibody. 
 
To investigate the possible protein-protein interaction between p300/CBP and 
master regulators in ES cells, coimmunoprecipitation experiments were 
performed using ES cell nuclear extracts. p300 and CBP were found to 
coprecipitate with Nanog (Figure 4.4C), whereas the reciprocal Co-IP also 
showed that Nanog  was able to coprecipitate with p300/CBP (Figure 4.4D).  
p300 and CBP are large nuclear proteins with eight distinct functional 
domains (N terminal, CH1, KIX, Bromo, CH2, HAT, CH3, glutamine-rich) 
(Blobel, 2000; Kraus et al., 1999), which mediate their interactions with 
numerous nuclear proteins and allow p300 and CBP to serve as scaffolds to 
assemble large regulatory complexes or to manipulate chromatin structure 
through histone modification to activate transcription. To map Nanog-
interactive elements on CBP, GST fusion proteins were generated with 
contiguous segments of murine CBP that collectively span the entire protein 
(Figure 4.5A). These were used in pull-down experiments with purified Nanog 
protein; proteins retained on the beads were immunoblotted with an antibody 
targeting Nanog. Only the fragment containing residues 451–721 of CBP, 
which is corresponding to KIX domain, retained Nanog proteins beyond 
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background level (Figure 4.5B). On the other hand, to localize the p300/ CBP 
interaction domain within Nanog, we expressed and purified recombinant 
Nanog and fragments of Nanog as GST-fusion proteins (Figure 4.5C). These 
proteins were immobilized onto GSH-Sepharose beads and incubated with 
purified CBP protein. Homeobox domain of Nanog as well as fragments with 
homeobox domain could interact with p300 (Figure 4.5D).           
 
Figure 4.5. Mapping the interaction domains of p300/CBP and Nanog. (A) 
Schematic diagram of wild type and deletion forms of Nanog protein. ND, N-
terminal domain; HD, homeobox domain; CD1, C-terminal domain 1;WR, 
tryptophan repeat domain; CD2, C-terminal domain 2. (B) GST pull down was 
carried out using GST-tagged Nanog proteins and purified p300 protein. 
Western blot was performed with anti-p300 antibody. GST served as negative 
control. (C) Portions of CBP expressed as GST fusion proteins in this study. 
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(D) Pull-downs with the indicated CBP amino acids fused to GST and purified 
Nanog protein. Western blot was performed with anti-Nanog antibody. GST 
served as negative control. 
 
KIX and HAT domains of p300 /CBP are critical for the self-renewal of 
ES cells. 
To further dissect the functional domain of p300 and CBP in mouse ES cells, 
we created a series of RNAi-immune expression constructs, each expressing a 





Figure 4.6. KIX and Histone acetylation (HAT) domain of p300 and CBP 
are important for their function in the maintenance of ES cells. (A) Panel 
of truncated p300 cDNA constructs used for rescue. The deletion of domain is 
indicated for each construct.  Nuclear receptor interaction domain (RID), 
cysteine/histidine-rich domains (CH1, CH2, CH3), KIX, bromodomain (Br), 
IRF3-binding domain (IBiD) and HAT. The deletion of domain is indicated 
for each construct. (B) Rescue of concurrent p300/CBP knockdown phenotype 
by co-expression of RNAi-resistant truncated p300 constructs. 
Undifferentiated ES colonies with positive alkaline phosphatase staining were 
maintained after rescue using truncated p300 constructs p300_DN1 and 
p300_DN4. (C-E) Quantitative real-time PCR analysis of expression of (C) 
p300 and CBP, (D) ES cell-associated genes and (E) lineage-specific marker 
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genes after rescue by overexpression of dominant negative p300 or CBP 
constructs. The levels of the transcripts were normalized against control empty 
vector transfection. Data are presented as the mean ± SEM and derived from 3 
independent experiments. (F) Panel of truncated CBP cDNA constructs used 
for rescue. The deletion of domain is indicated for each construct. (G) Rescue 
of concurrent p300/CBP knockdown phenotype by co-expression of RNAi-
resistant truncated CBP constructs. Undifferentiated ES colonies with positive 
alkaline phosphatase staining were maintained after rescue using truncated 
CBPconstructs CBP_DN1 and CBP_DN4. (H-J) Quantitative real-time PCR 
analysis of expression of (H) p300 and CBP, (I) ES cell-associated genes and 
(J) lineage-specific marker genes after rescue by overexpression of dominant 
negative p300 or CBP constructs. The levels of the transcripts were 
normalized against control empty vector transfection. Data are presented as 
the mean ± SEM and derived from 3 independent experiments.  
 
The mutant p300 or CBP constructs were then co-transfected with p300/CBP 
shRNA to check whether they can rescue the double knockdown effect as well 
as the constructs encoding wide type p300 and CBP. Interestingly, except the 
mutant with deleted KIX or HAT domain, all the other mutant p300 or CBP 
constructs are able to rescue the double knockdown cells, resulting in a normal 
morphology (Figure 4.6B, G) and gene expression profile as ES cells 
transfected with control shRNA (Figure 4.6C- E; H-J). These results suggest 
that the KIX and HAT domains are the functional domains of p300 and CBP 
in mouse ES cells. 
 
p300/CBP mediates intragenic looping interactions among  p300 and 
Nanog binding loci in the Tcf3 locus. 
From ChIP-Seq dataset, we identified over 3,000 high confidence p300 
binding loci(Chen et al., 2008). Interestingly, several p300 binding loci 
colocalize with Nanog and Oct4 and can be found in proximity within a single 
gene or between genes (Figure 4.7A). This raises the question of whether there 
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are physiological reasons for having multiple binding loci and if so, the 
molecular mechanisms involved in their functions. We hypothesize that these 
binding loci specifically interact with each other in ES cells by looping out the 
intervening regions, and thus may represent a unique chromatin structure in 
ES cells. To test our hypothesis, we study the loci that are densely bound by 
p300, Nanog and Oct4. 
We first confirmed the ChIP-Seq data by performing ChIP-qPCR analysis 
using primers targeting the putative binding loci in Tcf3. Tcf3 was chosen due 
to the presence of three ChIP-Seq identified binding loci of Nanog, Oct4 and 
p300 that are located at the 5′ end, middle, and 3′ end of the gene locus that is 
about 150 kb long (Figure 4.7D). Indeed, Nanog and p300 bound to all of the 
3 binding loci (Figure 4.7B, C). We observed enrichment with large variance, 
which could be due to differential efficiency in the crosslinking of protein to 
the various binding loci as Nanog or p300 may not be binding to all the sites in 
similar strength or that not all the sites are bound by Nanog and p300 directly. 
The results point toward an intriguing possibility that these binding loci are 
interacting with each other by looping and that the interaction is tethered by 
p300. 
To determine whether the binding loci are interacting with each other by 
looping out the intervening regions, we exploited the recently developed 
chromosome conformation capture (3C) assay. The 3C assay, which was first 
developed in yeast(Dekker et al., 2002), and later in mammalian 
cells(Spilianakis and Flavell, 2004; Tolhuis et al., 2002), is a powerful 
technique to analyze the overall spatial organization of chromosomes. Similar 
to ChIP assay, formaldehyde is used to preserve chromatin interactions in 
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living cells. After fixation, the DNA is then subjected to restriction digestion 
to create cohesive ends for efficient ligation. This assay relies on the ability of 
DNA restriction fragments in close juxtaposition to each other due to close 
linear distance, long range looping interactions or interchromosomal 
interactions in vivo to be ligated to form chimeric DNA fragments, which can 
be amplified using specific primer pairs. It has been used in several recent 
studies to detect interactions between 2 proposed DNA fragments located far 
away from each other(Murrell et al., 2004; Spilianakis and Flavell, 2004; 
Tolhuis et al., 2002)
,
 (Ling et al., 2006; Lomvardas et al., 2006; Spilianakis et 
al., 2005). 
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Figure 4.7. p300 and CBP mediate intragenic looping interactions among 
colocalization loci (A) ChIP-seq binding profiles for Nanog, Oct4 and p300 at 
the Tcf3 gene loci are shown. (B-C) ChIP assays were performed using anti-
Nanog (B) or anti-p300 (C) antibody with extracts from ES cells transfected 
with control RNAi construct, p300 RNAi construct, CBP RNAi construct or 
p300/CBP RNAi construct. (D) Schematic representation of the murine Tcf3 
locus. Dark boxes represent exons and red boxes represent ChIP-Seq 
identified Nanog binding loci, named by the Roman numerals indicated below 
them. Relevant BglII restriction fragments are indicated by short green 
horizontal bars. Primers are named by Roman alphabets and their orientations 
are indicated by arrows. (E) 3C analyses of Tcf3 locus on murine ES cells 
transfected with control Luc RNAi construct (top panel), p300 RNAi 
construct(second panel), CBP RNAi (third panel) and p300/CBP RNAi (fourth 
panel). Bottom panel, PCR controls done using BAC DNA harboring the Tcf3 
locus. (F) ChIP-3C analyses done on murine ES cells using p300 antibody 
(Left panel) and CBP antibody (right panel). Presence or absence of amplicons 
is detected in a 1.5% agarose gel using the primer combinations indicated on 
the left of each panel. Lane P is a BAC control and the leftmost lanes represent 
PCR markers to show sizes of the amplicons. DNA samples used in the PCR 
reactions were prepared with or without ligase added in the 3C assays to show 
that presence of amplicons is ligase-dependent.   
 
We first started the 3C analysis using an invariant primer (primer B, Figure 
4.7D), targeting the restriction fragment next to the Nanog and p300 binding 
locus at the 3′ end of Tcf3, together with one of a series of primers 
complementary to different restriction fragments along this gene. Successful 
amplification of a PCR product from a primer pair signifies the detection of a 
chimeric fragment (Figure 4.7E). The identities of all the PCR products were 
verified by sequencing. As recommended by Dekker(Dekker, 2006), we 
showed that detection of chimeric DNA fragments was ligation dependent in 
all 3C assays. Furthermore, all primer combinations were verified to be able to 
give rise to their respective amplicons and the sizes of the PCR products 
obtained from our 3C samples were identical to that obtained from the BAC 
controls (Figure 4.7E, lower panel). As an internal control for our 3C assays, 
we used a primer pair targeting two BglII restriction fragments, from the 
unrelated Ndufa4 locus, that were separated by 7.9 kb apart. Due to the 
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proximity of the restriction fragments, we would expect them to be ligated to 
form a chimeric DNA fragment in all our 3C assays as formaldehyde is able to 
capture random collisions between two nearby chromatin loci.   
 
The results indicated that there are interactions between region A with regions 
D, E, H, and I, which are regions close to Nanog and p300 binding loci. No 
PCR products were detected when the invariant primer A was used together 
with any other primers complementary to the regions (B, C, F, and G) in 
between the Nanog and p300 binding loci (Figure 4.7E,top panel). In addition, 
the looping interactions appeared to be ES cell-specific as amplicons 
corresponding to the chimeric DNA fragments were not detectable after 
subjecting ES cells to retinoic acid (RA)-induced differentiation, indicating the 
abolishment of looping interactions (Figure 4.8).         
 
Figure 4.8. Intragenic looping interactions are specific to the pluripotent 
state. (A) Schematic representation of the mouse Tcf3 locus. (B) 3C analyses 
of Tcf3. Top panel, 3C analyses on mouse E14 ES cells. Second panel, 3C 
analyses on RA treated ES cells. Bottom panel, PCR controls done using BAC 
DNA harboring the Tcf3 locus. 
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Since the chromosomal loops are formed between fragments bound by 
p300/CBP, our data strongly suggest that p300 and CBP are involved in the 
formation of the loops.To further confirm the dependence on p300/CBP, 3C 
analysis was performed using ChIP-enriched DNA samples (ChIP-3C), using 
either p300 or CBP as the antibody. Interactions between the binding 
fragments on the 5′ end and 3‟ end of Tcf3 (Figure 4.7F) were recapitulated. 
However, other interactions were not successfully verified by ChIP-3C in our 
hands, possibly due to the low enrichment of certain DNA fragments and/or 
impaired digestion and ligation efficiencies when both were done on beads. 
                
Figure 4.9. RNAi samples for 3C assays. (A) Morphology of Luc, p300, 
CBP and p300/CBP knockdown cells harvested for 3C assays. (B) Western 




To further determine whether p300 or CBP is required for the formation of the 
chromosomal loops, 3C analysis was performed on ES cells transfected with a 
p300 or CBP or p300/CBP double knockdown construct. A luciferase 
knockdown construct was also introduced into the cells as control. To exclude 
the effect of comprehensive differentiation, knockdown cells were harvested 
before morphological changes begin to appear, the protein levels of Nanog, 
Oct4 and Sox2 were not changed as well (Figure 4.9). The looping structure 
retained after knocking down either p300 or CBP. However, depletion of both 
p300 and CBP led to the abolishment of chromosomal loops, while the control 
knockdown had no effects (Figure 4.7E upper panel).  
Altogether, the data support a model whereby the 3′ end of Tcf3 forms loop 
structures with two other loci, one located about 50 kb away in the middle of 
intron 3 and the other located about 160 kb away at the 5′ end of the Tcf3 
gene. The long range communications between these loci correlate with the 
presence of Nanog and p300 binding loci and these structures are dependent 
on p300 and CBP. 
. 
p300/CBP mediates intergenic looping interactions among Nanog binding 
loci in the Dppa3-Nanog-Slc2a3 locus. 
Having shown the presence of long range intragenic chromosomal looping, we 
next extended our investigation further by looking for the presence of 
intergenic chromosomal looping. The Dppa3-Nanog-Slc2a3 gene cluster was 
chosen due to the presence of several ChIP-Seq identified Nanog and p300 
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binding loci within the cluster containing three genes preferentially expressed 






Figure 4.10. p300 and CBP mediate intergenic looping interactions among 
colocalization loci. (A) ChIP-seq binding profiles for Nanog, Oct4 and p300 
at the Dppa3-Nanog-Slc2a3 gene loci are shown. (B-C) ChIP assays were 
performed using anti-p300 (B) or anti-CBP(C) antibody with extracts from ES 
cells transfected with control RNAi construct, p300 RNAi construct, CBP 
RNAi construct or p300/CBP RNAi construct. (D) Schematic representation 
of the murine Dppa3-Nanog-Slc2a3 loci. Dark boxes represent exons and red 
boxes represent ChIP-Seq identified Nanog binding loci, named by the Roman 
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numerals indicated below them. Relevant BglII restriction fragments are 
indicated by short green horizontal bars. Primers are named by Roman 
alphabets and their orientations are indicated by arrows. (E) 3C analyses of 
Dppa3-Nanog-Slc2a3 loci on murine ES cells transfected with control Luc 
RNAi construct (top panel), p300 RNAi construct(second panel), CBP RNAi 
(third panel) and p300/CBP RNAi (fourth panel). Bottom panel, PCR controls 
done using BAC DNA harboring the Dppa3-Nanog-Slc2a3 loci. (F) ChIP-3C 
analyses done on murine ES cells using p300 antibody (Left panel) and CBP 
antibody (right panel). Presence or absence of amplicons is detected in a 1.5% 
agarose gel using the primer combinations indicated on the left of each panel. 
Lane P is a BAC control and the leftmost lanes represent PCR markers to 
show sizes of the amplicons. DNA samples used in the PCR reactions were 
prepared with or without ligase added in the 3C assays to show that presence 
of amplicons is ligase-dependent.   
 
We found that the four fragments bound by Nanog and p300, one located 2.1 
kb upstream of the transcriptional start site (TSS) of Dppa3, one located 5.1 
kb upstream of the TSS of Nanog, one located 2.5 kb upstream of the TSS of 
Slc2a3, and the last one located 30 kb upstream of the TSS of Slc2a3, can 
interact with each other by forming chromosome loops, excluding the 
intervening regions (Figure 4.10E). Again, such long-range interaction is ES 
cell-specific as the loops were abolished upon RA-induced differentiation 
(Figure 4.11) and are dependent on the presence of either p300 or CBP as 
proved by ChIP-3C and 3C on RNAi samples (Figure 4.10E, F).  
138 
 
         
Figure 4.11. Intergenic looping interactions are specific to the pluripotent 
state. (A) Schematic representation of the mouse Dppa3-Nanog-Slc2a3 loci. 
(B) 3C analyses of Dppa3-Nanog-Slc2a3 loci. Top panel, 3C analyses on 
mouse E14 ES cells. Second panel, 3C analyses on RA treated ES cells. 
Bottom panel, PCR controls done using BAC DNA harboring the Dppa3-
Nanog-Slc2a3 loci. 
 
Chromatin looping structure is evolutionarily conserved in human ES 
cells. 
To access whether similar intragenic looping interactions occur in human ES 
cells, interacting loci in the TCF7L1 gene, the ortholog of the murine Tcf3 
gene, were predicted by converting the position of the relevant genomic locus 
from the mouse assembly to that from the human assembly through the 
Convert function in the UCSC Genome Browser website (Figure 4.12A). 
When ChIP and 3C assays were then performed on human ES cells, the 
predicted interacting loci were confirmed to be bound by Nanog and p300 in 
vivo (Figure 4.12B) and that the regions encompassing the binding loci formed 
chromosomal loops with each other (Figure 4.12C), indicating that the 
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intragenic loop structures are evolutionarily conserved in mouse and human. 
Furthermore, this was also verified for intergenic loci. (Figure 4.12D-F). 
Additionally, we also found that these interactions are ES cell-specific as the 
looping interactions are not present in HEK293T cells, a differentiated human 
cell line (Figure 4.12C, F, bottom panel). Interestingly, the human DPPA3-
NANOG-SLC2A14 locus is located on human chromosome 12p, a region 
clustered with pluripotency genes, which has a distinctively central nuclear 
localization in ES cells but peripheral nuclear localization in differentiated 
cells27, probably correlating with its unique looping structure described here. 
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Figure 4.12. The intragenic and intergenic looping interactions are 
conserved in human ES cells. (A, D) Schematic representation of the human 
(A) TCF7L1 locus and (D) DPPA3-NANOG-SLC2A14 loci. Labels are as in 
(Figure 8, 10D). (B, E) ChIP analyses on Nanog binding loci shown in (B)  
TCF7L1 locus and (E) DPPA3-NANOG-SLC2A14 loci using Nanog antibody 
(anti-Nanog, white) and GST antibody (anti-GST, black) as a mock ChIP 
control. Labels are as in (Figure 8, 10E). (C, F) 3C analyses on the (C) 
TCF7L1 locus and (F) DPPA3-NANOG-SLC2A14 loci. Presence or absence of 
amplicons is detected in a 1.5% agarose gel using the variable primers 
indicated on top of each lane with the invariant primer G. Top panels, 3C 
analyses done on human ES cells. Middle panels, 3C analyses done on 
HEK293T cells (293 cells). Bottom panels (BAC control), 3C analyses done 
using BAC DNA harboring the relevant genomic regions to show that the all 
possible ligation products can be amplified using the indicated primer 
combinations.     
 
DNA fragments involved in looping interactions have enhancer activities. 
Our 3C and ChIP-3C data begs the question of whether such higher order 
chromatin structures have functional relevance. We hypothesized that the 
chromosomal loops may help to bring cis-regulatory elements such as 
enhancer regions in contact with promoters at the active gene loci. To test this, 
we sought to characterize the genomic DNA associated with the anchor of the 
loop. Since looping formation has been previously shown to mediate long 
range communications between enhancers and promoters(Tolhuis et al., 2002), 
we embarked on testing whether regions around the binding loci on the active 
loci have enhancer activities. As enhancers are defined as positively-regulating 
elements that are position-independent, we cloned fragments of about 400-
500bp encompassing each binding locus on the active gene loci downstream 
of a luciferase reporter driven by a Pou5f1 minimal promoter (Figure 4.13A). 
The reporters were co-transfected with either p300/CBP double knock down 
construct or empty vector construct into murine ES cells, which were then 
assayed for luciferase activity. Interestingly, we found that fragments 
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encompassing the Nanog promoter, the fourth Nanog/p300 binding locus on 
Slc2a3, and the second and third Nanog/p300 binding loci on Tcf3 have 
enhancer activities, as shown by the higher luciferase activity relative to a 
luciferase reporter containing the Pou5f1 minimal promoter only (Figure 
4.13B). The data also confirmed our previous identification of a functional 
enhancer about 5 kb upstream of Nanog28. Importantly, the enhancer 
activities are p300/CBP dependent as knocking down p300 and CBP resulted 
in a significant decrease in the enhancer activities (Figure 4.13B).  
To further investigate the functions of chromatin looping interactions in 
transcription activation in vivo, we took advantage of bacterial artificial 
chromosome (BAC), which encompasses the sequences that are involved in 
the formation chromatin looping. Human BAC clone RP11-277J24, which 
contains the genomic fragment from human chromosome12 spanning the 





Figure 4.13. Characterization of the DNA fragments involved in looping 
interactions. (A) Reporter constructs used to assay for enhancer activity are 
shown. Genomic fragment of approximately 300 bp (in red) was inserted 
downstream (Luc-Nanog Enh) of a luciferase gene driven by Oct4 minimal 
promoter. (B) Luciferase reporter assay. Murine ES cells were co-transfected 
with a luciferase reporter plasmid and either a p300/CBP knockdown construct 
(p300/CBP RNAi) or an empty vector (Vector RNAi) and then subjected to 
luciferase reporter assay analysis. Y-axis represents the fold enrichment of 
luciferase activity, calculated relative to a luciferase reporter containing the 
Oct4 minimal promoter only and normalized over an internal transfection 
control. X-axis represents the Nanog and p300 binding fragments (labeled as 
in Fig 5, 6) cloned into the luciferase reporter plasmid. Error bars represent 
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standard deviations obtained from 3 repeats. (C) Schematic representation of 
the human DPPA3-NANOG-SLC2A14 loci. Dark boxes represent exons and 
green boxes represent deleted regions, as indicated below them. (D) ClaI, 
PmeI, XhoI triple digestion of BAC DNA. Digested BAC DNA is detected in 
a 1.5% agarose gel. (E-G) Quantitative real-time PCR analysis of expression 
of (E) human NANOG gene (hNANOG),(F) mouse ES cell-associated genes 
and (G) mouse lineage-specific marker genes in stable mouse ES cell lines 
with the insertion of specific modified BAC clones. The levels of the 
transcripts were normalized against control empty vector transfection. Data are 
presented as the mean ± SEM and derived from 3 independent experiments. 
 
Three deletions have been introduced to RP11-277J24 specifically. Del1 is 
located in the middle of DPPA3 and NANOG gene and not involved in 
chromatin looping based on our results, it was used as a control modification. 
Del2 and Del3 are upstream of NANOG gene and bound by both Nanog and 
p300. They have been shown to interact with the other fragments and form 
chromatin loops (Figure 4.13C). To assess whether the BACs were correctly 
modified, we performed detailed restriction mapping of the original BAC, 
RP11-277J24 as well as the three modified BACs, Del2, Del3 and Del4, using 
digests with ClaI, PmeI and XhoI. Two clones for each modification had the 
desired deletion (Figure 4.13D). Then we transfected the three modified 
human BAC clones into murine ES cells and establish stable cell lines with 
entire BAC clones. The expression of mouse genes was not much changed in 
the BAC tranfected stable cell lines (Figure 4.13F, G). However, the 
expression of human NANOG and DPPA3 expression was significantly 
reduced in the cells transfected with Del2 and Del3 compared with control 
cells that transfected with Del1 (Figure 4.13E). These results demonstrated 
that deletion of interacting fragments that are involved in chromatin looping 





Self-renewal and pluripotency are the key characteristics through which the 
proliferation and function of ES cells are maintained. Our data demonstrate 
that two paralogous proteins which act as coactivators in the cells, p300 and 
CBP, are required for optimal support of ES cell maintenance, as ES cell lost 
its identity if lacking both p300 and CBP. In addition, p300 and CBP are 
shown to play overlapping functions in ES cells, probably due to the high 
protein homology shared by them. Introducing either p300 or CBP into 
p300/CBP double knock down ES cells to certain dosage is able to retain self-
renewal capacity of ES cells. Gene knockout experiments have shown that 
mice with homozygous p300 or CBP mutations are lethal, even with the 
normal expression level of the other paralogue, while double heterozygotes 
p300-/CBP- are also lethal, suggesting either that p300 and CBP have 
nonoverlapping functions, such that both coactivators are required, or that the 
total level of CBP and p300 is critical for normal development (Kung et al., 
2000; Oike et al., 1999; Yao et al., 1998). Our data, to some extent, support 
the later notion that the total level of p300 and CBP is essential for ES cell 
self-renewal, manipulating the overall dosage of p300/CBP is able to control 
the ES cell identity. However, it is also possible that these two paralogues may 
play distinct roles for maintaining the pluripotent state of ES cells. The earlier 
study of p300
-/-
 ES cells has shown that these cells, although having normal 
expression of CBP and self-renewal capacity, their ability of differentiation is 
significantly disturbed(Zhong and Jin, 2009). Study of p300 and CBP in 
hematopoietic stem cells (HSC) has demonstrated their essential but distinct 
roles in maintaining normal hematopoiesis. CBP, but not p300 is critical, in 
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maintaining the total pool of mouse HSC through self-renewal; whereas p300, 
but not CBP, appears to contribute to hematopoietic differentiation (Rebel et 
al., 2002). In our case of ES cells, to better understand whether p300 and CBP 
play distinct roles to regulate ES cells differentiation, further studies of 
pluripotency in CBP
-/-
 ES cells or by manipulating the dosage of p300/CBP 
are remained to be investigated. 
As coactivators, p300 and CBP are found to regulate transcription either 
through endogenous histone acetyltransferase (HAT) activity or through 
association with transcription factors as well as general transcriptional 
machinery as adaptor proteins. Domain mapping studies enabled us to 
discover the functional domains of p300 and CBP, thus understand their 
molecular mechanisms within the cells. Our domain mapping study has found 
that KIX domain is the interaction domain of p300/CBP with Nanog. The KIX 
domain is one of several domains p300/CBP that bind several transcriptional 
regulators; it is highly conserved in evolution, with 90% identity in human 
CBP and p300 (Radhakrishnan et al., 1997). It has been shown to have 
significant functions in mouse development, especially in haematopoiesis 
system, as in mice homozygous for point mutations in the KIX domain of 
p300 designed to disrupt the binding surface for the transcription factors c-
Myb and CREB7–9, multilineage defects occur in haematopoiesis, including 
anaemia, B-cell deficiency, thymic hypoplasia, megakaryocytosis and 
thrombocytosis (Kasper et al., 2002). It will be interesting to see whether 
mutation of KIX would have any effect on ES cell self-renewal and 
pluripotency as it disrupts the interaction between p300/CBP with master 
regulators in ES cells. Further characterization of functional domains of 
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p300/CBP in ES cells has identified that besides KIX domain, HAT domain is 
indispensable for p300/CBP fulfilling their function as well, suggesting that 
p300/CBP may regulate transcription through their histone acetyltransferase 
activity. p300 and CBP are found to be able to acetylate all four core histone 
in vitro, interestingly, they are found to mediate acetylation of histone H3 on 
lysine 56 recently(Das et al., 2009), which is a newly identified histone 
modification  marker that overlap strongly with the binding of the master 
regulators of ES cells(Xie et al., 2009). Altogether, these results strongly 
indicate that master regulators recruit p300/CBP through contacting KIX 
domain of them and the intrinsic HAT activity of p300/CBP acetylate histone 
H3K56 on the local chromatin, resulting in the co-localization of binding sites 
and H3K56 markers. 
Besides the study of transcriptional machinery, understanding the nuclear 
architecture and higher-order chromatin organization in ES cells is of interest 
to ES cell research due to the unusual chromatin structure that has been found 
in ES cells3. For example, chromatin in ES cells has been shown to be marked 
bivalently by activating and repressive histone modifications at many 
developmental or lineage specific genes, which is suggested to be a 
mechanism to silence gene expression while keeping the genes poised for 
activation during differentiation (Azuara et al., 2006; Bernstein et al., 2006; 
Giadrossi et al., 2007). In addition, ES cell chromatin has elevated levels of 
histone modifications associated with gene activity (Lee et al., 2004; Meshorer 
et al., 2006), and more dynamic interactions with chromatin proteins 
(Meshorer et al., 2006), pointing towards a unique chromatin state that is 
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relevant to how genes are regulated in ES cells and probably how pluripotency 
is maintained. 
In order to understand complex gene regulation, one key question is how 
distant regulatory DNA elements communicate with each other. Indeed, recent 
studies on higher-order chromatin organization in several gene loci have 
yielded accumulating information on the impact of cell type specific 
chromatin organizations on gene expression and cell function (Horike et al., 
2005; Murrell et al., 2004; Spilianakis and Flavell, 2004; Tolhuis et al., 2002). 
Several models have been proposed to explain the correct spatial organization 
of gene expression (Kellum and Schedl, 1991; West et al., 2002). The most 
widely accepted model of long-range regulatory interactions is the looping 
model, which proposes that distant enhancers and promoters are in physical 
contact, while the intervening regions are looped out. The first evidence to 
support this model is from the study of the chicken beta-globin gene cluster 
(Choi and Engel, 1988). In this case, all sequences necessary for the efficient 
transcription of one of the genes in the cluster were found in close proximity, 
while the inactive regions were pushed aside (Choi and Engel, 1988). The 
genetic study on the regulation of the homeotic Abdominal-B (Abd-B) gene in 
Drosophila, as one of the best studied systems, indicates that proper targeting 
of the Abd-B promoter is most likely to be a result of cooperation among a 
number of different elements, including promoter targeting sequence (PTS)-
like sequences, boundaries, upstream tethering elements, polycomb and 
trithorax response elements (PREs/TREs), and any other unidentified 
regulatory units (Kellum and Schedl, 1991). In addition, long-range 
chromosomal structures within Nanog locus in ES cells have been reported 
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previously by examining the DNaseI hypersensitive sites (HS) using high-
throughput quantitative chromatin profiling (QCP) approach. Nevertheless, the 
study of looping formation has been focused on cis-regulatory elements; 
information derived from trans-acting factors has only started to be 
appreciated.  
 In our study, Nanog and p300 binding loci on Tcf3 (TCF7L1) and Dppa3-
Nanog-Slc2a3 (DPPA3-NANOG-SLC2A14) cluster are proven to be involved 
in long range intragenic and intergenic looping interactions respectively. The 
interactions are not detectable in differentiated murine ES cells and in a 
differentiated human cell line. p300 and CBP are further confirmed to be 
involved in the looping interactions through ChIP-3C and depletion of 
p300/CBP through RNAi results in abolishment of the interactions. 
Furthermore, interacting loci are found to bear in vitro and in vivo enhancer 
activities which are reduced significantly upon p300/CBP depletion. Our 
current report on pluripotency-associated looping interactions among 
enhancers and promoters highlights a new dimension in studying and 
understanding three-dimensional chromatin architectures. In previous studies, 
such as those involving the α- and β-globin loci (Carter et al., 2002; Palstra et 
al., 2003; Spilianakis and Flavell, 2004; Tolhuis et al., 2002), TH2 cytokine 
locus (Spilianakis and Flavell, 2004), and the PSA locus (Wang et al., 2005), 
looping interactions are predicted when cis-regulatory elements and the 
respective genes have been characterized previously, including enhancers, 
LCRs, and presence of DNase I hypersensitivity sites. Here, we report that 
looping interactions can be predicted by examining binding locations that are 
densely occupied by cell type specific transcription factors and coactivators, 
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along individual chromosomes. Such predictions may not only be applied to 
other cell types in the study of long-range interactions, but also allow for the 
identification of novel cis-regulatory elements and the trans-acting factor that 
is mediating their functions and organizations. 
 Furthermore, we found that p300 and CBP are more likely to act as the 
molecular tethers to stabilize the large protein complex and maintain the 
higher order structure. Depletion of both p300 and CBP would disrupt the 
looping structure; even the protein level and binding intensity of Nanog and 
Oct4 were unchanged. So the model that we are suggesting for this long range 
looping regulation is that master regulators, such as Nanog, Oct4, recognizes 
their specific cis-regulatory elements and bind to specific loci within a gene or 
gene cluster; They recruit coactivators p300 and CBP and together with other 
transcription factors and cofactors, they form a large nucleoprotein complex 
and draw DNA into a looping structure to bring the self-renewal associated 
genes, such as Tcf3, Dppa3, Nanog, and Slc2a3, together for efficient 
transcriptional regulation, possibly in a transcription factory (Fraser, 2006). 
They might be sharing cis-regulating elements such as enhancers, activator 
and coactivator complexes, chromatin-remodeling complexes, and/or the 
transcription machinery for efficient expression. p300 and CBP are acting as 
molecular tether connecting different transcription factors and stabilizing this 
higher-order structure (Figure 4.14). Our finding is consistent with and 
extends the earlier studies of long range chromatin structure within Nanog 
locus in mouse ES cells. In the earlier study, they have shown that Oct4, as 
one of the master regulators in ES cells, is essential to maintain the higher 
order chromatin structure, as the looping structure is abolished in Oct4-
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depleted cells. Based on our model, depletion of Oct4 would reduce the 
recruitment of p300/CBP, thus abolish the looping that tethered by p300/CBP.  
         
Figure 4.14. Model showing the three-dimensional organization of Dppa3-
Nanog-Slc2a3 loci. Core regulators (eg., Nanog, Oct4, Sox2) recognize their 
specific cis-regulatory elements and bind to specific loci within the gene 
cluster of Dppa3-Nanog-Slc2a . They recruit coactivator complex p300/CBP, 
and together with other transcription factors and cofactors, they form a large 
nucleoprotein complex and draw DNA into a loop structure. p300/CBP act as 
the molecular tether to stabilize the protein complex and also by their intrinsic 
HAT activity, they may acetylate local chromatin to facilitate transcription 
response.  
 
In conclusion, this is the first study of in vivo higher-order chromatin 
organization that is unique to pluripotent cells based on the binding sites of 
transcription factors and coactivators, thereby adding a new player to the list 
of unusual findings regarding the chromatin structure in ES cells. Another 
unusual observation is that several enhancers seem to be interacting to 
coordinate gene expression. Such interactions may represent an important yet 
poorly understood mechanism whereby crosstalk among enhancers and 
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promoters contribute to proper gene regulation and pluripotency. In view of 
the recently identified hyperdynamic plasticity of ES cell chromatin (Meshorer 
et al., 2006), p300 and CBP may have a novel role in maintaining self-renewal 
and pluripotency by coordinating the chromatin domains into functionally 
distinct active and repressed domains that can be regulated properly and not 


















CHAPTER V: Conclusion and Perspectives 
Although Oct4, Sox2 and Nanog have long been established as master 
regulators and forming the core regulatory circuit in the transcriptional 
network in ES cells and their binding properties have been uncovered by ChIP 
combined sequencing technology, the large portion of the regulatory 
mechanism in ES cells is still missing and a few important questions are 
remained for answers. What are the real essential targets of master regulators? 
What are the functional partners for master regulators? Why master regulators 
bind to both activated and repressive loci? Are they activators or repressors? 
How can they differentiate their functions at different loci? How can they 
recognize their binding sites?  
This thesis work has greatly contributed to dissecting the transcriptional 
network and extensively expanded our knowledge of the network in mouse ES 
cells by introducing novel self-renewal and pluripotency associated 
transcription factors into the known core regulatory circuit. Understanding the 
molecular function of the novel factors and their interplay with the established 
master regulators in the network should illuminate fundamental properties of 
ES cells and shed light on the understanding of the process of directed 
differentiation and cellular reprogramming, thus ultimately lead to precise 
manipulation and realization of the full clinical therapeutic benefits of these 
unique cells.  
Furthermore, my research has combined computational and statistical tools 
with system biology to understand cellular differentiation process. Although 
microarray experiments are able to provide unprecedented quantities of 
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genome-wide data on gene-expression patterns and has been extensively 
developed and applied in many biological contexts, the management and 
analysis of the millions of data points that result from these experiments is still 
under development. The interpretation of the results from the analysis and its 
implication on biological questions are of more importance to biologists. 
Chapter III of my research has opened the possibility of identifying the early 
differentiation markers during ES cell differentiation based on statistical 
analysis of gene expression data. Besides Smacard1, which we have 
experimentally validated in our research, other candidate genes in the list 
derived from our statistical analysis, have also been identified and validated as 
critical regulators governing ES cell maintenance by other groups (Guo and 
Smith, 2010; Walker et al., 2010; Zhang et al., 2010). Their work further 
support the robust and reliability of our statistical algorithm. This work 
highlights the importance and necessity of combining novel and sophistical 
computational tools with genome-wide biological studies in advancing and 
understanding early cellular differentiation. As the price for microarray and 
sequencing continues dropping, a comprehensive study of total RNA 
transcripts may further developed and become popular (Wang et al., 2009). 
Application of in-depth bioinformatics analysis to these genome-wide data 
will provide more thorough insights into the dynamics of gene expression in a 
biological system (Pepke et al., 2009).  
In addition to the functional study of novel transcription factors, I looked into 
coactivators that facilitate the functions of transcription factors and further 
linked coactivator regulation to higher-order chromatin structure. This is the 
first study of in vivo higher-order chromatin organization that is unique to 
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pluripotent cells based on the binding sites of transcription factors and 
coactivators, adding a new content to the list of unusual findings regarding the 
chromatin structure in ES cells as well as a new layer to the ES cell specific 
transcriptional network. However, the higher-order looping structures are not 
only presented at activated loci, how they are stabilized and mediated at 
repressive loci by transcription factors and cofactors remain to be elucidated. 
 
 
Future work is needed in the following specific directions: 
1. In order to construct a more comprehensive transcriptional network in ES 
cells, putative novel transcription regulators indicated in our statistical analysis 
need to be identified and functionally characterized. On the other hand, to get 
a better understanding of cellular reprogramming, our statistical model can be 
applied to analyze the dynamics of time point gene expression during 
reprogramming process as well. It will be helpful to identify novel critical 
regulators of reprogramming and deepen our understanding of transcriptional 
network governing pluripotency from a reverse perspective. 
2. It would be interesting to study the dynamics of gene expression profile 
with the dynamics of binding affinity and binding profiles by essential 
transcription factors during cellular differentiation or reprogramming. A 
statistical model capturing these two dynamics would be instructive to 
understand how a specific transcription factor is functioning in vivo to control 
the cell identity. 
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3. Besides p300 and CBP, it is important to study other cofactors, including 
coactivators and corepressors, as embryos display severe defects with deletion 
of several cofactors. A proposed model is that although transcription factors 
bind to both activated and repressive loci, it is coactivators and corepressors 
recruited by transcription factors that mediate gene activation or repression, 
rather than the transcription factors. However, how coactivators or 
corepressors are recruited at specific loci would be another interesting 
question and it is possible that it may be mediated by their protein binding 
partners of transcription factors. This idea is supported by the study of Eset 
gene, which is shown to interact with Oct4 and restrict extraembryonic 
trophoblast lineage potential (Yuan et al., 2009). 
4. Chimera formation experiments by injecting an engineered ES cells with 
deletion of regulatory sequence mediating long-range looping structure should 
be extremely helpful to understand the in vivo function of higher-order 
chromatin structure during embryogenesis and development. 
5. It would also be interesting to study the higher-order chromatin structure at 
repressive loci. Combining the binding profile data of transcription factors, 
particularly transcriptional repressors as well as the cis-regulatory sequence, 
would shed light on how specific lineage is restricted and how we can 
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Transcription factors and their specific interactions with targets are crucial in 
specifying gene expression programmes. To gain insights into the 
transcriptional regulatory networks in embryonic stem cells, we use chromatin 
immunoprecipitation coupled to ultra-high-throughput DNA sequencing 
(ChIP-seq) to map the locations of thirteen sequence specific transcription 
factors (Nanog, Oct4, STAT3, Smad1, Sox2, Zfx, c-Myc, n-Myc, Klf4, Esrrb, 
Tcfcp2l1, E2f1 and CTCF) and two transcription regulators (p300 and Suz12). 
These factors are known to play different roles in ES cell biology as 
components of the LIF and BMP signaling pathways, self-renewal regulators 
and key reprogramming factors. Our study provides new insights into the 
integration of the signaling pathways to the ES cell-specific transcription 
circuitries. Intriguingly, we find specific genomic regions extensively targeted 
by different transcription factors. Collectively, the comprehensive mapping of 
transcription factor binding sites identifies new features of the transcriptional 





Embryonic stem (ES) cells are derived from early preimplantation embryos 
and they can be maintained for extended periods in culture through self-
renewing division (Evans and Kaufman, 1981; Martin, 1981). These cells are 
pluripotent as they retain the ability to differentiate into many, and perhaps all, 
cell lineages. The ability to generate transgenic mouse ES cells through 
homologous recombination has revolutionized biological research through the 
creation of genetically altered animals (Thomas and Capecchi, 1986). In 
addition, human ES cells can potentially serve as an inexhaustible source of 
cells for the derivation of clinically useful cells for regenerative medicine and 
cell-based therapy. 
Mouse ES cells were first isolated in 1981 from mouse blastocysts (Evans and 
Kaufman, 1981; Martin, 1981). Maintenance of the self-renewing state of 
mouse ES cells requires the cytokine leukemia inhibitory factor (LIF). The 
binding of LIF to its receptor activates STAT3 through phosphorylation 
(Matsuda et al., 1999; Niwa et al., 1998; Raz et al., 1999). LIF alone is 
however not sufficient to maintain ES cells as their maintenance requires the 
presence of fetal calf serum. Bone morphogenetic proteins (BMPs) appear to 
be a key serum-derived factor that acts in conjunction with LIF to enhance 
self-renewal and pluripotency of mouse ES cells (Ying et al., 2003). The 
binding of BMP4 to its receptors triggers the phosphorylation of Smad1 and 
activates the expression of members of the Id (inhibitor of differentiation) 
gene family. As ES cells overexpressing Ids can self-renew in the absence of 
BMP4, it is proposed that induction of Id expression is the critical contribution 
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of the BMP/Smad pathway. Hence, the LIF and BMP signaling pathways play 
a central role in the maintenance of pluripotent stem cell phenotype. 
Besides these signaling pathways, which sense the presence of extrinsic 
growth factors in the environment, intrinsic factors such as transcription 
factors (TFs) are also essential for specifying the undifferentiated state of ES 
cells. Oct4, encoded by Pou5f1, is a POU domain-containing transcription 
factor known to be essential to ES cells and early embryonic development 
(Boiani and Schöler, 2005; Nichols et al., 1998; Smith, 2001). Oct4 interacts 
with Sox2 (an HMG-containing transcription factor) and genome wide 
mapping of OCT4 and SOX2 sites in human ES cells show that they co-target 
multiple genes (Boyer et al., 2005). The cis-regulatory element in which the 
Sox2-Oct4 complex is bound consists of neighboring sox (CATTGTA) and 
oct (ATGCAAAT) elements (Loh et al., 2006). Recent works indicate that 
Oct4 and Sox2, along with c-Myc and Klf4, are sufficient to reprogram 
fibroblasts to induced pluripotent stem cells (iPS) which are functionally 
similar to ES cells (Maherali et al., 2007; Okita et al., 2007; Takahashi and 
Yamanaka, 2006; Wernig et al., 2007). Hence, these transcription factors can 
exert a dominant role in reconstructing the transcriptional regulatory network 
of ES cells. A third well studied transcription factor in ES cells is Nanog. 
Nanog is a homeodomain-containing transcription factor that can sustain 
pluripotency in ES cells even in the absence of LIF (Chambers et al., 2003; 
Mitsui et al., 2003). Other transcriptional regulators are required as well to 
maintain ES cells. Recent work has begun to identify new components of the 
transcriptional regulatory network required for the maintenance of 
pluripotency. Through genetic studies, Esrrb and Zfx have been shown to 
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regulate self-renewal of ES cells (Ivanova et al., 2006; Loh et al., 2006; 
(Galan-Caridad et al., 2007). 
Despite the critical roles of transcriptional regulators in the maintenance of 
mouse ES cells, detailed knowledge of their in vivo targets is lacking. The 
targets of the downstream effectors of key signaling pathways are poorly 
studied and the targets of many of the transcription factors in ES cells have not 
been defined. How the different transcriptional circuitries are integrated is also 
not clear. Elucidation of the transcriptional regulatory networks that are 
operating in embryonic stem cells is fundamental to understand the molecular 
nature of pluripotency, self-renewal and reprogramming. 
In this study, we use chromatin immunoprecipitation coupled to massively 
parallel ultrahigh throughput short tag based sequencing (ChIP-seq) (Barski et 
al., 2007; Johnson et al., 2007; Mikkelsen et al., 2007; Robertson et al., 2007) 
to map the in vivo binding loci for thirteen sequence-specific transcription 
factors and two transcription co-regulators in living mouse ES cells. 
Intriguingly, these transcription factors are wired to the ES cell genome in two 
major ways. The first cluster includes Nanog, Oct4, Sox2, Smad1 and STAT3. 
The second cluster consists of c-Myc, n-Myc, Zfx and E2f1. The co-activator 
p300 is predominantly recruited to dense binding loci involving proteins found 
in the first type of cluster. Our analysis also reveals that highly dense binding 
loci involving these factors have characteristic features of enhanceosomes. ES 
cell-specific gene expression is associated with binding of many of the factors 
studied.  Based on these associations between binding and expression, we 
have constructed a transcriptional regulatory network model that integrates the 
two key signaling pathways with the intrinsic factors in ES cells. 
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MATERIALS AND METHODS 
Cell culture and transfection. E14 mouse ES cells, cultured under feeder-
free conditions were maintained in Dulbecco‟s Modified Eagle-Medium 
(DMEM, GIBCO), with 15 % heat-inactivated ES qualified fetal bovine serum 
(FBS, GIBCO), 0.055 mM β-mercaptoethanol (GIBCO), 2mM L-glutamine, 
0.1 mM MEM non-essential amino acid, 5,000 units/ml 
penicillin/streptomycin and 1,000 units/ml of LIF (Chemicon). 293T cells 
were cultured in DMEM with 10 % FBS and maintained at 37 
o
C with 5 % 
CO2. For serum-free cell cultures, feeder-free E14 mouse ES cells were plated 
onto gelatin-coated plates in ESGRO Complete Basal Medium (Chemicon) 
supplemented with 10 ng/ml LIF (Chemicon) and 50 ng/ml BMP4 (Sigma). 
Cells were passaged every 2–3 days using accutase (Chemicon). Dissociated 
cells were pelleted and the cell pellet was resuspended and replated directly. 
Oct4, Sox2 and Nanog shRNA constructs were designed as described 
previously (Loh
 
et al. 2006). Transfection of shRNA was performed using 
Lipofectamine 2000 (Invitrogen) according
 to the manufacturer‟s instructions. 
For the ChIP assay, 35 µg
 
of plasmids were transfected into ES cells on 150-
mm plates.
 
Puromycin (Sigma) selection was introduced 1 d after transfection
 
at 1.0 µg/ml, the cells were cross-linked and harvested 48 h after transfection. 
Luciferase assay. For the 25 Nanog-Oct4-Sox2 cluster fragments and 8 Myc 
cluster fragments tested for enhancer activity, the fragments (about 300bp) 
were amplified from genomic DNA and cloned into BamHI and SalI sites of 
pGL3-Pou5f1 pp vector (an Pou5f1 minimal promoter driving luciferase) and 
sequence-verified. E14 mouse ES cells or 293T cells were transfected with 
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these reporter constructs by Lipofectamine 2000 (Invitrogen) following the 
manufacturer‟s protocol. A Renilla luciferase plasmid (pRL-SV40 from 
Promega) was co-transfected as an internal control. Cells were harvested 36 h 
after transfection and the luciferase activities of the cell lysates were measured 
using Dual-luciferase Reporter Assay System (Promega). 
ChIP assay. ChIP assay was carried out as described previously (Loh et al.
 
2006). Briefly, cells were cross-linked
 
with 1% formaldehyde for 10 min at 
room temperature and formaldehyde
 
was then inactivated by the addition of 
125 mM glycine. Chromatin
 
extracts containing DNA fragments with an 
average size of 500
 
bp were immunoprecipitated using antibodies shown in 
Table S1. Quantitative PCR
 
analyses were performed in real time using the 
ABI PRISM 7900
 
sequence detection system and SYBR green master mix. 
Threshold
 
cycles (Ct) were determined for both immunoprecipitated DNA
 
and 
known amount of DNA from input sample for different primer
 
pairs. Relative 
occupancy values (also known as fold enrichments)
 
were calculated by 
determining the immunoprecipitation efficiency
 
(ratios of the amount of 
immunoprecipitated DNA to that of the
 
input sample) and were normalized to 
the level observed at a
 
control region, which was defined as 1.0. All ChIP 
experiments
 
were repeated at least three times independently. For all the 
primers used,
 
each gave a single product of the right size, as confirmed by
 
agarose gel electrophoresis and dissociation curve analysis. 
Computational analyses. To identify the MTL, a list of genomic sites co-
bound by any of the 13 TFs was generated. Two binding regions were 
clustered if their centers were 100 bp apart at most. This clustering procedure 
was done iteratively to form the largest possible clusters, forming what we call 
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MTL. ChIP-seq data sets for p300 and Suz12 were also generated to determine 
where these coregulators are recruited with respect to the TFs profiled. 
Distances from one coregulator site to the nearest TFBSs were then calculated. 
Pairs of sites within 50 bp of one another were considered to belong to the 
same group. We computed the Pearson correlation coefficient for each pair of 
such colocalization vectors and used it as a similarity measure to cluster these 
factors. To associate binding site information with gene expression, we 
computed an association score for each pair of gene and TF based on the 
relative distance to the TSS of the gene. We then performed k-mean clustering 
on an association matrix to group the genes with similar TF association. Gene 
groups by this method were then analyzed with a previously published RA-
induced differentiation data set (Ivanova et al., 2006). 
Two published sets of gene-expression experiments were used in combination 
with the ChIP-seq data reported here to obtain a set of genes that are enriched 
in direct transcriptional targets (Ivanova et al., 2006; Zhou et al., 2007). For a 
given TF, we scored and ranked each gene based on the number and 
„„intensity‟‟ of ChIP-seq-defined binding sites. For a given expression change 
ranking and a given TF-binding ranking, we used responder analysis to 
determine the significance of association between binding and expression, as 
well as to define gene sets that are at least 2-fold enriched in direct targets. 
Regulatory targets were inferred from the intersection of top-ranked bound 






Mapping of in vivo binding sites of 13 transcription factors by ChIP-seq 
approach 
Whole genome binding sites of thirteen sequence-specific transcription factors 
(TFs) were profiled in mouse ES cells by the ChIP-seq approach (Barski et al., 
2007; Johnson et al., 2007; Mikkelsen et al., 2007; Robertson et al., 2007). 
Nanog, Oct4, Sox2, Esrrb and Zfx are known regulators of pluripotency and/or 
self-renewal. Smad1 and STAT3 are key components of the signaling 
pathways mediated by BMP and LIF, respectively. Tcfcp2l1 has 
uncharacterized DNA binding property and function, and is preferentially up-
regulated in ES cells. E2F1 is best known for its role in regulating cell cycle 
progression and has also been shown to associate extensively with promoter 
regions (Bieda et al., 2006). Klf4 and Myc TFs are reprogramming factors also 
implicated in maintenance of undifferentiated state of ES cells (Cartwright et 
al., 2005; Jiang et al., 2008). CTCF is required for transcriptional insulation 
(Kim et al., 2007). Through mapping the binding sites of these 13 TFs, we 
seek to investigate the binding behavior of these factors and uncover novel 
insights into how they are wired in the ES cell genome. Here, chromatin 
immunoprecipitation (ChIP) with specific antibodies against these TFs was 
used to enrich the DNA fragments bound by these transcription factors 
followed by direct ultra high throughput sequencing using Solexa Genome 
Analyzer platform. Genomic regions defined by multiple overlapping DNA 
fragments derived from the ChIP enrichments were considered as putative 
binding sites. We used Monte Carlo simulations to determine the minimal 
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number of overlapping ChIP fragment reads required to distinguish true 
binding from non-specific randomly expected overlaps. Regions with 
overlapping ChIP DNA counts higher than the threshold were further filtered 
by removing peaks that were also found in the negative control (anti-GFP 
ChIP) liberary. 
                          
Figure 1. Genome wide mapping of thirteen factors in ES cells using 
ChIP-seq technology. TFBS profiles for the sequence-specific transcription 
factors and mock ChIP control at the Pou5f1 and Nanog gene loci are shown. 
ChIP-qPCR validations were carried out on randomly selected sites with 
different “intensities” (i.e., ChIP tag counts within the defined overlap region) 
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to further refine the threshold used. Based on the ChIP-qPCR analyses, we 
determined that the specificity of binding site determination was greater than 
95% for the majority of the libraries. We identified between 1,126 to 39,609 
transcription factor binding sites (TFBS) for the 13 factors.  As examples, the 
binding profiles for all 13 factors at the Pou5f1 (Oct4) and Nanog gene loci 
are shown in Figure 1.  
 
Motif analyses of transcription factor binding sites 
To determine the in vivo sequence specificity of these TFs, we derived the 
consensus sequence motifs using de novo motif discovery algorithm (as 
described in Loh et al, 2006). Sequences (± 100 bp) from the top 500 binding 
peaks were selected from each factor, repeats were masked and the program 
Weeder (Pavesi et al., 2001) was used to find over-represented sequences. 
Because of the high resolution in defining the binding sites offered by the high 
sequence depth coverage, over-represented motifs could be uncovered from all 
of the thirteen factors except E2f1 (Figure 2). Consistent with our previous 
study, we obtained a sox-oct composite element consisting of a Sox2 binding 
site consensus (CATTGTT) and canonical Oct4-binding sequence 
(ATGCAAAT) adjacent to one another from both the Oct4 and Sox2 datasets 
(Loh et al., 2006). The presence of a common motif suggests that the Sox2 and 
Oct4 heterodimer is the functional binding unit. Interestingly, the de novo-
predicted matrices for Nanog and Smad1 bound sequences resemble the sox-
oct joint motif. This reflects the frequent co-binding of Nanog and Smad1 with 
Sox2 and Oct4. It is noteworthy that the Nanog motif reported previously (Loh 
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et al., 2006) can be found using another motif discovery algorithm 
NestedMICA (Figure S9). The binding consensus sequences identified for 
Klf4, Esrrb, CTCF, c-Myc, n-Myc, STAT3 and Zfx are closely related to the 
binding sequences reported previously (Ehret et al., 2001; Galan-Caridad et 
al., 2007; Kaczynski et al., 2003; Kim et al., 2007; Pettersson et al., 1996; 
Zeller et al., 2006). Hence, we showed that sequence motifs can be identified 
from the in vivo bound sites. 
               
Figure 2. Identification of enriched motifs using a de novo approach. 
Matrices predicted by de novo motif discovery algorithm Weeder. 
 
A subset of multiple transcription factor binding loci as ES cell 
enhanceosomes 
Upon close examination of the binding profiles from these thirteen TFs, we 
found that a subset of binding sites was bound by many of these TFs. To 
investigate their biological relevance, we first determined the significance of 
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such enrichments of TF binding sites (see Supplemental Experimental 
Procedures in Supplemental Data). Peak sites within 100 bp were iteratively 
clustered to define Multiple Transcription factor binding Loci (MTL) (see 
Table S8). The number of these MTL, plotted as a function of the number of 
different TFs in the MTL, is shown in Figure 3A. Loci bound by four or more 
TFs are highly significant (p<0.001, Figure 3A), and there is a total of 3,583 
such MTL. Of these, 1,440 loci (40.2 %) were found in the intergenic regions 
and the remaining loci were spread between promoter regions (1,334 loci, 37.2 
%) and within gene regions (809 loci, 22.6%). Less than 20% of the clusters 
with seven or more TFs are found at promoter regions (yellow columns, 
Figure 3B) compared with 40% of clusters that have fewer than 5 TFs. Hence, 
the co-occurrence of TFBS within the MTL is not mainly due to their 
occurrence at promoters. 
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Figure 3. Multiple Transcription factor binding Loci (MTL). (A) Plot of 
the number of TFs bound per co-bound loci. The distribution of randomly 
occurring co-bound loci is obtained by simulation. (B) Distribution of clusters 
with different number of co-bound TFs. Promoter regions are defined as 
sequences 2,500 bp upstream and 500 bp downstream of TSS (Heintzman et 
al., 2007). 
 
To further dissect the composition of the MTL, we examined the co-
occupancy of different factors found in the 3,583 MTL. Among the 13 TFs, 
Nanog, Sox2, Oct4, Smad1 and STAT3 (blue box, Figure 4A) tend to co-occur 
quite often, as do members of a second, distinct group comprised of n-Myc, c-
Myc, E2f1 and Zfx (green box, Figure 4A). In addition to these two high-level 
groupings of TFs, we find it useful to define four groups of MTLs based on 
the presence or absence of binding sites for (i) Oct4, Sox2 or Nanog and (ii) c-
Myc or n-Myc. The Nanog-Oct4-Sox2 clusters (binding sites for Nanog, Oct4 
or Sox2, but not n-Myc or c-Myc) constitute 43.4% of the 3,583 MTL (orange 
sector, Figure 4B). The Myc-specific clusters (n-Myc or c-Myc, but not 
Nanog, Oct4 or Sox2) make up 32.9% of the MTL (light blue sector, Figure 
4B).  
Consistent with the pair-wise co-occurrence shown in Figure 4A, 87.4% of 
Smad1 and 56.8% of STAT3 binding sites within MTLs were associated with 
the Nanog-Oct4-Sox2 specific MTL (orange sector, Figure 4C). This indicates 
that Smad1 and STAT3 share many common target sites with Nanog, Oct4 
and Sox2 and reflects a point of convergence of the two key signaling 
pathways (Smad1 and STAT3) with the core circuitry defined by Nanog, Oct4 
and Sox2 (Boyer et al., 2005). This is consistent with previous study showing 
the link between Nanog and the LIF pathway (Chambers et al., 2003). 56.9% 
of Esrrb and 41.9% of Klf4 binding sites within MTLs were found in the 
187 
 
Nanog-Oct4-Sox2 specific MTL. Indeed, Esrrb has been shown to reside in 
the same complex as Nanog (Wang et al., 2006). In contrast, the co-occurrence 
of Zfx, CTCF and E2f1 were skewed towards the Myc-specific cluster (light 
blue sector, Figure 4C). 
As the majority of the Nanog-Oct4-Sox2 specific MTL are found outside of 
promoter regions (91.2%), we assayed genomic sequences from this MTL 
cluster types for enhancer activity. 25 genomic fragments from the Nanog-
Oct4-Sox2 cluster and 8 genomic fragments from the Myc cluster were cloned 
downstream of a luciferase reporter. The genomic fragment was placed 2 kb 
away from the minimal Pou5f1 promoter used to drive the luciferase gene. 
These constructs were transfected into ES cells and 293T cells and luciferase 
activity was measured. Remarkably, all 25 constructs with genomic fragments 
spanning Nanog-Oct4-Sox2 clusters showed robust ES cell-specific enhancer 
activity (Figure 4D). 21 of the constructs were even more active than a Nanog 
enhancer positive control, which we had characterized previously. In contrast, 
the control constructs with genomic fragments from the Myc cluster were 




Figure 4. MTL associated with Nanog, Oct4, Sox2, Smad1 and STAT3 as 
ES cell enhanceosomes. (A) Co-occurrence of TF groups within MTL. Colors 
in the heat map reflect the co-localization frequency of each pair of 
transcription factors in MTL (yellow means more frequently co-localized, red 
less). Transcription factors have been clustered along both axes based on the 
similarity in their co-localization with other factors. (B) Dissection of the 
transcription factor makeup within MTL. Two major clusters exist within the 
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3,583 MTL. The first group (orange sector) consists of Oct4, Nanog or Sox2, 
The second group (light blue sector) consists of n-Myc or c-Myc. The purple 
sector is a mixture of the first two groups (orange and light blue sectors). (C) 
The occurrence of the other transcription factors (Smad1, STAT3, Esrrb, 
Tcfcp2l1, Klf4, Zfx, CTCF and E2f1) within the 3,583 MTL. The color legend 
is the same as B. (D) Genomic fragments associated with the Nanog-Oct4-
Sox2 cluster show enhancer activity. To test for enhancer activity, genomic 
fragment of approximately 300 bp (shown in red) was cloned downstream of a 
luciferase reporter (shown in blue) driven by minimal Pou5f1 promoter 
(shown in orange). These reporter constructs were transfected into ES cells or 
293T cells to determine ES cell-specific enhancer activity. The loci tested for 
enhancer activity and primers for cloning these genomic fragments are listed 
in Table S9. Data are presented as the mean ± SEM. (E) Smad1 occupancy is 
dependent on Oct4. ChIP assays were performed using anti-Smad1 antibody 
with extracts from ES cells transfected with control RNAi construct (yellow 
bar) or Oct4 RNAi construct (blue bar). Coordinates and q-PCR primers of 
Smad1-Oct4 co-bound sites and Smad1 specific sites are listed in Table S10. 
Fold enrichment is the relative abundance of DNA fragments detected by q-
PCR at the amplified region over a control amplified region. (F) STAT3 
occupancy is dependent on Oct4. ChIP assays were performed using anti-
STAT3 antibody with extracts from ES cells transfected with control RNAi 
construct (yellow bar) or Oct4 RNAi construct (blue bar). (G) Oct4 occupancy 
is not dependent on LIF and BMP pathways. ChIP assays were performed 
using anti-Oct4 antibody with extracts from ES cells treated with LIF+BMP4 
(orange bar), LIF alone (green bar), BMP4 alone (blue bar) or no LIF and 
BMP4 (grey bar). 
 
Combinatorial binding of transcription factors to enhancers can impart 
transcriptional synergy (Struhl, 2001). To address the relationships between 
Oct4, Smad1 and STAT3, we perturbed the binding of these factors through 
RNAi or growth factor withdrawal. Depletion of Oct4 led to reduction in 
Smad1 and STAT3 binding (Figure 4E, F). The alteration of Smad1 and 
STAT3 binding occurs specifically on Oct4, Smad1, STAT3 co-bound sites 
and was not due to reduction in Smad1 and STAT3 levels (data not shown). 
Perturbation of the two signaling pathways however did not affect the binding 
of Oct4 (Figure 4G). This indicates that Oct4 is pivotal in stabilizing the 
nucleoprotein complex and establishes a hierarchy of regulatory interactions 
between Oct4, STAT3 and Smad1. The mechanism for Oct4 dependent 
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STAT3 and Smad1 binding is not clear. It is possible that Oct4 may interact 
with STAT3 or Smad1 to facilitate their interactions with chromatin. 
In summary, through the global binding sites of transcription factor profiling, 
we uncovered over three thousand genomic regions densely bound by TFs. 
The Nanog-Oct4-Sox2 cluster exhibits features of enhanceosomes by 
enhancing transcription from a distance and shows extensive co-occupancy 
with Smad1 and STAT3. Importantly, we showed that Oct4 is required for the 
binding of Smad1 and STAT3, suggesting that Oct4 plays a pivotal role in 
stabilizing the TF complex. 
 
p300 is recruited to the Nanog-Oct4-Sox2 cluster  
To further assign functionality to the MTL, we determined the locations of 
transcriptional co-activator p300 using ChIP-seq. p300 is a histone 
acetyltransferase commonly found at enhancer regions (Heintzman et al., 
2007; Ogryzko et al., 1996). Genome-wide mapping of chromatin regulator 
like p300 has the potential to reveal the DNA binding factor(s) responsible for 
recruiting the regulator to specific sites in the genome (Birney et al., 2007). 
We also profiled the locations of another chromatin regulator Suz12, to serve 
as a control . 
Strikingly, p300 was found to co-occur with Nanog-Oct4-Sox2 cluster type 
(Figure 5A). Most p300 binding sites are associated with three to six other 
transcription factors, up to as many as nine in one case (Figure 5B). The 
composition of these p300-containing clusters is highly diverse, but typically 
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they include one or more of the factors Nanog, Oct4 or Sox2 followed, at 
lower probability, by Smad1, Esrrb, Klf4, Tcfcp2l1, and STAT3 (Figure 5B). 
In contrast to p300, Suz12 did not show strong association with any of the 13 
TFs (data not shown). Using the de novo motif discovery algorithm Weeder, 
we were able to uncover an enriched motif from p300-enriched sequences that 
resembles the sox-oct composite element (Figure 5C). The association of p300 
with Oct4 binding sites was validated for 12 sites using ChIP-qPCR.  
 
Figure 5. p300 is recruited to the Nanog-Oct4-Sox2 cluster. (A) p300 is 
associated with the Nanog-Oct4-Sox2 cluster, but not the Myc cluster. Pie-
chart showing the occurrence of p300 in different MTL types. Color legend is 
the same as Figure 4B. (B) Size distribution and composition of binding site 
groups containing p300. (top) Histogram showing the number of binding site 
groups of different sizes. Size, here, refers to the number of non-p300 
transcription factors that have binding sites in the same group. (bottom) 
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Composition of p300-containing binding site groups for different group sizes. 
Composition is expressed in terms of the percentage of p300-containing 
groups that contain the indicated transcription factor. For example, Nanog, 
Sox2 and Oct4 are each found in 70% or more of the p300 containing clusters 
that have five other factors bound, while Smad1, Esrrb, Klf4, Tcfcp2l1 and 
STAT3 are each found at a frequency of around 30-50%. (C) Motif predicted 
by de novo motif discovery algorithm Weeder. (D) Recruitment of p300 is 
dependent on Oct4, Sox2 and Nanog. ChIP assays were performed using anti-
p300 antibody with extracts from ES cells transfected with control RNAi 
construct (gray bar), Oct4 RNAi construct (orange bar), Sox2 RNAi construct 
(blue bar) or Nanog RNAi construct (green bar). Coordinates of loci and q-
PCR primers are listed in Table S10. Fold enrichment is the relative 
abundance of DNA fragments detected by real-time PCR at the amplified 
region over a control amplified region. The level of p300 was not altered after 
RNAi depletion of these TFs (data not shown). Data are presented as the mean 
± SEM. 
 
These data suggest that Oct4, Sox2 and Nanog are recruiting p300 to the 
genomic sites. To test this hypothesis, we depleted Oct4, Sox2 or Nanog by 
RNAi and checked for p300 binding. Our ChIP result showed that p300 
binding was reduced by Oct4, Sox2 or Nanog depletion (Figure 5D). Previous 
work has shown that c-Myc interacts with p300 and mediates the recruitment 
of p300 to hTERT promoter (Faiola et al., 2005). In ES cells, we did not 
observe global recruitment of p300 to Myc sites. Depletion of c-Myc by RNAi 
however did not affect p300 recruitment to these sites (data not shown). The 
data suggests that p300 could be a general factor being recruited to enhancers 
(Heintzman et al., 2007) and we conclude that p300 recruitment is promoted 
by Oct4, Sox2 and Nanog. 
 




Next we sought to establish the correlation between TF occupancies and gene 
expression. A commonly employed approach for assigning target genes to a 
TF is to associate TF binding sites with genes based on proximity. However, 
the relevant threshold for proximity could be different for different TFs. For 
that reason, we developed a novel approach to cluster genes based on TF 
binding data (see Supplemental Experimental Procedures in Supplemental 
Data). For each pair of transcription factor and gene, we assigned an 
association score based on the genomic location of the binding site that is 
closest to the transcription start site (TSS). This association score is based on 
the distribution of nearest site-to-TSS distances in the genome, and is thus 
different for, and characteristic of, each TF. A higher score implies higher 
chance of the gene being the target of the TF. This avoids an arbitrary 
threshold. Based on the association scores for all TFs, we performed k-means 
clustering to define five classes of genes that are associated with similar set of 




Figure 6. Association between TF binding and gene expression in ES cells. 
(A) Heatmap showing five classes of genes obtained from k-means clustering 
based on TF-gene association score. In this analysis, we included a Suz12 
ChIP-seq dataset to explore the potential association of Suz12 and the other 
thirteen TFs. (B) Enrichment of transcription factors in the five classes. The Y 
axis represents the ratio of average TF-gene association score for the group to 
the average association score for all genes. (C) Histogram of the levels of gene 
expression for genes found in each of the five classes. (D) Proportion of 
different classes of genes found in differentially (up- or down-regulated in ES 
cells) and non-differentially expressed genes in published expression dataset 




Class I genes are enriched in binding sites for Nanog, Oct4, Sox2, Smad1 and 
STAT3 (Figure 6B). Class II genes are bound heavily by c-Myc and n-Myc. 
Class III genes show enrichment (more than 1 fold) in binding by n-Myc, 
Klf4, Esrrb, Tcfcp2l1, Zfx and E2f1. Class IV is highly enriched in Suz12 
bound genes while class V genes are deficient in all the transcription factors. 
In total, 48% of genes are deficient in transcription factor binding by the 
thirteen transcription factors (class IV and class V). We note that E2f1 and 
Suz12 localization is essentially mutually exclusive, suggesting that polycomb 
repressor complexes inhibit the binding of E2f1 to its target sites.  
To further characterize the gene expression profiles of each class, we used a 
microarray dataset that interrogated the transcriptome dynamics of retinoic 
acid (RA)-induced differentiation (Ivanova et al., 2006). The genes in this 
dataset were divided into three categories (see Supplemental Experimental 
Procedures in Supplemental Data). They are genes up-regulated in ES cells, 
non-differentially expressed genes and genes down-regulated in ES cells. 
Class I genes constitute less than 10% of the non-differentially expressed 
genes and genes down-regulated in ES cells (compare the red columns in 
Figure 6D). This compares to 24% of the genes in the up-regulated category. 
The percentage of class II genes is only 12% among non-differentially 
expressed genes, but 36% in the up-regulated set (compare the blue columns 
in Figure 6D). Hence, class I and class II genes are 2.7 (p=8.14E-52) and 2.9 
(p=1.28E-91) fold enriched, respectively, in genes up-regulated in ES cells. In 
contrast, class IV and class V genes are underrepresented in this set.  Class III 
is slightly enriched in genes that are down-regulated in ES cells, but not 
enriched in genes that are preferentially up-regulated in ES cells. As a 
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validation, we compared the five classes with another independent microarray 
dataset (Zhou et. al. 2007) and similar results were obtained (Figure S14). In 
summary, our global analysis showed that 60% of genes up-regulated in ES 
cells are from class I and class II. Most importantly, the result demonstrates 
that gene clustering based on TF occupancies has the potential to predict ES 
cell-specific gene expression. This suggests that the TF binding patterns of 
these two groups are relevant in specifying ES cell-specific expression. In 
summary, we demonstrate that combinatorial binding patterns of TFs have 
greater predictive power for ES cell-specific expression.  
 
Constructing a regulatory network defining ES cell-specific expression 
The self-renewing state of undifferentiated ES cells is characterized by the 
expression of genes specifically up-regulated in this cell-type. We sought to 
construct a regulatory network that specifies ES cell-specific expression using 
binding sites of transcriptional regulators under the undifferentiated state. In 
order to infer regulatory interactions, we made use of published expression 
profiling data that compared undifferentiated with differentiating ES cells. The 
rationale is that nine (Nanog, Oct4, Sox2, Klf4, n-Myc, c-Myc, Esrrb, Zfx, 
Tcfcp2l1) out of the thirteen TFs we studied are known to be coordinately up-
regulated in ES cells and their levels are down-regulated upon differentiation 
or in differentiated cell-types (Fortunel et al., 2003; Ivanova et al., 2006; 
Ivanova et al., 2002; Ramalho-Santos et al., 2002). Two sets of published 
experiments were used to define genes that are differentially expressed during 
differentiation (Ivanova et al., 2006; Zhou et al., 2007b). The use of two 
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independently generated datasets minimizes biases in gene expression 
differences that are due to different ways of differentiating ES cells. 
The regulatory interaction between a transcription factor and its target gene is 
first defined for individual transcription factor by intersecting the rank-ordered 
bound genes (based on the total number of sequence tags associated with 
binding site peaks) and rank-ordered differentially expressed genes (see 
Supplementary Data for method). The thresholds for defining top-ranked 
genes in the two lists were determined empirically by maximizing the number 
of genes in the intersection subject to two constraints: there had to be at least 
twice as many genes in the intersection as the number expected by chance, and 
the null model (that there are no genes in excess) had to be rejected with p < 
10
-3
. This method allows us to make use of the unique features of our binding 
datasets (signal intensity and unbiased survey) and avoid the use of a single 
cutoff for all datasets. 
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Figure 7. Transcriptional regulatory network in ES cells.  Network of 
regulatory interactions inferred from ChIP-seq binding assays and from gene 
expression changes during differentiation. Nodes are ChIP-seq assayed 
transcription factors. Arrows point from the transcription factor to the target 
gene. Two sets of published experiments were used to define genes that are 
differentially expressed during differentiation (Ivanova et al., 2006; Zhou et 
al., 2007). Thick arrows represent interactions inferred from binding data and 
both expression experiments, while thin arrows represent interactions inferred 
from binding data and only one of the expression experiments. Regulatory 
targets were inferred from the intersection of top-ranked bound genes and top-
ranked differentially expressed genes.  Thresholds for defining top-ranked 
genes in the two lists were determined empirically by maximizing the number 
of genes in the intersection, subject to two constraints: the p-value for the 
enrichment of genes in the intersection had to be 0.001 or better, and there had 
to be at least twice as many genes in the intersection as expected.  All 
regulatory interactions in this network involve higher level expression in ES 
cells and lower level expression during differentiation. There were no 
interactions among the factors in this network when regulation in the opposite 
direction was evaluated. The network was drawn using Cytoscape. 
A network model based on the thirteen transcription factors as depicted in 
Figure 7 reveals both anticipated and novel aspects of the relationships 
between these transcription factors. Consistent with previous studies, this 
model shows regulatory feedback loops for Oct4, Sox2 and Nanog (Boyer et 
al., 2005; Chew et al., 2005; Loh et al., 2006). An interesting feature of this 
network is the inter-connectivity among eleven of the thirteen transcription 
factors being profiled.                 
DISCUSSION 
The repertoire of binding sites in mammalian genome revealed by global 
mapping of transcription factor binding sites 
Ultra high throughput sequencing technology through massively parallel short 
read sequencing has recently been developed for mapping transcription factor 
binding sites and histone modification profiles in mammalian cells (Barski et 
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al., 2007; Johnson et al., 2007; Mikkelsen et al., 2007; Robertson et al., 2007). 
In this study, we performed the first large scale mapping study of multiple TFs 
in mammalian cells. 
Genome-wide mapping studies reveal abundant binding sites for different TFs 
in mammalian cells (Bieda et al., 2006; Birney et al., 2007; Cawley et al., 
2004). It is thus a challenging task to identify the biologically relevant sites 
among the large repertoire of binding sites. It is also important to note that 
ChIP experiments may capture indirect TF-DNA interactions through protein-
protein interaction. While advances in mapping technologies allow for 
comprehensive and unbiased disclosure of the repertoire of binding sites, it is 
difficult to determine which sites are functional regulatory elements that 
influence transcription. It is also possible that a sizeable fraction of these 
binding sites are non-functional and are the consequence of biological noise 
(Struhl, 2007). The strength of this study lies in the concurrent survey of the 
locations of multiple TFs in a single cell-type. Our data show that there are 
genomic regions extensively co-occupied by TFs (transcription factor 
colocalization hotspots) and they could represent functional important sites. 
ES cell-specific enhanceosomes 
An enhanceosome is a nucleoprotein complex composed of distinct sets of 
transcription factors bound directly or indirectly to enhancer DNA (Thanos 
and Maniatis, 1995). The density of transcription factors occurring on this 
short segment of DNA is high compared to more “modular” enhancers that 
have less dense binding clusters occurring over a longer segment of genomic 
DNA (Arnosti and Kulkarni, 2005). The virus-inducible enhancer of the 
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interferon-β gene (IFN- β) is a prototypical enhanceosome. This 55 base pairs 
enhancer is bound by the p50 and p65 subunits of NF-kB, ATF-2, IRF-3, IRF-
7, c-Jun, and the architectural transcription factor HMGA. An atomic model 
for the complex of eight of these factors on the DNA has been constructed 
based on three crystal structures (Panne et al., 2007). The basis for 
cooperativity is unlikely to be mediated through protein-protein interactions as 
these structures reveal limited contact between the transcription factors. It is 
proposed that the binding of these eight transcription factors on a composite 
DNA interface creates a continuous surface for recruiting co-activators such as 
p300 (Merika et al., 1998; Wathelet et al., 1998). 
Our genome-wide mapping study reveals genomic regions with features of 
enhanceosomes. First, the binding sites are densely clustered within relatively 
compact genomic segments. It is of interest to note that the densest binding 
locus we identified is the distal enhancer of Pou5f1. This region (Chew et al., 
2005) was bound by eleven transcription factors. Second, we showed that 25 
of these genomic regions act as enhancers when placed downstream of the 
luciferase reporter. Third, they are associated with the H3K4me3 mark which 
is one of the signatures of active genomic regions. Fourth, our p300 ChIP-seq 
analysis revealed on a global scale the recruitment of this co-activator to the 
Nanog-Oct4-Sox2 cluster, but not the Myc cluster. Importantly, we showed 
that the recruitment of p300 is dependent on Oct4 and Sox2. 
In higher eukaryotes, transcriptional enhancers play important roles in 
integrating multiple signaling pathways to achieve activation of specific genes. 
By profiling multiple transcription factor binding sites on the whole genome 
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scale, we discovered extensive co-localization of multiple transcription factors 
on selective sites in the ES cell genome.  
Wiring of the ES cell genome 
LIF has long been known to be essential for the derivation or maintenance of 
mouse ES cells (Smith et al., 1988; Williams et al., 1988). Beside LIF, other 
factors in fetal calf serum (FCS) could be essential for self-renewal of mouse 
ES cells. Smith and co-workers have identified bone morphogenetic proteins 
as growth factors that work in conjunction with LIF to promote self-renewal 
(Ying et al., 2003). Addition of BMP4 to chemically defined media leads to 
the phosphorylation of Smad1 in ES cells. As constitutive expression of the Id 
genes bypasses the BMP4 or FCS requirement for maintenance of ES cells, 
the Id genes are implicated as downstream targets of the BMP / Smad 
signaling pathway (Ying et al., 2003). ES cells can be passaged without 
differentiation with LIF and BMP4, indicating that the pathways induced by 
these two ligands are sufficient to maintain stem cells. Importantly, we 
showed here that the binding of STAT3 and Smad1 to genomic sites is 
dependent on the LIF and BMP pathways respectively, confirming the 
importance of these transcription factors as effectors of the signal transduction 
pathways that maintain pluripotency in ES cells (Figure S3L, M). Until the 
present study, the role of transcriptional regulatory proteins downstream of 
these signaling pathways has not been well defined in the context of ES cell 
transcriptional regulatory networks. STAT3 had been shown to bind to the 




Consistent with a previous study implicating Id genes as downstream targets 
of BMP4 pathway (Ying et al., 2003), we identified a MTL (bound by Smad1, 
Oct4, Sox2, Nanog, Klf4, E2f1, Esrrb and Tcfcp2l1) at 1.5 kb upstream of the 
TSS of Id3. Strikingly, the majority (97.3%, 649/667) of Smad1 at the MTL is 
associated with Nanog, Oct4 or Sox2. STAT3 (72.5%, 521/718) is also 
predominantly localized with Nanog, Oct4 or Sox2 within the MTL. 
The multiple transcription factor binding site maps provide us with the 
opportunity to examine the mode of targeting genes by these factors on a 
global scale. E2f1 binds to approximately 50% of all genes, almost all of 
which fall into what we call classes I, II and III (Figure 6A). Genes in these 
three classes (I, II and III) are expressed at higher levels in ES cells than are 
the other classes (Figure 6C), and class I and class II genes are enriched in 
genes that are expressed at higher levels in ES cells than in differentiating 
cells. Roughly 50% of all genes, those in classes IV and V, are not enriched in 
transcription factor binding (Figure 6A). These transcription factor deficient 
genes are not expressed or are expressed at a low level. A fraction of these 
genes are bound by Suz12, suggesting that Suz12 plays a role in preventing 
transcription factor occupancy and in silencing these genes (Boyer et al., 
2006a; Lee et al., 2006). However, a larger fraction of the transcription factor 
deficient genes are not bound by Suz12. It is possible that the chromatin 
structure of these genes is not permissive to facilitate the binding of 
transcription factors. 
In summary, the genome-wide maps of transcription factors and co-regulators 
demarcate different gene compartments in the ES cell genome. The densely 
co-occupied sites represent key regions of potential functional importance and 
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will assist in the identification of new regulators of self-renewal, pluripotency 
and reprogramming. We demonstrate that the two key signaling pathways are 
integrated to the Oct4, Sox2 and Nanog circuitries through Smad1 and 
STAT3. Our data also provide a framework for modeling gene expression and 
















APPENDIX II: A biophysical model for analysis of 
transcription factor interaction and binding site arrangement 
from genome-wide binding data 
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How regulatory DNA sequences control gene expression, in a quantitative 
manner, through the combinatorial interactions with transcription factors (TFs) 
is not well understood. We present a computational method to address this 
question, relying on the established biophysical principles. This method, 
STAP (sequence to affinity prediction), takes into account all combinations 
and configurations of strong and weak binding sites to analyze large scale 
transcription factor (TF)-DNA binding data to discover cooperative 
interactions among TFs, infer sequence rules of interaction and predict TF 
target genes in new conditions with no TF-DNA binding data. The distinctions 
between STAP and other statistical approaches for analyzing cis-regulatory 
sequences include the utility of physical principles and the treatment of the 
DNA binding data as quantitative representation of binding strengths. 
Applying this method to the ChIP-seq data of 12 TFs in mouse embryonic 
stem (ES) cells, we found that the strength of TF-DNA binding could be 
significantly modulated by cooperative interactions among TFs with adjacent 
binding sites. However, further analysis on five putatively interacting TF pairs 
suggests that such interactions may be relatively insensitive to the distance and 
orientation of binding sites. Testing a set of putative Nanog motifs, STAP 
showed that a novel Nanog motif could better explain the ChIP-seq data than 
previously published ones. We then experimentally tested and verified the new 
Nanog motif. A series of comparisons showed that STAP has more predictive 
power than several state-of-the-art methods for cis-regulatory sequence 
analysis. In conclusion, STAP is an effective method to analyze binding site 
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arrangements, TF cooperativity, and TF target genes from genome-wide TF- 




The spatial-temporal patterns of gene expression are controlled by cis-
regulatory sequences (Davidson, 2006), through the binding of transcription 
factors (TFs) to specific sites in these sequences. Numerous studies point out 
that the final transcriptional “read-out” is determined, not by an individual TF, 
but by the combinatorial interactions of multiple TFs with DNA. Most 
notably, in developmental genes, multiple binding sites of different TFs are 
often located close to each other in genomes, forming so called cis-regulatory 
modules (CRMs), and work together to generate very precise expression 
patterns (Howard and Davidson, 2004).  
Sequence-specific binding of TF molecules to DNA has been well studied, 
both in theory (Berg and von Hippel, 1988) and in practice (Stormo, 2000). In 
contrast, the interactions between TF molecules that enhance or inhibit their 
DNA binding affinities or transcriptional effects are not well understood. It is 
not clear, at a quantitative level, how important such interactions are, and in 
most systems the identities of interacting TFs remain unknown.  In cases 
where multiple TF molecules do interact, it is unknown how the spatial 
organization of their binding sites affects DNA binding. Some studies suggest 
that binding sites must be arranged in specific ways, following “grammar-like 
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rules” (Beer and Tavazoie, 2004; Struhl, 2001) in order for them to interact 
properly; others provide evidence of a flexible organization of regulatory 
sequences (Arnosti and Kulkarni, 2005; Brown et al., 2007). Knowledge of the 
importance of TF interactions will be a central piece of our picture of gene 
regulation.  
Genomewide DNA-binding data from chromatin immunoprecipitation 
followed by either genome tiling array analysis (ChIP-chip) or sequencing 
(ChIP-seq), provide an opportunity to address the above-mentioned problems 
quantitatively (Barski and Zhao, 2009; Bulyk, 2006). DNA-binding by TFs is 
an inevitable step in transcriptional regulation, thus modeling the 
combinatorial TF-DNA interactions will serve as a bridge to understanding the 
complex transcriptional process. Focusing on ChIP-based data, instead of gene 
expression data, enables a simplification of the task at hand. Gene expression 
is often accomplished through an intricate process involving not only TF-DNA 
interactions, but also chromatin remodeling, epigenetic modifications, 
communications between multiple enhancers, etc (Blackwood and Kadonaga, 
1998). For this reason, several studies have argued for studying combinatorial 
interactions among TFs using ChIP-based technologies (Yu et al., 2008; 
Zhang et al., 2007).  
A number of computational methods have been proposed to study the 
combinatorial aspect of gene regulation. Typically, these methods attempt to 
extract information from the statistical patterns in DNA sequences, e.g., the 
occurrence of sequence motifs. For example, some researchers detect possible 
interactions between pairs of TFs based on frequent co-occurrence of their 
motifs (Smith et al., 2005a; Zhou et al., 2007a). Various techniques from 
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statistics and machine learning, such as Bayesian networks (Beer and 
Tavazoie, 2004), multivariate regression (Smith et al., 2005b), decision trees 
(Jin et al., 2006), SVMs and artificial neural networks (Zhou and Liu, 2008), 
have been developed to extract important features (e.g., motifs and their 
combinations) from sequences, using either gene expression data or ChIP-chip 
data. However, these statistical methods do not reflect underlying physical 
principles. As such, it is not clear to what extent their underlying assumptions, 
e.g., additivity of different features, are valid. Additionally, important 
sequence features, e.g. the interactions among adjacent binding sites, are often 
not represented in these approaches. In many cases, parts of the results, e.g. 
the physical meanings of the model parameters, are not easy to interpret.  
By directly modeling the underlying process, a biophysics-based approach can 
overcome many limitations of the statistical methods mentioned above. Shea 
and Ackers (Shea and Ackers, 1985) and Buchler et al. (Buchler et al., 2003) 
pioneered the use of thermodynamic principles in the study of regulatory 
mechanisms. A number of recent studies applied these principles to model 
expression data on promoters/enhancers (Gertz et al., 2009; Janssens et al., 
2006; Segal et al., 2008; Zinzen and Papatsenko, 2007; Zinzen et al., 2006) or 
TF-DNA binding data from ChIP-chip experiments (Foat et al., 2006; Roider 
et al., 2007). However, these methods have certain limitations when 
considered in the context of our study. Importantly, the possibility of multiple 
transcription factors interacting with DNA and at the same time influencing 
each other has not been adequately addressed in most of these methods (Foat 
et al., 2006; Janssens et al., 2006; Roider et al., 2007; Segal et al., 2008; 
Zinzen and Papatsenko, 2007). Often the physical interactions were not 
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explicitly modeled (Janssens et al., 2006; Segal et al., 2008) or overly 
simplified (Zinzen and Papatsenko, 2007; Zinzen et al., 2006). Finally, the 
studies are often limited to individual regulatory sequences (Janssens et al., 
2006; Zinzen and Papatsenko, 2007; Zinzen et al., 2006), or theoretical 
simulations (Zinzen and Papatsenko, 2007), or artificial promoters, which are 
by design far simpler than natural systems (Gertz et al., 2009).  
We developed a novel method, called STAP (Sequence To Affinity 
Prediction), to analyze large scale TF-DNA binding data. The heart of this 
method is a thermodynamic model adapted from earlier theoretical studies 
(Buchler et al., 2003; Shea and Ackers, 1985). The key novel feature of our 
model is the explicit treatment of cooperative interactions among different TF 
molecules. In addition, our specially developed computational techniques 
based on dynamic programming will enable the model to be efficiently applied 
to complex sequences and ChIP-seq data. This combined biophysical and 
computational approach distinguishes our method from previous methods that 
rely on statistical patterns of DNA sequences or inadequate modeling of 
physical details. Another main feature of our method is the utility of ChIP-seq 
data not only as binary indicators of TF binding regions, as been done by most 
existing studies, but also as quantitative measurements of the binding strengths 
of a region. Thus, more information from ChIP-seq data will be utilized by 
this new model.   
STAP was applied to analyze the ChIP-seq data of 12 TFs in mouse 
embryonic stem (ES) cells (Chen et al., 2008a) . A novel DNA binding motif 
of NANOG was identified and subsequently experimentally validated. 
Consistent to previous observations, we found that the TFs were often “co-
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localized”, in the sense that multiple TFs would bind to the same loci. We a lso 
identified several instances of cooperative interaction between TFs 
contributing to enhancing their DNA-binding, although such instances were in 
the minority among all instances of co-localization. Finally, the analysis 
suggested that the precise arrangement of binding sites is not critical for 
cooperative interactions between TFs.  
 
MATERIALS & METHODS 
Biophysical model of TF-DNA interaction. Given a sequence S , our goal is 
to predict its binding intensity with the experimental TF, denoted as TFexp. 
For a single binding site iS , its binding affinity to the TF is given by (Berg 
and von Hippel, 1988):  
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where ][TF is the TF concentration, (.)K is the equlibrium constant of a site, 
maxS denotes the consensus sequence of this TF, and  )( iSE  is the mismatch 
energy of iS  in the unit of kT/1 . Note that )(][ maxSKTF  can be 
considered as a single TF-specific constant, denoted as R . Supposing there 
are a total of n  binding sites, a state   is represented by an n -bit vector, 
where i  represents whether the i -th site is occupied by its corresponding TF 
(equal to 1) or not (0). The sequence is thus viewed as being in a mixture of 
n2  states.  The probability of a state  , denoted as )(P , is determined by its 
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where ( , )i j  denotes the interaction between the two sites i  and j  when 
both are occupied. Note that the interaction may depend on the arrangement of 
the binding sites. Our default model of interaction is a simple binary model: 
the bound factor at position i ,  f , and the bound factor at position j , f  , can 
interact with constant ', ff  if the distance of their binding sites is less than 
maxd . Basically, the above equation states that the weight of a particular state 
has two components: one from the binding of TF to each individual site; and 
the other from cooperative interactions among bound TFs. In theory, any two 
bound TF molecules can form interactions; in reality, however, this is quite 
unlikely to be true. So we make the assumption that only two adjacent bound 
TF molecules can interact with each other. We assume that the binding affinity 
of the whole sequence to TFexp (denoted as index k ) is proportional to the 
expected number of bound molecules of k , averaging over all states:  
 
( ) ( )


















where )(kN  is the number of bound molecules of k  in the state   (a simple 
counting).  
Because the number of states is exponential to the number of sites in a 
sequence, the computation of the above quantity is expensive. We developed a 
dynamic programming algorithm that computes it efficiently. In the first step, 
we compute the denominator ( )Z W

 . Let [ ]i  be one configuration up 
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to the site i , where i  is bound by its cognate TF 
if . We could decompose the 
configuation [ ]i : supposing the nearest site to i  that is occupied in this 
configuration is j  ( j i , 0j   if no site is occupied before i ), then we have:  
 ( [ ]) ( [ ]) ( ) ( )W i W j i j q i    (4) 
We use ( )Z i  to denote the total statistical weight of all configurations up to i , 
where the site i  is occupied, i.e., 
[ ]
( ) ( [ ])
i
Z i W i

 . Summing over all 
[ ]i  in the above equation and plugging in the expression of ( )Z j  lead to the 
following recurrence:   
 
( )
( ) ( ) ( ) ( ) 1
j i
Z i q i i j Z j

 
   
 
 (5) 
where ( )i  is the set of sites before i  that do not overlap with i . In order to 
compute Z , we note that the last bound site in any configuration could be 







  . 
Next we compute the numerator ( ) ( )k kY W N   . We define the variable 
[ ]
( ) ( [ ]) ( [ ])k kiY i W i N i   . For any specific configuration [ ]i , we have:  
213 
 
   ( [ ]) ( [ ]) ( [ ]) ( ) ( ) ( [ ]) ( )k k iW i N i W j q i i j N j I f k         (6) 
where ( )iI f k  is the indicator variable of whether if  is equal to k . Summing 




( ) ( ) ( ) ( ) ( ) ( ) ( )k k i i
j i
Y i q i i j Y j I f k Z j I f k

 
      
 
 (7) 
The last bound site could be 1 2 n    (if no site is bound, no contribution to 





 .  
Model fitting in ChIP-seq data. In the model, the free parameters are fR  for 
each factor f , and ', ff  for any two factors f  and 'f . The mismatch energy 
of any site is related to the commonly used PWM matching score (Berg and 
von Hippel, 1988; Stormo, 2000). Given the data mapping sequence to binding 
intensities, we use the simplex and BFGS algorithms (Press et al., 1992; Segal 
et al., 2008) to train the parameter values that maximize the Pearson 
correlation between the observed binding intensities and the predicted values.  
Our program takes as input ChIP-seq data of one experiment (i.e. of one TF) 
and a set of TF motifs (including TFexp), learns a TF-binding model that can 
be used to predict the binding affinities of any new sequences, and predict a 
set of interactions between other TFs and TFexp. Specifically, as the first step, 
we identify the genomic loci with the highest tag counts and extract the 
surrounding sequences, defined as 250 bp upstream/downstream of the peaks. 
We also randomly choose sequences which do not show significant binding.  
This collection of pairs of sequences and binding intensities will be used for 
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training data. In the next step, we perform a step-wise learning of the model: 
starting from TFexp, if adding a motif significantly improves the predictability 
of the model (reflected via the Pearson correlation between predicted and 
observed binding intensities), it will be added to a motif set. Once a motif is 
added, we will check the existing motifs in the set: if removing it does not 
significantly drop the model‟s predictability, it will be removed. This process 
is repeated until it converges to a stable set of motifs. At this stage, the 
program outputs the final set of motifs, ranked by their contributions to 
binding, and the model parameters.  
Models of cooperative interactions. We denote the cooperative interaction 
between two bound factors, ( )d , where d  is the distance between the two 
sites. It may also depend on the orientations of the two sites (in the same 
direction or not). Let 
maxd  be the maximum distance where two bound factors 
can interact. We consider several forms of the function ( )d . Under the 
Binary function, the interaction term is equal to a constant,  , if d  is less 
than 
maxd ; and 1.0 otherwise (no interaction, corresponding to free energy at 
0). The orientation bias (one orientation will be favored over the other) is 
modeled by multiplying a constant to   if two sites are at different strands. 
The Linear function is defined by:  
 
0
0 maxmax max 0
max
( ) 1 ( ) ( 1) ( )
1
d d













        

(8) 
The orientation bias is modeled similarly. To derive the Periodic function, we 
assume that the free energy of interaction consists of a constant plus a term 
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corresponding to the energetic cost of DNA looping. Following (Saiz et al., 
2005), the effective interaction between A  and B  is given by: 




       (9) 
where T  is the period,   is the phase parameter and A BG  and G  are 
constants. The interaction weight is exp( )G RT   when d   is less than maxd  
and 1.0 otherwise. Also note that   can in fact take two values, depending on 
whether the two sites are in the same orientation.  
Learning the Interaction Model between Two TFs. In studying the effect of 
binding site arrangement on TF interaction, we adopt a different model fitting 
procedure. Suppose we want to study the interaction of the factors A and B. 
We estimate a single set of parameters: RA, RB and the relevant interaction 
parameters (depends on how we model their interaction) from the binding data 
of both factors. The objective function is the average correlation coefficients 
between predictions and observations in the two sets of sequences. Also we 
vary the interaction parameters to observe their effects on the predictability of 
the model, as shown in the text, instead of estimating single optimal values. 
We note that such procedure is not applicable to fitting a „„global‟‟ model of a 
large number of TFs (e.g. all 12 TFs in the mouse ESC dataset). In that case, 
the number of possible interactions is probably too large (66 in the ESC case) 
to be reliably estimated. Our software, however, does support estimating the 
global model when the number of factors is small (less than four, for instance). 
Testing TF co-localization. We took the ChIP-seq data from (Chen et al., 
2008b) and followed their procedure to identify peaks that are bound by a TF. 
Our goal is to test if a factor, A, co-localizes with another factor, B. This 
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translates to the hypothesis that A sites which are adjacent to some B sites 
(250 bp in our experiments) are enriched among all sites of A. We estimated 
the expectation of this number as well as the expected number of A sites that 
are not adjacent to some B sites, assuming the distribution of B sites follows a 
Poisson distribution whose rate is the genome-wide density of B peaks. These 
expected numbers are compared with the observed numbers of peaks via 
Pearson‟s χ2 test. 
Expression of Nanog protein. Recombinant proteins of the Nanog (GST 
tagged) were used for the gel shift assays. The full length Nanog protein was 
cloned into the pET42b (Novagen) vector. The proteins were expressed and 
purified with GSH-sepharose beads (Amersham). Eluents were dialyzed 
against a dialysis buffer (10 mM Tris–HCl, pH 7.4, 100 mM NaCl, 10 mM 
ZnCl2 and 10% glycerol) at 4°C for 6 h. Proteins were stored at -
80°C.Concentrations of proteins were verified with the Biorad protein 
measurement assay. 
Electrophoretic Mobility Shift Assay (EMSA). DNA oligonucleotides 
(Proligo) labeled with biotin at the 5‟ end of the sense strands were annealed 
with the antisense strands in the annealing buffer (10 mM Tris-HCl , pH 8.0, 
50 mM NaCl, 1 mM EDTA) and purified with agarose gel DNA extraction kit 
(Qiagen). DNA concentrations were determined by the NanoDrop ND-1000 
spectrophotometer. The gel shift assays were performed using a LightShift 
Chemiluminescent EMSA kit (Pierce Biotechnologies). 100 ng of protein were 
added to a 5ul reaction mixture (final) containing 1 ug of poly(dI-dC) 
(Amersham), 1 ng of biotinlabeled oligonucleotide in the binding buffer (12 
mM HEPES, pH 7.9, 12% glycerol, 60mM KCl, 0.25 mM EDTA, 1 mM 
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DTT). Binding reaction mixtures were incubated for 20 min at room 
temperature. Binding reaction mixtures were resolved on pre-run 6%native 
polyacrylamide gels in 0.5X Tris-buffered EDTA. Gels were transferred to 
Biodyne B nylon membranes (Pierce Biotechnologies) using Western blot 
techniques and detected using chemiluminescence. 
 
RESULTS 
ChIP-seq data can be quantitatively reproduced. 
We hypothesized that ChIP-seq data quantitatively reflect the binding strength 
between the TF and the respective genomic binding regions. The rationale is 
that the binding strength is proportional to the proportion of cells that have this 
genomic locus bound by this TF (Buchler et al., 2003), and therefore 
proportional to the counts of overlapping ChIP-seq tags. To verify this 
hypothesis, we randomly picked 28 Nanog ChIP-seq detected binding regions 
from (Chen et al., 2008a) and repeated the ChIP experiments in E14 mouse ES 
cells. We used real-time qPCR to quantify the ChIP precipitated DNA on the 
28 pre-selected regions. The ChIP-seq and ChIP-qPCR signals exhibited a 
strong correlation (r2= 0.656).  We performed the same experiment on 11 
SUZ12 binding regions from ChIP-seq data and similarly found a strong 
correlation (r2= 0.792). These data suggest that the counts of overlapping 
ChIP-seq tags are quantitatively reproducible by independent experiments. 
Thus it becomes possible to model and utilize the quantitative nature of ChIP-




Transcription factors are extensively co-localized  
We studied ChIP-seq data on 12 TFs active in embryonic stems cells (Chen et 
al., 2008a): cMyc, CTCF, E2f1, Esrrb, Klf4, Nanog, nMyc, Oct4, Sox2, 
STAT3, Tcfcp2l1 and Zfx. Combinatorial gene regulation leads to a statistical 
tendency of multiple factors to bind to proximally located sites, a phenomenon 
we call TF “co-localization”. We developed a statistical test for co-localization 
of TF pairs and found extensive evidence for this phenomenon. The majority 
(121) of all 132 possible pairs show significant co-localization (P-value < 
0.01, Pearson‟s χ2 test). Our results are broadly consistent with the results of 
Chen et al. (Chen et al., 2008a), which also revealed extensive co-localization 
of TFs (though no statistical tests were provided). In summary, both analyses 
strongly indicate a combinatorial mode of action by multiple factors. 
 
A biophysical model of TF binding to DNA sequences 
A possible explanation for TF co-localization is that DNAbinding of one 
factor helps recruit another factor to its binding site, through favorable TF-TF 
interaction. (Note that the binding sites in this paper refer to 10–20 bp regions 
actually occupied by TFs, while other papers may refer to putatively larger 
regions identified in ChIP-chip or ChIP-seq experiments – these will be called 
TF bound regions in our paper). Thus, when co-localized, both factors may 
access the DNA with higher affinity than their individual binding sites alone 
would allow. We adapted the biophysical model from (Buchler et al., 2003) 
that incorporates such cooperative binding, for the purpose of analyzing TF-
DNA binding data. Given a transcription factor (called „„TFexp‟‟), our goal is 
219 
 
to predict the binding affinity of TFexp to any sequence. The basic assumption 
is that many putative binding sites, including the sites of TFexp and of other 
factors, not just the single best match, may contribute to interaction of this 
sequence to TFexp. Indeed, the importance of weak binding sites and 
cooperative interactions has been supported by a number of recent studies 
(Gertz et al., 2009; Roider et al., 2007; Segal et al., 2008; Tanay, 2006). Under 
this picture: binding sites of TFexp directly attract TFexp, and sites of other 
factors may interact cooperatively with TFexp, thus indirectly recruiting 
TFexp. The cooperative interactions may occur among adjacent binding sites 
of the same TF (self-cooperativity) or of different TFs (heterotypic 
cooperativity). Thermodynamically, each binding site of a sequence may be 
occupied or not, thus a sequence with n sites exists in 2n states, where each 
state represents the occupancy status of all sites (Figure 1). The probability of 
a state depends on interactions of TFs with their binding sites, as well as TF-
TF interactions, as quantified by Equation (2) in Methods. Following earlier 
work on ChIP-chip data analysis (Foat et al., 2006; Roider et al., 2007), we 
assume that the binding affinity of TFexp to this sequence is proportional to 
the average number of TFexp molecules occupying their sites, over all states 
weighted by their probabilities (Figure 1). Note that the number of states is 
exponential to the number of binding sites, thus it is computationally difficult 
to calculate the binding affinities of complex sequences by the brute-force 
method. We developed a dynamic programming algorithm to carry out the 
computation efficiently. The details of the model and the algorithm can be 
found in Methods. 
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When analyzing the genome-wide binding data of some TF (hereafter called 
the primary factor), the goal is to learn the TFs (called cooperative factors) 
that interact with this factor, as well as the relevant model parameters. The 
STAP model is fit by maximizing the Pearson‟s correlation coefficient 
between the predicted binding affinities and the overlapping ChIP-seq counts 
(or ChIP-chip intensities). To search for interacting factors, we iterate the 
motifs in a motif collection, such as the JASPAR database (Bryne et al., 2008) 
. Each motif in this collection is tested by whether adding this motif to the 
STAP model with only the primary factor will significantly improve the 
Pearson‟s correlation coefficient. The significance of this improvement is 
assessed by using a large number of randomized motifs as negative controls. 
After all cooperative factors are learned, and STAP re-trains the model 
parameters. The STAP model is designed for analyzing ChIP data from a 
single TF; a variation of STAP is developed for simultaneously analyze ChIP 
data from several TFs (see “Exploring the effects of binding sites 
arrangement”). 
 
Figure 1. Models of cooperative DNA binding. The sequence contains three 
binding sites, two for factor A, and one for factor B. All possible eight 
configurations of the sequences, in terms of binding site occupancy, are 
shown. The arrow connecting two adjacent bound molecules indicates 
cooperative interaction. For each configuration, the first column represents the 
weight, i.e., un-normalized probability, and the second column represents the 
number of bound molecules of A. The parameters in the weight terms are: qA 
(qB) – strength of factor A (B) binding to DNA; wAB – strength of the 
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interaction between A and B. The binding affinity of the sequence to A is the 
average of the second column, weighted by the first column.  
 
ChIP-seq data reveals a novel characterization of Nanog binding 
specificity 
Our method needs to use motifs of TFs, representing binding specificities, to 
identify  putative binding sites in target sequences (though it is theoretically 
possible to learn  novel motifs under our framework, similar to (Foat et al., 
2006)). So at the first step, we identified the motifs of the 12 TFs. For each 
factor, we ran the MEME program (Bailey and Elkan, 1994) on the top 100 
regions (ranked by tag counts) detected in the ChIP-seq experiments. These 
motifs are by and large similar to those reported in the original ChIP-seq paper 
(Chen et al., 2008b). However, we noted that the motifs of Oct4, Sox2 and 
Nanog, learned by (Chen et al., 2008b) were remarkably similar to each other. 
We hypothesized that this similarity was due to co-localization of the factors, 
which resulted in similar collections of genomic regions being used for 
enrichment-based motif finding. To test this hypotheses, we used sequences 
bound exclusively by each of these three factors and performed MEME 
analysis again (NestedMICA (Down and Hubbard, 2005) and Gibbs sampler 
(Thompson et al., 2007) gave similar results). The resulting Oct4 and Sox2 
motifs are similar to the corresponding parts of the previously identified Oct4-
Sox2 joint motif, while the Nanog motif is different (Figure 2A, Nanog1). We 
also note that several other DNA binding profiles of Nanog were reported 
from previous studies [(Chen et al., 2008b; Loh et al., 2006; Mitsui et al., 
2003), but they do not resemble each other. Inspired by the importance of 
Nanog as an essential regulator in ES cell proliferation and self-renewal 
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(Mitsui et al., 2003), we set out to characterize the binding specificity of 
Nanog using a combination of computational and experimental approaches.  
Even though STAP was not designed for de novo motif finding, it is applicable 
to compare multiple motifs of the same factor. By setting these motifs as 
alternative inputs and comparing the model fit to genome-wide binding data, 
the best motif can be recognized. We applied this strategy to the new Nanog 
motif as well as two previously published ones (Nanog2 (Mitsui et al., 2003) 
and Nanog3 (Loh et al., 2006), Figure 2A) to test if the new motif better 
explains the ChIP-seq data. The new Nanog motif resulted in a higher 
correlation than the other two in the sequences bound only by Nanog, but not 
Oct4 and Sox2 (Figure 2B, Nanog-only), providing initial support to the novel 
Nanog motif. In a second test, we utilized STAP‟s capability of analyzing 
cases where multiple factors are bound. As discussed before, the enrichment 
of Oct4 and Sox2 binding sites in the Nanog-bound sequences tend to confuse 
the motif discovery tools. This obstacle was resolved by setting Oct4 and Sox2 
as cooperative factors, and varying the candidate primary motif. In this way, 
the difference of results was attributed to the different Nanog motifs, with the 
effects of Oct4 and Sox2 sites automatically disentangled. Again, the new 
Nanog motif provided a significantly better fit to the ChIP-seq counts of the 
Nanog bound sequences than the other motifs (Figure 2B, Nanog-500). In 
addition, the fitting of observations with the new Nanog motif is highly 




Figure 2. Comparison of three versions of the Nanog motif.  (A) Nanog1 – 
the motif learned from the sequences bound by Nanog, but not Oct4 and Sox2, 
in the ChIP-seq data; Nanog2 – the motif in (Mitsui et al., 2003); Nanog3 – 
the motif in (Loh et al., 2006). (B) Performance of models using three 
different versions of the motif, measured by the correlation between model 
predictions and observations. The models are applied to two different sets of 
data. Nanog only: the sequences bound by Nanog, but not Oct4 and Sox2; 
Nanog-500: the 500 sequences with strongest binding to Nanog. 
 
 
Experimental tests of the novel Nanog motif 
We used electrophoretic mobility shift assay (EMSA) to test the binding of 
Nanog to the DNA sequences that match the novel Nanog motif. First, from 
the the Nanog ChIP-seq positive regions, we randomly selected five sequences 
that match to the new Nanog motif but do not match the Oct4-Sox2 joint motif 
(Table S-EMSA). EMSA produced the same band from these five sequences, 
which also match the band produced from a positive control region that is 
224 
 
known to interact with Nanog. In contrast, a randomly selected negative 
control sequence produced a completely different band (Figure 3).  
                            
 
Figure 3. EMSA experiments of five genomic regions with high 
similarities to the new Nanog motif. Probes 1 to 5 correspond to the genomic 
regions 1 to 5 in the Table. Probes P and N are positive and negative control 
probes, respectively. Negative control region: chr12:122668133–122668172 
(mm8). Positive control region: chr18: 46513245–46513285 (mm8). 
 
Second, we performed a series of point mutations to a wild type sequence that 
matches the new Nanog motif. EMSA was again used to test the binding 
affinities of the mutated sequences. Since the “TGA” from position 2 to 
position 5 is the most conserved part of the new motif, we focused the point 
mutations to these three positions. First, mutating the “TGA” core of the motif 
completely abolished the binding. Second, except the “G to A” mutation on 
position 3, all the rest six point mutations to the “TGA” core severely reduced 
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the binding or completely abolished the binding. All these results were 
reproduced by at least two independent EMSA experiments. We also tested 
the potential difference between the DNA binding domain (DBD) of Nanog 
and the whole Nanog protein. Nanog DBD and Nanog generated the same 
binding specificities in all of EMSA experiments. In summary, both the 
EMSA data on the five wildtype sequences and the point mutation data are 
consistent with the notion that Nanog bind to the the novel Nanog DNA motif.  
                   
Figure 4. Mutation results do not depend on the wild-type binding sites. A 
subset of mutations was repeated on two independent wild-type sequences. 
EMSA results of these mutated sequences are shown. The two independent 
wild-type sequences in the mutagenesis analysis generated similar results. 
Cooperativity among TFs is frequently associated with DNA binding 
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We next assessed the importance of cooperative interactions among TFs for 
DNA binding. For each ChIP-seq experiment, we compared the effectiveness 
of a “non-cooperative model” (that disables cooperative interactions) and a 
“cooperative model” that allows these interactions. To account for different 
complexities of the compared models, we used 10-fold cross validation on 500 
sequences from each experiment, and measured performance as the average 
correlation coefficient between predictions and observations. For most factors, 
incorporating cooperative TF interactions substantially improved the 
predictive ability of the model (Table 1).  In a different test, we trained the 
model on the strongest bound 500 sequences and used the next strongest 500 
sequences as independent test data. Again, we found that the cooperative 
model explains the test data significantly better than the non-cooperative 
model. These results suggest that cooperative interactions are an important 
part of the process of TF-DNA binding.  
Table 1. Cooperative interactions among factors are important in 
explaining TF-DNA binding data. In non-cooperative (non-coop.) model, 
only the motif of TFexp is used for fitting the data and no cooperativity is 
allows. In cooperative (coop.) model, both the motif of TFexp and the motifs 
of significant cooperative factors are used, and the cooperative interactions 
among factors, including the homotypic interaction, are allowed. The 
performance of a model is measured by the Pearson correlation between 
model predictions and observations in an independent testing data (not used 
for training the models). Significance of a cooperative factor is determined 
through comparison with a large number of randomized motifs. Only the 





Many of the specific predictions of cooperative interaction listed in Table 1 
are either known or consistent with evidence from the literature. Oct4 is a 
cooperative factor of Sox2, and both Oct4 and Sox2 are found to stimulate 
DNA-binding by Nanog. These results are consistent with the observation that 
Oct4, Sox2 and Nanog work together to control gene regulation in ES cells 
(Boyer et al., 2005). Similarly, the specific interaction between Esrrb and 
Nanog has been reported earlier in a study of protein-protein interactions 
among TFs in ES cells (Wang et al., 2006). We also found that Klf4 is 
cooperative with a number of other factors, including Oct4, Sox2, Nanog and 
STAT3. Interestingly, Klf4 has been recently found to be a key factor for 
maintaining self-renewal of ES cells (Jiang et al., 2008),  through mechanisms 
that are not yet clear. Our results suggest that the cooperative interaction 
between Klf4 and other key TFs may underlie the function of Klf4.  
We repeated the above analysis using motifs from the JASPAR database 
(Bryne et al., 2008), in addition to the motifs in this dataset. In the most 
interesting result from this analysis, we found the GABPA factor to cooperate 
with Oct4. (The correlation coefficients for the non-cooperative and 
cooperative models were 0.45 and 0.54 respectively.) GABPA expression is 
known to be induced in undifferentiated ES cells and its expression decreases 
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during differentiation (Hailesellasse Sene et al., 2007). Moreover, GABPA has 
been shown to regulate the expression of Oct4 in mouse ES cells (Kinoshita et 
al., 2007). Thus, it would be interesting to test experimentally how GABPA is 
related to the function of Oct4. This is an example where our method can be 
utilized to automatically discover biologically plausible hypothesis from 
existing resources of DNA binding and motif data.  
STAP Improves Prediction of TF Targets over Existing Methods. 
An intended application of STAP is to use the learned binding model to 
predict affinities of unseen sequences to a set of TFs. An initial support to this 
application came from the results above showing incorporating cooperative 
interactions were more predictive than simple models without interactions 
(Table 1). We then compared STAP with the existing methods that are also 
capable of predicting TF target sequences. Two popular programs were chosen 
for this purpose, Cluster-Buster (Frith et al., 2003) and Stubb (Sinha, 2006). 
Both programs take a set of TF motifs as input, and predict if some binding 
site clusters appear in a test sequence. To use these programs to predict the 
targets of some TF, it was necessary to obtain the relevant motifs (in addition 
to the motif of this TF). Neither program provides such capabilities, and 
therefore we used another program Clover for this purpose (Frith et al., 2004). 
In summary, the executed procedure of applying these two programs was: first 
learn all overrepresented motifs using Clover from TF-bound sequences in the 
training data, and then classify all sequences in the test data using Cluster-
Buster or Stubb (the same training and testing data as used in the previous 
section). We evaluated the classification performance with the standard ROC 
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curves, which quantifies the tradeoff of specificity and sensitivity as the 
classification threshold varies. 
Clover identified a number of overrepresented motifs from the collection of 12 
motifs of the 12 assayed TFs. These results were similar to STAP‟s 
predictions in some aspects: both predicted few interacting factors for CTCF, 
E2f1 and Esrrb, and some pairs were predicted by both including Nanog-Sox2 
and Tcfcp2l1-Esrrb. But Clover and STAP generated quite different results on 
other factors.We noticed that Clover results were largely parallel to the co-
localization results in (Chen et al., 2008b), with Oct4, Sox2, Nanog and Esrrb 
forming a cluster of mutually interacting factors. Clover effectively identified 
motifs whose presence in the training sequences could not be explained by 
chance alone, regardless of whether these motifs actually facilitate binding of 
the primary factor. We comment on these different ways of defining 
„„interacting‟‟ factors in Discussion. For now, this motif set was simply 
applied to predict TF targets by Cluster-Buster and Stubb. In almost all cases, 
STAP better classified the sequences in the testing data than the other two 
programs (see Figure 5 for the Oct4 result). 
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Figure 5. ROC curves comparing the performance of three methods for 
classification of Oct4 target sequences in the ChIP-seq data of Oct4. For 
evaluation of Cluster-Buster and Stubb, the Clover program is run first on the 
training data to extract a set of overrepresented motifs, which will be used as 
inputs of Cluster-Buster and Stubb. 
 
Exploring the effect of binding site arrangement 
How binding sites are arranged in a regulatory sequence is an important, but 
poorly understood aspect of combinatorial gene regulation. Our biophysical 
model includes a component that describes how the strength of interaction 
between bound TF molecules depends on the arrangement (distance and 
relative orientation) of their respective binding sites. By varying the details of 
this component, we tested if the data supports a particular mode of TF 
interaction over others. Specifically, we compared three different models of 
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cooperative interaction between two bound TF molecules. In each, we assume 
that there is a maximum distance dmax between the two bound factors, 
beyond which there is no interaction. Under the “Binary” model, which is also 
our default model used in previous studies, the strength of interaction is 
constant within the range of 0 to dmax. Under the “Linear” model, the 
interaction is stronger when the two cooperative sites are closer. For both 
Binary and Linear models, there may also be an orientation bias: the 
interaction when two factors bind in the same direction may be different from 
that when they bind in the opposite direction. The extent to which one 
orientation is favored over the other is encoded by a bias parameter. Finally, 
under the “Periodic” model, the strength of interaction is a periodic function of 
the distance. This periodicity has been reported in a few cases before and often 
corresponds to the helical period of DNA molecules (Makeev et al., 2003; Saiz 
et al., 2005). In all cases, a particular model is evaluated by the Pearson 
correlation between predictions and observations in an independent testing 
dataset, which is distinct from the one used for training the model parameters.  
We focused on two TF pairs: Oct4-Sox2 and Nanog-Esrrb. Both interactions 
have been suggested before by earlier work (Chen et al., 2008a; Wang et al., 
2006). First, for the Binary model of cooperative interaction, we vary the the 
dmax parameter and for each value of dmax, we optimize the orientation bias 
parameter and compare this optimized model with the one without bias. We 
found small orientation bias in most cases, in the range of 0.4-1.0 kBT, in 
terms of the free energy that penalizes one orientation over the other. For 
comparison, the energy of TF interaction falls in the range of 2.0-4.0 kBT. As 
further evidence of the lack of orientation bias, the performance of the models 
232 
 
which optimized the bias parameter is very close to the one without bias 
(Figure 6A, B). The differences in terms of correlation are less than 1% in 
most cases. In contrast, the parameter dmax plays a much larger role (Figure 
6A, B). We found that most TF interactions occur in the range of 200 bp, but 
for Oct4-Sox2 pair, the majority of interaction seems to happen within 60 bp 
(Figure 6A). Next, we found that the Linear models did not improve the 
predictability (the differences between Linear model and Binary model are 
less than 0.5% for both pairs), suggesting that interaction between the two 
factors does not decrease significantly with distance, i.e. the interaction is 
tolerable to distance change. Finally, for the Periodic model, we vary the 
periodicity from 10.0 to 12.0 bp, and for each of these values, we also vary the 
amplitude parameter, which is a measure of the strength of periodicity, i.e. 
how greatly the interaction changes within a period (see Methods). 
 
Figure 6. The effect of binding site arrangement on TF interactions.  (A,C) 
Under the Binary model of interaction, the relationship between model 
performances, measured by correlation between predictions and observations, 
and the distance parameter (maximum distance, measured in bp, where two 
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factors can interact along DNA sequence). For each value of the distance 
parameter, two models are compared: one in which the orientation bias 
parameter is optimized, and the other not allowing the bias. (B,D) Under the 
Periodic model of interaction, the relationship between model performances 
and the amplitude parameter (the change of the interaction strength within a 
period). Only two values of periodicity are shown. 
 
Similar to the results from the Linear model, we found that the correlations 
under this more complex model is no better than the simpler Binary model. In 
fact, the performance of the Periodic model always decreases when the 
amplitude parameter is increased under all values of periodicity we tested, 
suggesting that the interactions are not periodic for both pairs (Figure 6C, D, 
only two values of periodicity are shown). All these results: lack of orientation 
bias, tolerance to distance and lack of periodicity, together indicate that 
binding site interactions do not follow strict rules; rather, a flexible 





In this work, we adapted the theoretical models pioneered by Shea-Ackers 
(Shea and Ackers, 1985)and formulated by Buchler et al. (Buchler et al., 
2003)to the analysis of large-scale TF binding data. Different from these 
previous works, we explicitly expressed the expected number of TFs bound by 
a given regulatory sequence, and thus derived a variation of the Shea-Ackers 
model suitable for analysis of genome-wide binding data. We developed a 
dynamic programming algorithm that efficiently computes the binding affinity 
of any sequence. We provided software, STAP, to automatically learn the best 
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models from the binding data. Through extensive evaluations, we 
demonstrated that this is an effective computational framework to extract 
information from and extrapolate over TF-DNA binding data. 
STAP was applied to several important analysis tasks, including comparison 
of TF binding profiles, identification of TF interactions, studying the effect of 
binding site arrangement (regulatory grammar) and prediction of TF target 
sequences. These tasks are commonly encountered in analysis of genome-wide 
data, and we believe STAP offers key benefits over existing methods. First, 
STAP was applied to compare several putative Nanog motifs. Such 
functionality can be useful, for example, when one needs to compare outputs 
from multiple motif-finding programs or from different experiments. 
Furthermore, when multiple factors access the same target regions, STAP is 
able to disentangle the effects of confounding factors. This was demonstrated 
in the analysis of Nanog-bound sequences, which are often bound by Oct4 and 
Sox2 as well. Second, we took advantage of the new method to predict TF-TF 
interactions. Similar analyses were done previously by first predicting the 
binding sites of the pair of motifs, and then analyzing the co-occurrence 
pattern of two types of sites (Smith et al., 2005a; Zhou et al., 2007a). Co-
occurrence based analysis does not utilize the measured TFbinding intensities, 
sacrificing a significant amount of available information. Co-occurrence based 
analysis also requires the explicit annotation of binding sites, a task known for 
its inaccuracy. Weak binding sites were shown to contribute significantly to 
TF binding (Roider et al., 2007; Segal et al., 2008), making a binary 
demarcation of sites and nonsites more problematic. Thirdly, STAP was 
applied to test different regulatory rules for binding site arrangement. This task 
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has been gaining attention from the community (Arnosti and Kulkarni, 2005; 
Brown et al., 2007), but a computational tool for addressing this challenge has 
been missing so far. Finally, we demonstrated that STAP is able to make more 
accurate predictions of TF targets in new sequences than other state-of-the-art 
programs. This capability enables the study of the evolution of TF binding 
across species despite that the binding data are often available in only one 
species. We also found that limiting to sequences with conserved affinities 
would improve the identification of functional TF targets.  
The recent work by Segal et al. (Segal et al., 2008)also uses the 
thermodynamic model to predict the functional properties (expression 
patterns) of DNA sequences, and it is worthwhile to point out the similarity 
and the difference between the two papers. Both Segal et al. and this work rely 
on the same thermodynamic framework of Buchler et al. (Buchler et al., 
2003)to model TF-DNA interactions as well as cooperative DNA binding by 
multiple TFs. In the algorithmic side, both use dynamic In this work, we 
adapted the theoretical models pioneered by Shea-Ackers (Shea and Ackers, 
1985) and formulated by Buchler et al. (Buchler et al., 2003) to the analysis of 
large-scale TF binding data. Different from these previous works, we 
explicitly expressed the expected number of TFs bound by a given regulatory 
sequence, and thus derived a variation of the Shea-Ackers model suitable for 
analysis of genome-wide binding data. We developed a dynamic programming 
algorithm that efficiently computes the binding affinity of any sequence. We 
provided software, STAP, to automatically learn the best models from the 
binding data. Through extensive evaluations, we demonstrated that this is an 
effective computational framework to extract information from and 
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extrapolate over TF-DNA binding data. STAP was applied to several 
important analysis tasks, including comparison of TF binding profiles, 
identification of TF interactions, studying the effect of binding site 
arrangement (regulatory grammar) and prediction of TF target sequences. 
These tasks are commonly encountered in analysis of genome-wide data, and 
we believe STAP offers key benefits over existing methods. First, STAP was 
applied to compare several putative Nanog motifs. Such functionality can be 
useful, for example, when one needs to compare outputs from multiple motif-
finding programs or from different experiments. Furthermore, when multiple 
factors access the same target regions, STAP is able to disentangle the effects 
of confounding factors. This was demonstrated in the analysis of Nanog-
bound sequences, which are often bound by Oct4 and Sox2 as well. Second, 
we took advantage of the new method to predict TF-TF interactions. Similar 
analyses were done previously by first predicting the binding sites of the pair 
of motifs, and then analyzing the co-occurrence pattern of two types of sites 
(Smith et al., 2005a; Zhou et al., 2007a). Co-occurrence based analysis does 
not utilize the measured TFbinding intensities, sacrificing a significant amount 
of available information. Co-occurrence based analysis also requires the 
explicit annotation of binding sites, a task known for its inaccuracy. Weak 
binding sites were shown to contribute significantly to TF binding (Roider et 
al., 2007; Segal et al., 2008), making a binary demarcation of sites and 
nonsites more problematic. Thirdly, STAP was applied to test different 
regulatory rules for binding site arrangement. This task has been gaining 
attention from the community (Arnosti and Kulkarni, 2005; Brown et al., 
2007), but a computational tool for addressing this challenge has been missing 
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so far. Finally, we demonstrated that STAP is able to make more accurate 
predictions of TF targets in new sequences than other state-of-the-art 
programs. This capability enables the study of the evolution of TF binding 
across species despite that the binding data are often available in only one 
species. We also found that limiting to sequences with conserved affinities 
would improve the identification of functional TF targets. The recent work by 
Segal et al. (Segal et al., 2008) also uses the thermodynamic model to predict  
the functional properties (expression patterns) of DNA sequences, and it is 
worthwhile to point out the similarity and the difference between the two 
papers. Both Segal et al. and this work rely on the same thermodynamic 
framework of Buchler et al. (Buchler et al., 2003) to model TF-DNA 
interactions as well as cooperative DNA binding by multiple TFs. In the 
algorithmic side, both use dynamic programming to optimize the 
computational task, which is also a familiar technique in statistical mechanics 
(known as the transfer matrix method), and has been used before for similar 
calculations involving cis-regulatory sequences (Hermsen et al., 2006; Teif, 
2007). These similarities are not surprising as both attempts to capture the 
same underlying physics. There are two main differences. Segal et al. uses a 
logistic function as the expression „„readout‟‟ of any molecular configuration 
(s in our notation) and predicts the expression of the sequence as the average 
readout over all configurations. The downside of this approach is that the 
logistic function has no connection to thermodynamics, and the computation 
involves expensive sampling. In this work, the relevant quantity we compute 
has a clear physical interpretation: the average number of TF molecules bound 
to the sequence. This also enables the derivation of dynamic programming, 
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which is far more efficient than sampling. The other main difference lies in the 
intended applications of the models. STAP was applied to questions that were 
not addressed previously, such as the characterization of rules of cooperative 
interactions and evolution of TF-target relationship. 
Combinatorial gene regulation by definition involves the relationship among 
different transcription factors. However, how such relationships should be 
defined and inferred is not clear in practice. We believe it is important to 
distinguish among three types of relationship between a pair of transcription 
factors: (A) co-localization of two factors as revealed by ChIP experiments; 
(B) direct binding of two factors to the neighboring DNA sites (co-binding) 
and (C) cooperative interaction of two factors bound in the neighborhood. 
Note that these three classes correspond to progressively more specific 
relationships. Colocalization of two TFs in a ChIP experiment may be due to 
cobinding, or due to one of the TFs being bound to DNA and recruiting the 
other TF (without the latter directly binding to DNA). Similarly, when two 
factors bind to adjacent sites on DNA (co-binding), they may not actually 
interact with each other, i.e. no cooperative interactions. The different results 
we obtained from our co-localization analysis, from motif enrichment test 
using Clover and from our identification of cooperative factors may partly 
come from these distinctions. This picture of a hierarchy in the relationships of 
TFs (in the context of DNA binding) suggests that it is important to interpret 
the results in a way that is appropriate for the type of analysis performed. 
We assumed that cooperative interactions are due to proteinprotein 
interactions, but this may not always be true. For example, the factor B may 
stimulate DNA-binding of the factor A through chromatin modification that 
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makes DNA more accessible. This point has also been commented before 
(Hermsen et al., 2006). It is difficult to distinguish different mechanisms of 
cooperative interactions when only DNA binding data is available. This is 
important for interpreting the results, as the predictions may not be 
confirmable through protein-protein interaction assays. In addition, this 
suggests that the cooperative interactions, as defined by stimulated effects of 
DNA binding on another factor, may not be symmetric. In the example we 
cited above, the factor A itself may not modify chromatin structure, thus has 
no effect on DNA binding affinity of the factor B. 
We studied the effect of binding site orientation and relative distance on the 
cooperative TF interactions. Because the effect is likely to be subtle, we 
focused on the TF pairs with the strongest signals in the data. We did not 
found evidence supporting rigid rules, such as the periodicity of distance (in 
the range of period tested). This may suggest that the interactions may occur 
indirectly, rather than through physical protein-protein interactions, such as 
the well known case of lambda repressor (Hochschild and Ptashne, 1986). If a 
TF modifies the chromatin structure through chemical modifications of 
histones or remodeling of nucleosomes, the effect of this TF on other TFs will 
be less specific (as it could affect all binding sites in the neighborhood) and 
less likely to follow strict rules. We recognize there are several limitations in 
our methodology: only several forms of cooperative functions were tested 
while the actual function may be much more complex; and in the 
thermodynamic model, only immediately adjacent binding sites may interact 
with each other, an assumption taken for the ease of computation without 
much theoretical justification. These limitations coupled with the fact that only 
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five TF pairs were tested in a single dataset limit our ability to extrapolate any 
general regulatory rules. Still, the STAP method is relatively sensitive, as 
demonstrated by the large effect of dmax and the amplitude parameters we 
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